fluorodeoxyglucose f18 has been researched along with Liver Neoplasms in 1055 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (0.57) | 18.7374 |
| 1990's | 56 (5.31) | 18.2507 |
| 2000's | 305 (28.91) | 29.6817 |
| 2010's | 529 (50.14) | 24.3611 |
| 2020's | 159 (15.07) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, D; Chen, S; Gu, J; Hu, P; Liu, G; Mao, W; Qi, C; Shi, H; Sui, X; Tan, H; Yu, H; Zhang, Y | 1 |
| Borello, A; Ferrero, A; Guerra, M; Langella, S; Lo Tesoriere, R; Russolillo, N | 1 |
| Kan, X; Kong, X; Li, Q; Li, X; Liu, F; Ren, Y; Zhang, Y; Zheng, C | 1 |
| Gantumur, D; Kamioka, H; Li, Y; Mizoi, K; Ogihara, T; Tsushima, Y; Zhang, X; Zhu, M | 1 |
| Ince, V; Kutlu, R; Pasahan, R; Sahin, E; Sahin, TT; Yilmaz, S | 1 |
| Padma, S; Pavithran, P; Sarma, M; Somasundaram, VH; Sundaram, PS | 1 |
| Dueland, S; Grut, H; Labori, KJ; Line, PD; Schulz, A | 1 |
| Gambhir, S; Hassan, A; Ora, M; Saini, VK; Singh, AK | 1 |
| Deng, Y; He, J; Li, Y; Wang, S; Wang, T | 2 |
| Balcı, NC; Çelebi, F; Görmez, A; Ilgun, AS; Tokat, Y | 1 |
| Doroudinia, A; Ghadimi, N; Karam, MB; Yousefi, F | 1 |
| An, J; Jung, JH; Kim, HI; Kim, JS; Kim, SY; Kim, W; Oh, B; Oh, JH; Oh, M; Oh, YJ; Shim, JH; Sung, CO | 1 |
| Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Matsumura, M; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y | 1 |
| Jiao, J; Yang, T; Zhang, Y; Zou, MH; Zou, Q | 1 |
| Boudousq, V; Desmarets, G; Fidani, T; Goupil, J; Pouget, JP | 1 |
| Lu, X; Wang, W; Yang, J; Zhou, Z | 1 |
| Hong, HS; Hwang, SH; Kim, D; Kim, DY; Kim, GM; Lee, HW; Lee, M; Park, MA; Yun, M | 1 |
| Fu, R; Jin, G; Luo, S; Wang, Y; Yu, Z; Zhang, J | 1 |
| Alataş, Ö; Çapa Kaya, G; Derebek, E; Gülcü, A; Karahan Şen, NP; Özdoğan, Ö | 1 |
| Li, F; Wang, P | 1 |
| Akutsu, N; Hirano, T; Ishigami, K; Kawakami, Y; Nakase, H; Numata, Y; Sasaki, S; Wagatsuma, K | 1 |
| Kesim, S; Ozguven, S | 1 |
| Duvivier, A; Goyers, JF; Namur, G; Radermacher, J | 1 |
| Harada, M; Otomi, Y; Otsuka, H; Shinya, T; Shono, N | 1 |
| Han, S; Hong, YS; Kim, HJ; Kim, JC; Kim, JS; Kim, S; Kim, SK; Kim, TS; Kim, TW; Kwak, JM; Kwak, JY; Kwon, HW; Lee, HS; Lee, JS; Lim, SB; Oh, HS; Oh, JH; Oh, M; Park, S; Yu, CS | 1 |
| Aloglu, M; Atikcan, Ş; Çimen, F; Düzgün, S; Özmen, Ö; Şentürk, A | 1 |
| Haq, A; Jahromi, AH; Parihar, AS; Wahl, RL | 1 |
| Comito, T; Di Cristina, L; Di Gallo, A; Dominici, L; Franceschini, D; Franzese, C; Lo Faro, L; Marini, B; Marzo, MA; Scorsetti, M; Spoto, R; Stefanini, S; Vernier, V | 1 |
| Fu, L; Xie, F; Zhou, W | 1 |
| Adam, R; Allard, MA; Azoulay, D; Besson, FL; Cherqui, D; Ciacio, O; Ghidaglia, J; Golse, N; Gomez, L; Lewin, M; Pittau, G; Sa Cunha, A; Salloum, C; Sönmez, RE; Vibert, E | 1 |
| Buck, AK; Hartrampf, PE; Higuchi, T; Kosmala, A; Lindner, T; Michalski, K; Schirbel, A; Schlötelburg, W; Serfling, SE; Weich, A; Werner, RA | 1 |
| Choyke, PL; Chung, JY; Escorcia, FE; Hernandez, J; Jakhete, N; Jones, J; Kassin, M; Lindenberg, L; Maass-Moreno, R; Mena, E; Molitoris, JK; Monge, C; Rabiee, A; Saboury, B; Salerno, KE; Shih, J; Turkbey, B; Unger, KR; Wood, B | 1 |
| Dong, DH; Ji, G; Li, XH; Wei, JP; Yan, CY; Yang, XS | 1 |
| Azamat, S; Bulut, MT; Keskin, M; Kulle, CB; Omarov, N; Ozkan, ZG; Uymaz, DS | 1 |
| Dong, A; Wang, Y; Zhang, J | 1 |
| Chen, X; Deng, H; Huang, Y; Ou, L; Song, Y; Wang, Y; Zhou, Y | 1 |
| Cui, Z; Han, Y; Liu, J; Tian, X | 1 |
| Hotchi, S; Iwanaga, N; Machida, M; Ogura, K; Okubo, H; Sugo, H; Tanaka, H; Watanobe, I | 1 |
| Cao, S; Chen, S; Hu, Y; Liu, G; Shi, H; Yang, X; Zhou, Y | 1 |
| Dong, C; Hu, G; Huo, L; Li, F; Shi, X; Xing, H; Zhu, W | 1 |
| Akkus Gunduz, P; Araz, M; Erden, GA; Kir, KM; Kucuk, NO; Kuru Oz, D; Ozkan, E; Soydal, C; Yavuz, Y | 1 |
| Diaz Nieto, R; Fenwick, SW; Gordon-Weeks, A; Jones, R; Kok, NF; Kuhlmann, KF; Malik, HZ; Poston, GJ; Tufo, A | 1 |
| Liu, W; Ou, X; Yao, X | 1 |
| Shao, F; Xie, P | 1 |
| Fukui, A; Hatano, E; Takai, A; Uchida, Y; Yoh, T | 1 |
| Besson, FL; Durand, E; Golse, N; Pascale, A; Sebagh, M; Sivapathasundaram, A | 1 |
| Ayaz, S; Ayaz, UY | 1 |
| Dasgupta, S; Kashyap, Y; Kote, R; Kumar, A; Mishra, A; Ravina, M; Reddy, M | 1 |
| Huang, Z; Liu, Y; Tang, W | 1 |
| Biechele, G; Buchner, J; Froelich, MF; Grawe, F; Ingenerf, M; Kaiser, CG; Kunz, WG; Rübenthaler, J; Schmid-Tannwald, C; Schnitzer, ML; von Münchhausen, N | 1 |
| Halanaik, D; Meenakshi, LA; Pottakkat, B; Rajaraman, V; Selvaraj, AJ | 1 |
| Mori, Y; Novruzov, E; Novruzov, F | 1 |
| Boo, SH; Moon, SW; Park, HL; Park, SY; Yoo, IR | 1 |
| Agrawal, A; Purandare, N; Puranik, A; Rangarajan, V; Shah, S; Suthar, RR | 1 |
| Huang, W; Kang, L; Qiu, Y; Yang, Q; Zhou, Y | 1 |
| Lv, J; Shi, H; Yin, H; Yu, H | 1 |
| Chen, R; Hu, Y; Huang, G; Liu, J; Sun, H; Zhou, X | 1 |
| Inan, N; Sokmen, BK | 1 |
| Algarra, MA; Caminal, JM; Cortes-Romera, M; Del Carpio, LP; Gutierrez, C; Leiva, D; Lladò, L; Lorenzo, D; Piulats, JM; Ramos, E; Rodriguez-Vida, A; Rossi-Seoane, S; Ruiz, S; Sabaté-Llobera, A | 1 |
| Liu, J; Lu, S; Luan, X; Ma, G; Wang, G; Wang, R; Wang, Z; Xu, B; Xu, X; Zhang, J; Zhang, W | 1 |
| Khan, D; Kumar, R; Sagar, S; Sarswat, S | 1 |
| Guo, P; Hu, Y; Li, X; Liu, H; Qiao, Y; Sun, H | 1 |
| Lin, D; Liu, B; Liu, Q; Zhang, K | 1 |
| Lee, Z; Lu, ZR; Sexton, S; Xin, W | 1 |
| An, S; Huang, G; Kang, F; Liu, J; Wei, W | 1 |
| Huang, R; Liu, Y; Qi, M; Su, M | 1 |
| Basu, S; Chalikandy, A; Yadav, S | 1 |
| Zirakchian Zadeh, M | 1 |
| Chen, X; Guo, Z; Jakobsson, V; Lin, R; Miao, W; Wang, C; Wen, X; Wu, X; Yang, Y; Zang, J; Zhang, J; Zhao, T | 1 |
| Cai, L; Chen, X; Liu, H; Liu, M; Zhang, S | 1 |
| Chekuri, S; Doroudinia, A | 1 |
| Auernhammer, CJ; Bartenstein, P; Cyran, CC; Ebner, R; Fabritius, MP; Grawe, F; Hinterberger, A; Ingenerf, M; Knösel, T; Kunz, WG; Lohse, A; Mansournia, S; Ricke, J; Rübenthaler, J; Schmid-Tannwald, C; Schnitzer, ML; Sheikh, GT; Soltani, V; Spitzweg, C; Winkelmann, M | 1 |
| Chen, S; Lin, Z; Miao, W; Wang, C | 1 |
| Chen, Y; Li, Z; Su, D; Wang, Y; Zhou, S | 1 |
| Jiang, L; Liu, ET; Ren, JY; Wang, P; Zhang, Q | 1 |
| Jing, H; Shi, X; Wang, P; Zhang, Y | 1 |
| Li, T; Liu, Z; Zhang, J; Zhang, Z; Zhao, X | 1 |
| Li, W; Liu, Z; Zhang, R | 1 |
| Drescher, R; Freesmeyer, M; Gühne, F; Seifert, P | 1 |
| Chisthi, MM | 1 |
| Alavi, A; Ayubcha, C; Hunt, SJ; Seraj, SM; Zadeh, MZ | 1 |
| Drabkin, MJ; Kishore, SA; Sofocleous, CT | 1 |
| Chapiro, J; Pucar, D; Saperstein, L; Savic, LJ; Schobert, I | 1 |
| Bastiaannet, R; de Jong, HWAM; Lam, MGEH; Lodge, MA | 1 |
| Baltacioglu, F; Dulundu, E; Kesim, S; Ones, T; Ozguven, S | 1 |
| Guo, JQ; Jiang, C; Shao, CX; Zhu, JD; Zou, JJ | 1 |
| Araki, K; Handa, T; Harimoto, N; Higuchi, T; Igarashi, T; Ishii, N; Kubo, N; Oyama, T; Shirabe, K; Tsukagoshi, M; Watanabe, A; Yamanaka, T; Yokobori, T | 1 |
| Eura, R; Fujii, K; Higashi, Y; Hirohata, Y; Kanekura, T; Nakagawa, M; Okubo, A; Osako, Y; Tada, KI; Yoshino, H | 1 |
| Nakamoto, R; Oka, S; Okuyama, C | 1 |
| Machado-Aranda, D | 1 |
| Baum, RP; Kulkarni, HR; Zhang, J | 1 |
| Huo, L; Wang, J; Wang, X; Yang, X; Zhao, H | 1 |
| Chen, J; Deivasigamani, A; Gao, H; Hui, KM; Kong, SN; Shi, M; Xia, H; Xie, T | 1 |
| Geist, BK; Hacker, M; Huo, L; Li, F; Li, X; Lin, J; Wang, J; Wang, X; Yang, X; Zhang, H; Zhao, H | 1 |
| Aikata, H; Akagi, M; Awai, K; Chayama, K; Fujino, H; Hiramatsu, A; Imamura, M; Kawaoka, T; Kobayashi, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Nakamura, Y; Namba, M; Ohdan, H; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M | 1 |
| Aslan, N; Erhamamci, S | 1 |
| Dong, P; Hu, W; Tian, B; Wang, L | 1 |
| Chung, JI; Jeon, J; Jo, H; Kim, SY; Ko, HY; Lee, J; Lee, M; Yun, M | 1 |
| Duran, C; Elmohr, MM; Elsayes, KM; Ganeshan, D; Javadi, S; Lubner, MG; Morani, AC; Pickhardt, PJ | 1 |
| Braren, R; Heid, I; Hörl, M; Kaissis, GA; Lohöfer, FK; Munoz-Alvarez, KA; Paprottka, P; Rummeny, EJ; Schwaiger, M; Steiger, K; Weichert, W | 1 |
| Amano, T; Hiyama, T; Hoshiai, S; Kawasaki, H; Minami, M; Mori, K; Nasu, K; Saitoh, H | 1 |
| Cai, M; Hong, S; Li, G; Shen, Y; Wang, F | 1 |
| Al-Kandari, F; Ghanem, M; Marafi, F; Rasheed, R; Usmani, S | 1 |
| Balcı, C; Çelebi, F; Cindil, E; Dogusoy, GB; Tokat, Y; Yaghouti, K | 1 |
| Aubuchon, S; Dahman, B; Deng, Y; Heuman, D; Hubert, J; John, BV; Konjeti, VR; Love, E; Singal, AG; Solomon, C; Sundaram, LT; Tatum, JL; Thomas, S | 1 |
| Hirose, M; Ishibashi, H; Ohta, S | 1 |
| Gabata, T; Harada, K; Kimura, H; Kosaka, N; Ozaki, K; Terayama, N | 1 |
| Lerut, J; Li, QY; Luo, FZ; Wang, S; Xu, X; Yang, Z; Zheng, SS; Zhuang, L | 1 |
| Aggarwal, A; Goel, S; Gupta, M; Iqbal, A; Rao, A; Singh, S | 1 |
| Dede, DS; Gumuskaya, B; Yildirim, N | 1 |
| Yao, S; Zheng, J | 1 |
| Amaddeo, G; Calderaro, J; Chalaye, J; Galletto Pregliasco, A; Itti, E; Kharrat, R; Kobeiter, H; Laurent, A; Legou, F; Luciani, A; Mulé, S; Regnault, H; Tacher, V; Tenenhaus, A | 1 |
| Chen, H; Wu, H | 1 |
| Bagni, O; Cianni, R; Filippi, L; Schillaci, O | 1 |
| Beishuizen, A; Cho, S; Flerlage, JE; Hagleitner, MM; Kelly, KM; Kluge, R; Kurch, L; Mauz-Koerholz, C; Metzger, ML; Voss, SD | 1 |
| Alexiou, G; Argyropoulou, MI; Naka, C; Tsili, AC | 1 |
| Kaye, EA; Sofocleous, CT; Vasiniotis Kamarinos, N | 1 |
| Liu, Y; Xu, B | 2 |
| Dormagen, JB; Dueland, S; Grut, H; Labori, KJ; Schulz, A; Stern, NM | 1 |
| Sagir Kahraman, A | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Tang, M; Wang, Z; Zhou, J; Zhu, X; Zou, S | 1 |
| Ida, Y; Iguchi, M; Kitano, M; Maekita, T; Maeshima, S; Shimizu, R; Shingaki, N; Tamai, H; Terada, M | 1 |
| Carnahan, MB; Conley, CR; Larsen, JT; Yang, M | 1 |
| Bundschuh, L; Bundschuh, RA; Essler, M; Hartmann, L; Zsótér, N | 1 |
| El-Rassi, Z; Haddad, L; Jabbour, T; Raad, RA | 1 |
| Gerbaudo, VH; Khorasani, R; Levesque, VM; Shyn, PB; Yan, Z | 1 |
| Liao, Z; Lu, Y; Luo, D; Pan, T; Thomas, MA | 1 |
| Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Iritani, S; Kajiwara, A; Kawamura, Y; Kobayashi, M; Kobayashi, Y; Kumada, H; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y; Yamashige, D | 1 |
| Choi, SY; Ha, SY; Hwang, JA; Hyun, SH; Kim, HS; Kim, SH; Kim, SW; Min, JH | 1 |
| Guniganti, P; Kierans, AS | 1 |
| Abouzian, S; Camacho, V; Carrió, I; Duch, J; Estorch, M; Fernández, A; Flotats, A; Fuentes-Ocampo, F; López-Mora, DA; Sizova, M | 1 |
| Han, J; Li, F; Li, X; Li, Y; Qu, L | 1 |
| Hu, C; Jin, H; Zhang, M | 1 |
| Lv, J; Mao, W; Shi, H; Yin, H | 1 |
| Choi, JY; Kim, YI; Lee, HS | 1 |
| Erdil, TY; Filizoglu, N; Oksuzoglu, K; Ones, T; Ozguven, S | 1 |
| Castell-Conesa, J; García-Burillo, A; Iglesias-Felip, C; Monturiol-Duran, JA; Villasboas-Rosciolesi, D | 1 |
| Graham, RP; Kendi, AT; Venkatesh, SK; Young, JR | 1 |
| Casadaban, LC; Catalano, PJ; Gerbaudo, VH; Hyun, H; Lee, LK; Shyn, PB; Tuncali, K | 1 |
| Catalano, PJ; Chao, RT; Cubre, AJ; Gerbaudo, VH; Hyun, H; Kapur, T; Lee, LK; Levesque, VM; Seol, JG; Shyn, PB; Silverman, SG; Tuncali, K | 1 |
| Du, Z; Guan, Y; Huang, Q; Lu, L; Ren, S; Wang, H; Xie, F; Zhu, W | 1 |
| Bom, HS; Cho, SG; Jeon, S; Kang, SR; Kim, DY; Kim, GJ; Kim, J; Kwon, SY; Lee, C; Min, JJ; Pyo, A; Song, HC; Yoo, SW | 1 |
| Abouzied, MM; Al Qahtani, M; Al Sugair, AS; Alhinti, N; AlMuhaideb, A | 1 |
| Cai, L; Chen, Y; Deng, M | 1 |
| Freesmeyer, M; Malessa, C; Rauchfuss, F; Rudakoff, W; Settmacher, U; Winkens, T | 1 |
| Luo, ZY; Shen, XZ; Wang, W | 1 |
| Guo, W; Hu, H; Huang, K; Jiang, H; Lin, X; Wang, S; Zhang, R | 1 |
| Jiang, H; Jiang, HJ; Wang, ZC; Zhang, MY; Zhang, RJ | 1 |
| Amorim, BJ; Bernstine, H; Blaszkowsky, LS; Canamaque, LG; Caravan, P; Catalano, OA; Catana, C; Domachevsky, L; Ferrone, CR; Groshar, D; Ken, H; Mahmood, U; O'Shea, A; Parente, CA; Salvatore, M; Soricelli, A; Umutlu, L; Zhang, C | 1 |
| Miao, W; Nie, P; Rao, W; Wang, Y; Wang, Z; Wu, F; Yan, L; Yang, G; Yu, M; Yu, T; Zhao, Y | 1 |
| Buck, A; Fassnacht, M; Fröhling, S; Fuss, CT; Germer, CT; Hübschmann, D; Kickuth, R; Kircher, S; Kroiss, M; Lenschow, C; Reibetanz, J; Schlegel, N; Stenzinger, A; Wiegering, A | 1 |
| Gao, J; Gong, R; Gong, Y; Li, Z; Ma, Y; Yang, J; Zhu, J | 1 |
| Chen, FH; Chung, YH; Hong, JH; Lin, G; Tsai, CK; Wang, WL; Yang, CL; Yen, TC; Yu, CF | 1 |
| Ding, H; Geist, BK; Hacker, M; Huo, L; Li, F; Li, X; Liu, B; Shao, Y; Wang, J; Wang, X; Zhang, H; Zhao, H | 1 |
| He, J; Li, B; Li, P; Shi, H; Wang, Q; Wang, S; Xie, R | 1 |
| Cheng, S; Cheng, Z; Song, S; Zhu, X; Zou, S | 1 |
| Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Iritani, S; Kawamura, Y; Kobayashi, M; Kobayashi, Y; Kumada, H; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y | 1 |
| Kim, K; Kim, SJ | 1 |
| Li, W; Shakir, TM; Wang, Z; Zhao, Y | 1 |
| Işık, EG; Kuyumcu, S; Sanli, Y | 1 |
| Chantalat, E; Ferron, G; Gabiache, E; Martinez, A; Zerdoud, S | 1 |
| Fukumitsu, K; Hamaguchi, Y; Hata, K; Ishii, T; Kaido, T; Nakamoto, Y; Ogiso, S; Seo, S; Taura, K; Uemoto, S; Yoh, T | 1 |
| Chen, Z; Dong, H; Huang, J; Liu, C; Liu, E; Liu, Z; Wang, S; Xie, Q; Xu, W | 1 |
| Dwyer, JP; Khan, SA; Vaughan, R | 1 |
| Bohmer, R; Burgess, JR; Kornaczewski Jackson, ER; Pointon, OP | 1 |
| Blandamura, S; Passuello, N; Pozza, G; Sperti, C; Valmasoni, M | 1 |
| Beeke, C; Chen, J; Karapetis, CS; Kumar, R; Padbury, R; Price, TJ; Ullah, S; Wong, GYM | 1 |
| Andreatos, N; Margonis, GA; Pawlik, TM; Weiss, MJ | 1 |
| Berkovic, P; Coucke, PA; Dechambre, D; Gulyban, A; Jansen, N; Janvary, L; Lakosi, F; Martinive, P; Nguyen, PV | 1 |
| Hacker, M; Haug, A; Kaczirek, K; Li, S; Mitterhauser, M; Nanoff, C; Peck-Radosavljevic, M; Pinter, M; Rainer, E; Ubl, P; Wadsak, W; Wang, H | 1 |
| Abdollahi, H; Bitarafan-Rajabi, A; Geramifar, P; Ghaffarian, P; Rahmim, A; Shiri, I | 1 |
| Geng, L; Wang, T; Wang, W; Yan, S; Ye, YF; Yu, J; Yu, SF; Zheng, SS | 1 |
| Cho, IH; Chun, KA; Kong, E | 1 |
| Beiderwellen, K; Deuschl, C; Forsting, M; Grüneisen, J; Herrmann, K; Heusch, P; Kirchner, J; Lauenstein, TC; Sawicki, LM; Umutlu, L | 1 |
| Cho, A; Hwang, SH; Kim, D; Kim, HJ; Lee, JW; Yun, M | 1 |
| Francis, R; Hardy, LE; Hessamodini, H; Wallace, M | 1 |
| He, Q; Shi, X; Wang, X; Zhang, B; Zhang, X | 1 |
| Gonoi, W; Hashimoto, M; Nishioka, Y; Shindoh, J; Sugawara, T; Yoshida, S; Yoshioka, R | 1 |
| Ahond-Vionnet, R; Bettinardi, V; Crivellaro, C; De Ponti, E; Dziuk, M; Elisei, F; Fioroni, F; Guerra, L; Landoni, C; Morzenti, S; Nodari, G; Picchio, M; Tkaczewski, K; Todde, S; Versari, A | 1 |
| Fu, T; Gao, Y; Kang, F; Li, G; Ma, W; Ma, X; Wang, J; Wang, S; Wang, Z; Yang, W; Zhao, M | 1 |
| Agarwal, KK; Mayank, M; Shah, D; Shah, N | 1 |
| Fukuhara, H; Ishitobi, H; Kobayashi, Y; Komazawa, Y; Kuroda, H; Nagaoka, M; Sato, S; Shizuku, T; Takahashi, Y; Yuki, M | 1 |
| Aleman, BMP; Grootscholten, C; Lalezari, F; Steinberg, JD; van Dieren, JM; van Sandick, JW; Vegt, E; Voncken, FEM | 1 |
| Ceyhan, GO; Friess, H; Kornberg, A; Kornberg, J; Mueller, K; Schernhammer, M; Thrum, K; Witt, U | 1 |
| Kim, DY; Kwon, SY; Lee, C; Min, JJ; Yoo, SW | 1 |
| Ariake, K; Fukase, K; Hayashi, H; Maeda, S; Masuda, K; Mizuma, M; Motoi, F; Naitoh, T; Ohtsuka, H; Shimomura, H; Takadate, T; Taki, Y; Tatewaki, Y; Terao, C; Unno, M | 1 |
| Ahn, TS; Baek, MJ; Lee, JW; Lee, SM | 1 |
| Bae, SH; Choi, JY; Hwang, S; Jang, JW; Park, HL; Song, MJ; Sung, PS; Yang, K; Yoo, IR; Yoon, SK | 1 |
| Bellò, M; Deandreis, D; Finessi, M; Giunta, FP; Veltri, A | 1 |
| Chung, YA; Eo, JS; Hong, IK; Hyun, SH; Kim, TS; Lee, JW; Na, SJ; Oh, JK; Song, BI; Yun, M | 1 |
| Hatano, E; Higashi, T; Ishii, T; Kaido, T; Kawai, T; Nakamoto, Y; Ogiso, S; Okuda, Y; Seo, S; Taura, K; Uemoto, S; Yoh, T | 1 |
| Eshghi, N; Frankl, J; Kuo, PH; Lundeen, TF | 1 |
| Fu, L; Li, J; Ma, G; Xu, B | 1 |
| Cui, R; Li, F; Liu, Y; Zheng, K | 1 |
| Bergesio, F; Bertone, E; Botto, D; Cerello, P; Chauvie, S; Terulla, A | 1 |
| Derlin, T; Hartung, D; Hueper, K | 1 |
| Binkovitz, LA; Broski, SM; Jundt, MC | 1 |
| Cheng, Z; Kuang, D; Song, S; Zhu, X; Zou, S | 1 |
| Anas, JM; Bao, C; Chen, D; Lin, L; Liu, K; Qian, W; Wei, J; Zhao, K; Zhao, X | 1 |
| Allaire, M; Amaddeo, G; Azoulay, D; Baranes, L; Calderaro, J; Chalaye, J; Costentin, CE; Duvoux, C; Ganne-Carrié, N; Itti, E; Luciani, A; Mallat, A; Nahon, P; Nault, JC; Seror, O; Soussan, M | 1 |
| Hu, Y; Liu, Y; Shi, H | 1 |
| Ahmed, HS; Farwell, MD; Metz, JM; Pantel, AR; Plastaras, JP | 1 |
| Bian, Y; Hu, Y; Tian, C; Wei, Q; Wu, D | 1 |
| Jiang, HJ; Li, M; Li, X; Pan, WB; Wang, YQ; Xu, HL; Zhang, MY; Zhang, RJ | 1 |
| Hou, J; Li, B; Shi, H; Yu, H; Zhang, Y | 2 |
| Fan, G; Guo, J; Hao, S; Sun, M; Wang, Z; Zhang, G | 1 |
| Akashi, K; Ariyama, H; Baba, E; Doi, G; Harimoto, N; Itoh, S; Kohashi, K; Kusaba, H; Maehara, Y; Nio, K; Oda, Y; Odawara, J; Shimoda, S; Takayoshi, K; Tsuchihashi, K; Tsuruta, N; Yoshihiro, T | 1 |
| Dong, A; Wang, Y; Zhong, X | 1 |
| Anconina, R; Ezroh Kazap, D; Hod, N; Lantsberg, S; Levin, D; Shaco-Levy, R | 1 |
| Dueland, S; Grut, H; Line, PD; Revheim, ME | 1 |
| Amanavicius, N; Bharadwaz, A; Kramer, S; Larsen, LP; Morre Pedersen, E; Schlander, S; Sivesgaard, K; Sørensen, M; Tønner Nielsen, D; Viborg Mortensen, F | 1 |
| Aiello, D; Alongi, F; Alongi, P; Di Paola, G; Fersino, S; Gregucci, F; Mazzola, R; Pasetto, S; Ruggieri, R; Salgarello, M; Tebano, U | 1 |
| Lai, P; Lian, Z; Liu, E; Wang, S | 1 |
| Dong, C; Tan, Y; Wang, Y; Xiao, Z; Yang, X; Zhang, H | 1 |
| Abadi-Korek, I; Bernstine, H; Domachevsky, L; Goldberg, N; Groshar, D; Guindy, M; Nidam, M; Sosna, J; Stein, D | 1 |
| Koizumi, M; Koyama, M; Sato, Y; Tanaka, H; Terauchi, T | 1 |
| Chen, XY; Luo, QY; Zhang, GQ; Zhang, XY | 1 |
| An, H; Cheung, GTC; Chiu, KWH; Choy, TS; Lam, KO; Lau, JKS; Lee, VHF | 1 |
| Ding, CY; Li, TN; Tang, B | 1 |
| Li, Q; Li, Y; Liao, S; Liao, X; Liu, Z; Wei, C; Wei, J; Zhong, J | 1 |
| Hu, Y; Mao, W; Qiu, L; Shi, H; Tan, H; Zhang, H; Zhou, J | 1 |
| Kang, SH; Kim, HB; Kim, SK; Kim, TS; Park, JW; Park, S | 1 |
| Annovazzi, A; Fabi, A; Rea, S; Sciuto, R; Vici, P | 1 |
| Lin, J; Tang, K; Yin, W; Zheng, X | 1 |
| Hu, Y; Luo, R; Shi, H; Xiu, Y; Yin, H | 1 |
| Balcı, NC; İnan, N; Koyuncu Sökmen, B; Öz, A; Tokat, Y | 1 |
| Araki, K; Arima, K; Baba, H; Harimoto, N; Kuwano, H; Shirabe, K; Tetsuya, H; Watanabe, A; Yamashita, Y; Yoshizumi, T | 1 |
| Seo, S; Yoh, T | 1 |
| Basturk, O; Corrias, G; Giancipoli, RG; Keohan, ML; Klimstra, D; Mannelli, L; Monti, S; Sawan, P; Schillaci, O | 1 |
| Bozkurtlar, E; Celikel, CA; Erdil, TY; Inanir, S; Oksuzoglu, K; Ones, T; Ozguven, S; Turoglu, HT | 1 |
| Mahadevan, P; Pratap, T; Ramesh, H; Senthil, R; Visakh R, A | 1 |
| Bai, X; Wang, X; Zhang, X | 1 |
| Azoulay, D; Chalaye, J; Costentin, CE; Feray, C; Itti, E; Lahat, E; Lim, C; Osseis, M; Salloum, C | 1 |
| Ko, H; Lee, M; Yun, M | 1 |
| Bergner, C; Gock, M; Göder, A; Klar, E; Krämer, OH; Krause, BJ; Lange, F; Linnebacher, M; Mullins, CS; Prall, F; Ramer, R | 1 |
| Chen, Y; Fang, C; Liu, H; Zhang, W | 1 |
| Cheng, Z; Song, S; Zhu, D; Zhu, X; Zou, S | 1 |
| Behr, SC; Flavell, RR; Kelley, RK; Perez, PM; Umetsu, S | 1 |
| Amaral Ferreira, L; Caseiro-Alves, F; Costa, JF; Donato, P | 1 |
| Dong, M; Yang, J; Zhang, J; Zhu, Y | 1 |
| Huang, G; Li, P; Liu, Q; Song, S; Wang, X | 1 |
| Banks, KP; Gusman, M; Peacock, JG; Wickley, AB; Zhao, JM | 1 |
| Gabata, T; Inoue, D; Kitao, A; Kobayashi, S; Koda, W; Kozaka, K; Matsui, O; Minami, T; Yoneda, N; Yoshida, K | 1 |
| Byun, JH; Choi, SH; Hong, SB; Kim, KW; Kim, SY; Lee, MG; Lee, SJ; Lee, SS; Park, SH | 1 |
| Kan, Y; Liu, J; Wang, W; Yang, J; Yang, X | 1 |
| Abuqbeitah, M; Akgün, E; Akovali, B; Asa, S; Demir, M; Gülsen, F; Sager, S; Sahin, O; Sayman, H; Sönmezoglu, K; Uslu-Beşli, L; Yeyin, N | 1 |
| Bachmeier, CAE; Barrett, HL; Haque, M; Morton, A | 1 |
| Kim, HS; Lee, JW; Lee, S; Lee, SM | 1 |
| Ashrafinia, S; Bak-Fredslund, KP; Horsager, J; Keiding, S; Lu, L; Morsing, A; Munk, OL; Rahmim, A; Schmidtlein, CR; Subramaniam, RM | 1 |
| Shi, H; Tan, H; Wu, B; Zhang, Y | 1 |
| de Greef, BTA; Jansen, FH; Maaskant-Braat, AJG; Nieuwenhuijzen, GAP; Poodt, IGM; Schipper, RJ; Voogd, AC; Vugts, G; Wyndaele, DNJ | 1 |
| Fukushi, M; Inoue, K; Kishimoto, S; Minamimoto, R; Mitsumoto, T; Sunaoka, F | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH; Moon, SH | 1 |
| Chen, FH; Chiu, H; Chiu, SC; Chung, YH; Hong, JH; Hsu, ST; Wu, CR; Yang, CL; Yen, TC; Yu, CF | 1 |
| Cheng, X; Huo, L; Li, F; Wang, J; Wang, X | 1 |
| Hausauer, B; Islam, Z; Keshavamurthy, J; Pucar, D | 1 |
| Hope, TA; Kassam, Z; Loening, A; McNamara, MM; Paspulati, R | 1 |
| Liu, C; Liu, ET; Sun, TT; Wang, HL; Wang, SX | 1 |
| Armani, M; Cadiot, G; Couvelard, A; Cros, J; de Mestier, L; Hentic, O; Lebtahi, R; Rebours, V; Ruszniewski, P; Sauvanet, A | 1 |
| Miles, K; Yeoh, E | 1 |
| Dong, ZR; Li, T; Zhi, XT | 1 |
| Chan, YC; Chen, CL; Cheng, YF; Elsarawy, AM; Hsu, CC; Kuo, FY; Li, WF; Lin, CC; Lin, LM; Lin, TL; Ling, LL; Wang, CC; Yong, CC | 1 |
| Domínguez Ferreras, E; García Vicente, AM; Jiménez Aragón, F; Molino Trinidad, C; Pineda Pineda, MD; Poblete García, VM; Sánchez Pérez, V; Soriano Castrejón, Á; Villa Guzmán, JC | 1 |
| Bae, SH; Choi, JI; Choi, JY; Chun, HJ; Kim, HY; Lee, HG; Lee, SW; Lee, YJ; Song, DS; Song, MJ; Yoo, IeR; Yoon, SK | 1 |
| Bilgic, S; Elhan, AH; Gecim, EI; Kucuk, ON; Soydal, C | 1 |
| Dong, A; Dong, H; Zuo, C | 2 |
| Dong, A; Dong, H; Xiao, Z; Zuo, C | 1 |
| Choi, BW; Jo, I; Kim, SH; Won, KS; Zeon, SK | 1 |
| Blickman, JG; Maffione, AM; Rampin, L; Rubello, D | 1 |
| Ishii, K; Kuroda, H; Matsuki, M; Murakami, T; Okada, M; Tsurusaki, M | 1 |
| Okano, K; Oshima, M; Suzuki, Y; Yachida, S; Yamamoto, N | 1 |
| Freesmeyer, M; Lopatta, E; Marlowe, RJ; Opfermann, T; Schierz, JH; Settmacher, U; Stallmach, A; Steenbeck, J | 1 |
| Araz, M; Bilgic, S; Ibis, E; Kucuk, ON; Soydal, C | 1 |
| Enoki, Y; Fujimoto, S; Fukui, A; Morishita, H; Okuyama, Y; Yoshida, N | 1 |
| Jackson, T; Malladi, A; Mercier, G; Subramaniam, RM; Viner, M | 1 |
| Chen, J; Cong, L; Cui, Y; Han, J; Luan, Y; Sha, D; Shen, R; Wang, C; Wang, W; Zhang, Z | 1 |
| Farrell, EV; Haase, A; Janich, MA; Khegai, O; Menzel, MI; Nekolla, S; Otto, AM; Schulte, RF; Schwaiger, M; Wiesinger, F | 1 |
| Chen, D; Chen, ZF; Hu, AB; Wang, XY; Zhang, XS | 1 |
| Ceelen, W; De Bruyne, S; Geboes, K; Goethals, I; Laurent, S; Mertens, J; Peeters, M; Smeets, P; Troisi, R; Van Damme, N; Van de Wiele, C | 1 |
| Adalet, I; Basaran, M; Ozkan, G; Poyanli, A; Sanli, Y; Serin, K; Turkmen, C; Ucar, A; Vatankulu, B | 1 |
| Freesmeyer, M; Marlowe, RJ; Sänger, P; Schierz, JH | 1 |
| Pant, V; Sen, IB; Soin, AS | 1 |
| Andreou, A; Fisher, C; MacVicar, D; Sohaib, A; Whitten, C | 1 |
| Bartenstein, P; Fendler, WP; Hacker, M; Haug, AR; Heinemann, V; Ilhan, H; Jakobs, TF; Paprottka, PM; Philippe Tiega, DB | 1 |
| Constantinesco, A; Goetz, C; Hassler, S; Hubele, F | 1 |
| Dunet, V; Koehli, M; Meuli, R; Montemurro, M; Prior, JO; Schmidt, S | 1 |
| Aoki, H; Fukumoto, T; Kitajima, K; Kono, A; Matsumoto, I; Okunaga, T; Suenaga, Y; Sugimura, K; Tanaka, K | 1 |
| Alavi, A; Basu, S; Kwee, TC; Lam, MG | 1 |
| Boellaard, R; Hayes, W; Hoekstra, OS; Jongsma, F; Lammertsma, AA; Nissen, IA; van Velden, FH; Velasquez, LM | 1 |
| Chan, SC; Chen, S; Cheung, TT; Fan, ST; Ho, CL; Lo, CM; Poon, RT | 1 |
| Osborne, J; Petre, EN; Sofocleous, CT; Tewari, SO | 1 |
| Warner, RR; Zanzi, I | 1 |
| Ahn, SG; Cho, HJ; Jeon, TJ; Kim, KS; Kim, SH; Lee, JD; Lee, SD; Park, SJ; Park, YN; Yun, M | 1 |
| Chan, CY; Lee, SY; Lim, D; Lim, KH | 1 |
| Bashir, MR; Jaffe, TA; Neville, AM; Thacker, JM; Uronis, HE | 1 |
| Ahn, SJ; Kang, WJ; Kim, I; Kim, KA; Kim, MJ; Lee, SK; Park, JY; Park, MS | 1 |
| Lupinacci, RM; Menegaux, F; Simon, JM; Spano, JP | 1 |
| Chang, LP; Chao, HL; Chen, CM; Chiu, CH; Huang, WS; Huang, WY; Jen, YM; Kao, CH; Lee, MS; Lo, CH | 1 |
| Armbruster, M; Auernhammer, CJ; Haug, A; Ingrisch, M; Nikolaou, K; Paprottka, PM; Reiser, MF; Rist, C; Sommer, WH; Sourbron, S; Zech, CJ | 1 |
| Beiderwellen, K; Bockisch, A; Buchbender, C; Gomez, B; Hartung, V; Kuehl, H; Lauenstein, TC; Nensa, F; Poeppel, TD | 1 |
| Boér, K; Borbély, K; Kásler, M; Németh, Z | 1 |
| Ahmadzadehfar, H; Ezziddin, S; Meyer, C; Pieper, CC; Schild, HH; Wilhelm, KE | 1 |
| Basso, ME; Bova, V; Cistaro, A; Fagioli, F; Fania, P; Ficola, U; Pagano, M; Quartuccio, N; Treglia, G | 1 |
| Jolepalem, P; Rydberg, JN; Wong, CO | 1 |
| Dong, A; Dong, H; Wang, Y; Yu, H; Zuo, C | 1 |
| Schembri, GP; Sounness, BD | 1 |
| Cho, YK; Jeon, WK; Ju, DY; Kim, BI; Kim, HJ; Lee, JY; Park, DI; Park, JH; Shin, DS; Sohn, CI; Yim, SH; Yu, JH | 1 |
| Berlangieri, SU; Lee, ST; Scott, AM; Tan, GJ | 1 |
| Barron, B; Eaton, BR; Fox, T; Galt, JR; Kim, HS; Kim, S; Landry, J; Liu, Y; Schreibmann, E; Schuster, DM | 1 |
| Athwal, T; Fenwick, SW; Malik, HZ; Poston, GJ; Wieshmann, H; Yip, VS | 1 |
| Fujihara, S; Izuishi, K; Kameyama, R; Masaki, T; Mori, H; Suzuki, Y; Yamamoto, Y | 1 |
| Chondrogiannis, S; Colletti, PM; Galeotti, F; Grassetto, G; Maffione, AM; Marzola, MC; Rampin, L; Rubello, D | 1 |
| Chang, ZH; Guo, QY; Han, CB; Liu, ZY; Lu, ZM; Ma, JT; Zheng, JH | 1 |
| Bernardin, L; Desouza, NM; O'Flynn, EA | 1 |
| Cheon, GJ; Choe, JG; Kim, DS; Oh, SY; Park, BJ; Park, TG; Yu, YD | 1 |
| Dutta, J; Leahy, RM; Li, Q | 1 |
| Armbruster, M; Auernhammer, CJ; Ceelen, F; Haug, A; Reiser, MF; Rist, C; Singnurkar, A; Sommer, WH; Sourbron, S; Zech, CJ | 1 |
| Hatano, E; Hayakawa, N; Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Seo, S; Togashi, K; Uemoto, S | 1 |
| Abe, K; Aishima, S; Ikeda, T; Ikegami, T; Kimura, K; Maehara, Y; Shirabe, K; Toshima, T; Yamashita, Y; Yoshizumi, T | 1 |
| Balogova, S; Decazes, P; Fartoux, L; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Rosmorduc, O; Talbot, JN; Vereb, M | 1 |
| Eaton, A; Fazio, M; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; Lilienstein, J; Morris, PG; Patil, S; Ulaner, GA | 1 |
| Catalano, PJ; Forgione, K; Mauri, G; Morrison, PR; Sadow, CA; Sahni, VA; Shyn, PB; Silverman, SG; Tatli, S | 1 |
| Anil, G; Singh, P | 1 |
| Lodge, MA; Tahari, AK; Wahl, RL | 1 |
| Anne, PR; Bar-Ad, V; Dicker, A; Doyle, L; Eldredge-Hindy, H; Eschelman, D; Gonsalves, C; Intenzo, C; Li, J; Ohri, N; Sato, T | 1 |
| Ayez, N; de Ridder, J; de Wilt, JH; Oyen, WJ; Verhoef, C; Wiering, B | 1 |
| Fan, M; Hu, S; Hu, X; Li, T; Shui, R; Zhang, Y | 1 |
| Ammori, BJ; Bonanni, L; de'Liguori Carino, N; Deshpande, R; O'Reilly, DA; Sherlock, DJ; Tam, E; Valle, JW | 1 |
| Bowen, SR; Chaovalitwongse, WA; Grabowski, TJ; Kinahan, PE; Sandison, GA; Wang, S | 1 |
| Blay, JY; Combemale, P; Giammarile, F; Goulart, DM; Guillot, B; Mognetti, T; Pinson, S; Valeyrie-Allanore, L; Wolkenstein, P | 1 |
| Ansaloni, L; Baiocchi, GL; Capponi, MG; Coniglio, A; D'Ugo, D; De Manzoni, G; Di Leo, A; Giacopuzzi, S; Giulini, SM; Marchet, A; Marrelli, D; Morgagni, P; Nitti, D; Pacelli, F; Rosa, F; Roviello, F; Saragoni, L; Tiberio, GA; Verlato, G | 1 |
| Chang, JS; Choi, SH; Jeong, YH; Lee, Y; Seong, J; Yun, M | 1 |
| Hong, YS; Kim, HO; Kim, JC; Kim, JS; Kim, TW; Lee, HS; Yu, CS | 1 |
| Choi, D; Choi, JY; Jang, KM; Kang, TW; Kim, SH; Park, CK | 1 |
| Christophi, C; Lau, LF; Lee, ST; Muralidharan, V; Scott, AM; Williams, DS | 1 |
| Endo, K; Hatano, E; Higashi, T; Kagawa, S; Kishibe, Y; Kitamura, K; Matsumura, K; Nishii, R; Seo, S; Takahashi, M; Takemoto, K; Tanabe, K; Taura, K; Toriguchi, K; Uemoto, S; Yamauchi, H; Zaima, M | 1 |
| Annunziata, S; Caldarella, C; Galiandro, F; Treglia, G | 1 |
| Fjeld, JG; Haugvik, SP; Johnsrud, K; Mathisen, Ø; Revheim, ME; Skretting, A | 1 |
| Bae, KS; Choi, BH; Jeong, CY; Kim, HO; Kim, JE; Lee, JS | 1 |
| Song, L; Zhang, W; Zhang, Y | 1 |
| Chen, YL; El Fakhri, G; Huang, C; Li, Q; Ouyang, J; Petibon, Y; Reese, TG; Syrkina, A | 1 |
| Castelli, P; Crippa, S; Falconi, M; Laiti, S; Partelli, S; Salgarello, M; Spinelli, AE; Tamburrino, D; Zamboni, G | 1 |
| Enomoto, M; Fujii, H; Hagihara, A; Iwai, S; Kawabe, J; Kawada, N; Kawamura, E; Kotani, K; Morikawa, H; Murakami, Y; Shiomi, S; Tamori, A; Uchida-Kobayashi, S | 1 |
| Abbadi, RA; Cheow, HK; Ford, HE; Harper, SJ; Huguet, EL; Jah, A; Jamieson, NV; Praseedom, RK; Sadat, U; Whitley, S; Wilson, CB | 1 |
| Cheng, X; Cui, R; Dang, Y; Huo, L; Li, F; Lü, J; Mao, Y; Xing, H | 1 |
| Bie, P; Huan, H; Lau, WY; Li, G; Ma, K; Qian, C; Wu, L; Xia, F | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Bruhman, J; Ezziddin, S; Meyer, C; Pieper, CC; Sabet, A; Wasmuth, JC | 1 |
| Chang, D; Harris, C; Kauser, A; Lake, ES; Lapsia, S; Subar, D; Wadhwani, S | 1 |
| Eo, JS; Lee, DS; Paeng, JC | 1 |
| Abrantes, AM; Botelho, MF; Brito, AF; Mendes, M; Tralhão, JG | 1 |
| Bai, M; Bai, W; Fan, D; Han, G; Jia, J; Ma, W; Quan, Z; Wang, J; Wang, S; Yi, J; Yin, Z | 1 |
| Arisaka, Y; Higuchi, T; Kumasaka, S; Nakajima, T; Tokue, A; Tsushima, Y | 1 |
| Hirokawa, T; Matsuo, Y; Morimoto, M; Sato, M; Sato, T; Shamoto, T; Shibata, T; Takahashi, H; Takeyama, H; Tsuboi, K | 1 |
| Jeng, LB; Kao, CH; Lin, WY; Lin, Y; Tsai, SC; Wang, HY | 1 |
| Belsack, D; Buls, N; de Mey, J; Everaert, H; Ilsen, B; Ros, PR; Vandemeulebroucke, J; Vandenbroucke, F; Verdries, D | 1 |
| Cappelli, A; Castellucci, P; D'Errico, A; Di Fabio, F; Ercolani, G; Giampalma, E; Golfieri, R; Pinna, AD; Pinto, C; Rojas Llimpe, FL; Serra, C | 1 |
| Alavi, A; Chauhan, MS; Hess, S; Jacob, MJ; Ravina, M | 1 |
| Chang, Z; Duan, F; Liu, F; Song, P; Wang, M; Wang, Y; Wang, Z | 1 |
| Bärwolf, R; Freesmeyer, M; Zirnsak, M | 1 |
| Jain, TK; Karunanithi, S; Kumar, R; Sharma, P; Vijay, MK | 1 |
| Comans, EF; Hoekstra, OS; Kazemier, G; Meijer, S; Meijerink, MR; Nielsen, K; Oprea-Lager, DE; Pieters, IC; Scheffer, HJ; Schreurs, HW; Sietses, C; van den Tol, PM; van Tilborg, AA; van Waesberghe, JH | 1 |
| Barrington, SF; Cavalli, F; Cheson, BD; Fisher, RI; Lister, TA; Schwartz, LH; Zucca, E | 1 |
| Aishima, S; Baba, S; Kubo, Y; Maehara, Y; Mano, Y; Motomura, T; Oda, Y; Shirabe, K; Tanaka, Y; Toshima, T | 1 |
| Barker, DW; Finegold, MJ; Hall, NC; Hingsbergen, EA; Samarghandi, A | 1 |
| Cho, Y; Cho, YY; Choi, WM; Chung, JK; Kang, KW; Kim, YJ; Lee, DH; Lee, HS; Lee, JH; Lee, M; Lee, YB; Paeng, JC; Yoo, JJ; Yoon, JH; Yu, SJ | 1 |
| Hirata, K; Huang, SC; Kobayashi, K; Manabe, O; Surmak, A; Tamaki, N; Wong, KP | 1 |
| Kubota, K; Minamimoto, R; Miyata, Y; Morooka, M; Nakajima, K; Okasaki, M; Sato, T | 1 |
| Burger, IA; Humm, JL; Li, G; Ridge, CA; Schmidtlein, CR; Solomon, SB | 1 |
| Deng, J; Shen, N; Tang, J | 1 |
| Heo, NY; Joo, YD; Kim, IH; Kim, JY; Kim, SH; Lee, SI; Park, JI; Park, SH; Shim, HK | 1 |
| Ahn, SY; Cheon, GJ; Choi, BI; Han, JK; Joo, I; Lee, ES; Lee, JM; Lee, SJ | 1 |
| Akdemir, UO; Algin, E; Benekli, M; Buyukberber, S; Cetin, B; Coskun, U; Gumusay, O; Kapucu, O; Ozet, A; Uner, A | 1 |
| Bluemel, C; Giammarile, F; Herrmann, K; Lopci, E; Maffione, AM; Rubello, D | 1 |
| Chan, PC; Chang, CA; Chang, CW; Chen, FD; Chiou, SH; Chou, LS; Ho, CH; Hwang, JJ; Lin, WJ; Liu, RS; Wang, HE; Wu, CY | 1 |
| Wang, WL; Ye, S; Zhao, K | 1 |
| Fingerle, AA; Holzapfel, K; Maegerlein, C; Rummeny, EJ; Souvatzoglou, M | 1 |
| Aouf, A; Biersack, HJ; Ezziddin, S; Ghamari, S; Mayer, K; Meyer, C; Pieper, CC; Sabet, A | 1 |
| Wang, X; Xu, Z; Zhang, L; Zhang, X | 1 |
| Cha, RR; Jung, WT; Kim, HJ; Kim, NY; Kim, TH; Lee, JH; Lee, OJ; Oh, HW | 1 |
| Carney, JA; Chen, CC; Papadakis, GZ; Patronas, NJ; Stratakis, CA | 1 |
| Cheng, JY; Fu, Y; Hu, SL; Song, HJ; Zhang, GY; Zhang, YJ | 1 |
| Choi, HJ; Kang, WJ; Kim, GM; Kim, JH; Seo, HJ | 1 |
| Ji, YH; Li, HS; Lv, L; Tian, Y; Wang, QS; Wang, SB; Wu, HB; Zhou, WL | 1 |
| Ahn, BC; Jeong, SY; Kim, DH; Lee, J; Lee, SW | 1 |
| Cho, YH; Choi, GS; Choi, HJ; Choi, MH; Chung, JC; Jang, JY; Jeong, SW; Jin, SJ; Kim, BS; Kim, DC; Kim, HS; Kim, SG; Kim, YS; Lee, MH; Lee, SH; Lee, YN; Moon, JH; Park, JM; Song, JY | 1 |
| Kim, J; Seltzer, M; Siegel, A; Yen, SP | 1 |
| Friess, H; Kornberg, A; Kornberg, J; Thrum, K; Witt, U | 1 |
| Asman, Y; Even-Sapir, E; Evenson, AR; Shibolet, O | 1 |
| Cho, A; Han, KH; Kim, DY; Lee, JD; Lee, JW; Lee, SM; Yun, M | 1 |
| Bhambhvani, P; O'Malley, JP; Surasi, DS | 1 |
| Apte, AP; Burger, IA; Carlin, SA; Deasy, JO; Dogan, S; Durack, JC; Erinjeri, JP; Fanchon, LM; Humm, JL; Kirov, AS; Maybody, M; Moreira, AL; Schmidtlein, CR; Schöder, H; Siegelbaum, RH; Sofocleous, CT; Solomon, SB; Yorke, E | 1 |
| Adachi, S; Akagi, K; Dono, K; Hatano, H; Imamura, H; Iwazawa, T; Komori, T; Masuike, Y; Morita, S; Noda, T; Oshima, K; Tanida, T; Yasumoto, T | 1 |
| Chau, I; Chua, SS; Cook, GJ; Cunningham, D; Drake, B; Du, Y; Koh, DM; Tam, HH; Zerizer, I | 1 |
| Cai, L; Chen, Y; Huang, Z; Wu, J | 1 |
| Bletard, N; Delwaide, J; Deroover, A; Detry, O; Govaerts, L; Honoré, P; Hustinx, R; Lamproye, A; Malenga, S; Mbendi, C; Meunier, P; Meurisse, N; Vandermeulen, M | 1 |
| Bilgic, S; Idilman, R; Keskin, O; Kir, MK; Kucuk, ON; Ozkan, E; Soydal, C | 1 |
| Chen, F; Hu, P; Hu, R; Liao, S; Lyu, Q; Zhang, J; Zhang, Z | 1 |
| de Geus-Oei, LF; Heerschap, A; Heijmen, L; Oyen, WJ; Punt, CJ; ter Voert, EE; van Laarhoven, HW; van Spronsen, DJ | 1 |
| Bae, KT; Goshima, S; Hirose, Y; Kanematsu, M; Kawada, H; Kawai, N; Kondo, H; Matsunaga, K; Nishibori, H; Noda, Y; Suzui, N; Tanahashi, Y; Watanabe, H | 1 |
| Baxa, J; Daum, O; Ferda, J; Ferdová, E; Kreuzberg, B; Skalický, T; Třeška, V | 1 |
| Hong, SK; Kim, SH; Kim, YK; Lee, SD; Park, SJ | 1 |
| Bush, J; Dizdarevic, S; Keramida, G; Peters, AM | 1 |
| Kim, SH; Kim, SK; Kim, YK; Lee, SD; Park, SJ | 1 |
| Da Prat, V; de Braud, F; Di Bartolomeo, M; Iaculli, A; Inno, A; Morosi, C; Orlandi, A; Pietrantonio, F; Spada, D | 1 |
| Fletcher, J; Maluccio, M; McCarthy, BP; Riley, AA; Saxena, R; Skill, NJ; Tann, M; Territo, PR | 1 |
| Cho, YH; Choi, DL; Jang, HY; Jang, JY; Jeong, SW; Kim, BS; Kim, HS; Kim, MJ; Kim, SG; Kim, YS; Lee, JM; Lee, MH; Lee, SH; Lee, WH; Park, JM; Song, JY | 1 |
| Allen, PJ; Cercek, A; Correa-Gallego, C; D'Angelica, MI; DeMatteo, RP; Fong, Y; Gavane, S; Gewirtz, AN; Grewal, R; Jarnagin, WR; Kemeny, N; Kingham, TP; Klimstra, DS | 1 |
| Chiu, YL; Lee, SD; Peng, NJ; Wu, CS | 1 |
| Barthel, H; Busse, H; Jochimsen, TH; Kurch, L; Sabri, O; Sattler, B; Schaudinn, A; Schulz, J; Seese, A; Werner, P; Zeisig, V | 1 |
| Cho, E; Choi, SK; Choi, WS; Jun, CH; Kim, BS; Son, DJ | 1 |
| Donswijk, ML; Hess, S; Lam, MG; Mulders, T | 1 |
| Alavi, A; El-Haddad, GE; Lam, MG; Molenaar, IQ; Prevoo, W; Samim, M; van den Bosch, MA | 1 |
| Fruchart, C; Le Naoures, C; Quak, E; Salaun, V | 1 |
| Lu, Y; Patel, D | 1 |
| Marcus, C; Parikh, U; Sarangi, R; Subramaniam, RM; Taghipour, M | 1 |
| Laurens, ST; Oyen, WJ | 1 |
| Bradley, KM; Franklin, JM; Gleeson, FV; McGowan, DR; Parvizi, N; Teoh, EJ | 1 |
| Cho, H; Choi, JY; Kim, HK; Kim, J; Lee, HY; Lee, KS; Um, SW | 1 |
| Akcan, AB; Şahin, E | 1 |
| Aide, N; Binns, D; Bourhis, D; Callahan, J; Desmonts, C; Hicks, RJ; Hofman, MS; Le Roux, PY; Quak, E; Robin, P; Salaun, PY | 1 |
| Alamgeer, M; David, S; Ganju, V; Ng, SP | 1 |
| Dieckmann, W; Kebebew, E; Nilubol, N; Patel, D; Satoh, K | 1 |
| Damhuis, RA; Derks, JL; Dingemans, AM; Hendriks, LE; Hochstenbag, MM; Houben, RM; Postmus, PE; Smit, EF; Troost, EG | 1 |
| Chegai, F; Mannelli, L; Monti, S; Orlacchio, A | 1 |
| Ardito, A; Arena, V; Basile, V; Brambilla, R; Duregon, E; Massaglia, C; Pelosi, E; Penna, D; Perotti, P; Terzolo, M; Vigna-Taglianti, F; Zaggia, B | 1 |
| Arslanoglu, A; Gonzalez-Guindalini, FD; Parekh, K; Seyal, AR; Tochetto, SM; Velichko, YS; Yaghmai, V | 1 |
| Gu, T; Jiang, L; Liu, F; Luan, L; Shi, H | 1 |
| Aishima, S; Maehara, Y; Shirabe, K; Yamashita, Y | 1 |
| Jiang, L; Panje, CM; Shi, H; Tan, H; Xiu, Y; Yu, H | 1 |
| Chung, YA; Ham, HJ; Jang, KS; Jung, YJ; Lee, J; Lee, JH; Maeng, LS; Park, MS; Park, SI | 1 |
| Camacho, JC; Edalat, F; Galt, JR; Kendi, AT; Kim, HS; Kokabi, N | 1 |
| Galloway, S; Mirza, A | 1 |
| Fuccio, L; Giaccherini, L; Guido, A; Morganti, AG | 1 |
| Comans, EF; Meijerink, MR; Nielsen, K; Scheffer, HJ; van den Bergh, J; van den Tol, PM; van der Meijs, BB; van Kuijk, C; van Tilborg, AA; Vroomen, LG | 1 |
| Capel, A; Cascales-Campos, PA; Frutos, L; Gonzalez, R; Llacer, E; Lopez, V; Muñoz-Ramon, P; Navarro, JL; Parrilla, P; Pons, JA; Ramírez, P; Robles, R; Saenz-Mateos, L; Sánchez Bueno, F | 1 |
| Bailly, M; Orain, I; Ribeiro, MJ; Salamé, E; Venel, Y | 1 |
| Agostini, H; Castilla-Lièvre, MA; Désarnaud, S; Franco, D; Gervais, P; Helal, BO; Kuhnast, B; Marthey, L | 1 |
| Feng, Y; Huang, G; Jiang, Y; Liu, J; Liu, Y; Ni, Y; Song, S; Tong, L; Wu, C; Xia, Q; Yin, T | 1 |
| Bagni, O; Cianni, R; Filippi, L; Pelle, G; Schillaci, O | 1 |
| Guo, W; Ji, D; Li, J; Li, W; Liu, X; Tao, Z; Wang, C; Zhang, X; Zhang, Y; Zhou, M; Zhu, X | 1 |
| Albert, NL; Bartenstein, P; Boeck, S; Fendler, WP; Heinemann, V; Ilhan, H; Lehner, S; Michl, M; Paprottka, PM | 1 |
| Bach-Gansmo, T; Dormagen, JB; Godt, JC; Holtedahl, JE; Johansen, CK; Kløw, NE; Labori, KJ; Schulz, A; Viktil, E | 1 |
| Choi, Y; Hong, G; Kim, H; Lee, KW; Paeng, JC; Park, MS; Suh, KS; Suh, SW; Yi, NJ; Yoo, T | 1 |
| Bartenstein, P; Fendler, WP; Haug, AR; Jakobs, TF; Lechner, H; Lehner, S; Michl, M; Paprottka, KJ; Paprottka, PM; Todica, A | 1 |
| Chung, YA; Eo, JS; Hong, IK; Hyun, SH; Kim, DY; Kim, SU; Kim, TS; Lee, JD; Lee, JW; Moon, DH; Na, SJ; Oh, JK; Song, BI; Yun, M | 1 |
| Cillo, U; Crivellari, G; Giuliani, T; Herrero Manley, LM; Polacco, M; Vitale, A | 1 |
| Hwang, SH; Kim, CK; Lee, M; Lee, N; Park, MA; Park, S; Yun, M | 1 |
| Artiko, V; Grozdic-Milojevic, I; Obradovic, V; Odalovic, S; Pavlovic, S; Sobic Saranovic, D; Stojiljkovic, M; Susnjar, S | 1 |
| Cherqui, D; Jarnagin, WR; Jessurun, J; Kingham, TP; Kluger, MD; LaGratta, MD; Lee, SY | 1 |
| Dauer, LT; Gao, Y; Khong, PL; Liu, D; Mahmood, U; Quinn, B; St Germain, J; Xu, XG | 1 |
| An, L; Li, TF; Lv, GY; Mu, L; Shi, XJ; Sun, DW; Wang, CL; Wei, F; Zhao, ZW | 1 |
| Azoulay, D; Baranes, L; Boussouar, S; Calderaro, J; Chalaye, J; Chiaradia, M; Costentin, C; Decaens, T; Duvoux, C; Evangelista, E; Itti, E; Laurent, A; Lin, SJ; Luciani, A; Pigneur, F; Rahmouni, A | 1 |
| Cheng, W; Jing, H; Li, Y; Shao, H; Yu, L | 1 |
| Cornelis, F; Durack, JC; Humm, J; Maybody, M; Schoder, H; Siegelbaum, RH; Sofocleous, CT; Solomon, SB; Sotirchos, V; Violari, E | 1 |
| Cheng, Z; Hu, N; Luo, J; Tan, Y; Wang, Y | 1 |
| Choi, JY; Chung, YA; Eo, JS; Hong, IK; Hyun, SH; Kim, KS; Kim, TS; Lee, JW; Lee, KH; Moon, DH; Na, SJ; Oh, JK; Song, BI; Yun, M | 1 |
| Abrantes, AM; Botelho, MF; Brito, AF; Casalta-Lopes, JE; Gonçalves, AC; Laranjo, M; Mamede, AC; Ribeiro, M; Sarmento-Ribeiro, AB; Tralhão, JG | 1 |
| Fujimoto, Y; Hatano, E; Kaido, T; Mizumoto, M; Mori, A; Nitta, T; Okajima, H; Seo, S; Taura, K; Uemoto, S; Wu, TH; Yamanaka, K; Yasuchika, K | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, YI; Lee, DS; Paeng, JC; Suh, KS | 1 |
| Dong, A; Xiao, Z; Yang, J; Zuo, C | 1 |
| Hou, Y; Jiang, L; Luan, L; Shi, H; Yun, H | 1 |
| Han, JK; Hur, BY; Joo, I; Kang, KW; Lee, DH; Lee, JM; Suh, KS; Yi, NJ | 1 |
| Doi, H; Fukushima, K; Hirota, S; Kaibe, N; Kawanaka, Y; Kitajima, K; Miwa, H; Mouri, M; Niwa, H; Oshima, T; Sasako, M; Tomita, T | 1 |
| Nie, P; Wang, Z; Xing, X; Yang, G | 1 |
| Boas, FE; Do, RK; Gavane, S; Gonen, M; Kishore, S; Osborne, JR; Shady, W; Sofocleous, CT; Ulaner, GA; Ziv, E | 1 |
| Anderson, TM; Lu, Y; Patel, D | 1 |
| Fujii, T; Gabata, T; Harada, K; Matsui, O; Ozaki, K; Saitoh, S; Terayama, N; Tomimaru, Y | 1 |
| Albano, D; Bertagna, F; Giubbini, R | 1 |
| Chan, YC; Chen, CL; Cheng, YF; Eng, HL; Hsu, CC; Lee, WF; Lin, CC; Lin, TL; Lin, YH; Liu, YW; Wang, CC; Wang, SH; Wu, YJ; Yong, CC | 1 |
| Carlino, MS; Guminski, A; Kefford, RF; Kong, BY; Liniker, E; Long, GV; Menzies, AM; Ramanujam, S; Saunders, CA | 1 |
| Hashimoto, J; Hirabayashi, K; Ichikawa, T; Imai, Y; Mori, N; Yamada, M; Yamashita, T | 1 |
| Carrasquillo, JA; Do, RK; Gonen, M; Pandit-Taskar, N; Shady, W; Sofocleous, CT; Sotirchos, VS | 1 |
| Chong, S; Huang, YT; Hugh, TJ; Lin, M; Ng, WL; Park, J | 1 |
| Chotipanich, C; Kunawudhi, A; Promteangtrong, C; Sricharunrat, T; Tungsuppawattanakit, P; Wongsa, P | 1 |
| Cho, YS; Choe, YS; Im, YH; Kim, BT; Lee, KH; Lim, CH; Moon, SH | 1 |
| Alauddin, Z; Fatima, N; Masood, M; Mirza, ZR; Qureshi, A; Shahid, A | 1 |
| Basuroy, R; Ramage, JK; Srirajaskanthan, R | 1 |
| Anderson, TM; Cai, K; Knuttinen, MG; Kumar, N; Lu, H; Lu, Y; Mehta, R | 1 |
| Yoon, SN | 1 |
| Acar, E; Çapa Kaya, G; Durak, H | 1 |
| Honda, Y; Nagasaki, Y; Ochi, N; Takigawa, N; Yamane, H | 1 |
| Law, SY; Lee, EY; Lo, AW; Vardhanabhuti, V | 1 |
| Gautam, S; Rathi, PM; Sharma, S | 1 |
| Agarwal, KK; Bal, C; Kumar, R; Mukherjee, A | 1 |
| Han, KH; Hwang, SH; Kim, DY; Lee, JW; Yun, M | 1 |
| Cho, HJ; Choi, GH; Hwang, SH; Kim, KS; Lee, JW; Yun, M | 1 |
| Coolen, J; Coosemans, W; Demey, K; Deroose, CM; Haustermans, K; Nafteux, P; Van Cutsem, E; Van Veer, H; Vandecaveye, V | 1 |
| Byun, HK; Han, KH; Hwang, SH; Rhee, WJ; Seong, J; Yun, M | 1 |
| Akamatsu, N; Egawa, H; Endo, I; Furukawa, H; Gotoh, M; Hakamada, K; Honda, M; Inomata, Y; Ishiyama, K; Ito, E; Kaido, T; Kawagishi, N; Kenjo, A; Kokudo, N; Ku, Y; Kubo, S; Kuramitsu, K; Maehara, Y; Miyazaki, M; Nagano, H; Nakanishi, C; Ohdan, H; Ohtsuka, M; Okajima, H; Shirabe, K; Sugawara, Y; Takada, T; Takada, Y; Takahara, T; Takamura, H; Takeda, K; Taketomi, A; Toyoki, Y; Uemoto, S; Wada, H; Wakabayashi, G; Yamaue, H | 1 |
| Chiti, A; Costa, G; Lopci, E; Pedicini, V; Poretti, D; Rodari, M; Solbiati, L; Torzilli, G; Viganò, L | 1 |
| Ding, LY; Jiang, ZL; Liu, KJ; Wu, HY; Wu, SX | 1 |
| Balci, D; Bilgic, S; Elhan, AH; Gecim, E; Kucuk, NO; Soydal, C | 1 |
| Hadas, M; Halankar, J; Hussey, D; Langer, D; Metser, U; Mohan, R; Tamir, S | 1 |
| Ishii, K; Ito, K; Kudo, Y; Miwa, K; Oda, K; Osawa, T; Unno, Y; Wagatsuma, K; Yokokawa, N | 1 |
| Fanfani, F; Ferrandina, G; Gentileschi, S; Mattoli, MV; Palluzzi, E; Pennacchia, I; Scambia, G; Valentini, AL; Zannoni, G | 1 |
| Dudek, W; Grützmann, R; Schreiner, W; Sirbu, H; Stapel, P; Vassos, N | 1 |
| Ahn, BC; Hong, CM; Jang, YJ; Jeong, SY; Lee, J; Lee, SW | 1 |
| Abuodeh, Y; Ahmed, KA; Anaya, DA; Biebel, B; Choi, J; El-Haddad, G; Frakes, JM; Hoffe, SE; Kim, R; Kim, Y; Kis, B; Malafa, M; Naghavi, AO; Sweeney, J; Venkat, PS | 1 |
| Chu, LY; Hsu, CN; Jeng, LB; Kao, CH; Liao, CW; Lin, CL; Lin, CY; Yen, KY | 1 |
| Xie, P; Zhuang, H | 1 |
| Anaye, A; Denys, A; Dunet, V; Halkic, N; Meuli, RA; Prior, JO; Schmidt, S; Sempoux, C | 1 |
| Beeke, C; Chen, J; Karapetis, C; Kumar, R; Padbury, R; Price, T; Ullah, S; Wong, GYM | 1 |
| Anderson, KL; Borgatti, A; Feeney, DA; Froelich, J; Koopmeiners, JS; Modiano, JF; Ober, CP; Scott, R; Stuebner, K; Vallera, DA; Winter, AL | 1 |
| Fischer, G; Hakami, YA; Huellner, MW; Veit-Haibach, P; Wagner, F; Warnock, G | 1 |
| Acuff, S; Fu, Y; Kaman, A; Neveu, M; Osborne, DR; Syed, M | 1 |
| Ahn, CS; Hwang, S; Jung, DH; Kang, WH; Kim, KH; Lee, SG; Lee, YJ; Moon, DB; Park, GC; Song, GW | 1 |
| Abaalkhail, F; Ahmed, B; Al Sebayel, M; Al-Hamoudi, W; Al-Kattan, W; Alabbad, S; Alotaibi, F; Alsofayan, M; Boehnert, MU; Broering, D; Chorley, A; Elbeshbeshy, H; Elsiesy, H; Kabbani, M | 1 |
| Crukley, C; Desjardins, L; Hadway, J; Lee, TY; Morrison, L; Stewart, E; Wang, Y | 1 |
| Guo, QY; He, YX | 1 |
| Bipat, S; IJzermans, JN; Oyen, WJ; Planting, AS; Stoker, J; van Leeuwen, MS | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Kuehl, H; Rosenbaum-Krumme, S; Stergar, H; Veit-Haibach, P | 1 |
| Brouwers, AH; Hospers, GA; Mulder, NH; Siemerink, EJ | 1 |
| Arena, V; Casoni, R; Douroukas, A; Pelosi, E; Skanjeti, A | 1 |
| de la Morena, E; Gasent Blesa, JM; Laforga Canales, JB; Vázquez, C; Vilaseca Martínez, D | 1 |
| Deguchi, A; Kaji, M; Kameyama, R; Kashiwagi, H; Nishiyama, Y; Ohkawa, M; Okano, K; Yamamoto, Y | 1 |
| Akiyoshi, T; Fujimoto, Y; Koyama, M; Kuroyanagi, H; Matsueda, K; Muto, T; Oya, M; Tanaka, H; Ueno, M; Yamaguchi, T | 1 |
| Chen, MY; Fan, W; Liang, PY; Lin, XP; Zhang, X; Zhao, C; Zhi, SF | 1 |
| Dehdashti, F; Fernandez, FG; Finkelstein, SE; Hawkins, WG; Linehan, DC; Siegel, BA; Strasberg, SM | 1 |
| Arora, A; Pathak, S; Purandare, NC; Rajnish, A; Rangarajan, V; Shah, S | 1 |
| Badiee, S; Chu, B; Coakley, F; Franc, BL; Hawkins, RA; Singer, L; Webb, EM | 1 |
| Balabanova, AA; Berezin, SM; Granov, AM; Iakovleva, EK; Kalashnikov, PA; Pozdniakov, AV; Prozorovskiĭ, KV; Rozengauz, EV; Ryzskova, DV; Shelkoplias, EN; Stanzhevskiĭ, AA; Tiutin, LA; Tlostanova, MS | 1 |
| Balabanova, AA; Kostenikov, NA; Prozorovskiĭ, KV; Ryzskova, DV; Tiutin, LA; Tlostanova, MS | 1 |
| Endo, K; Nakajima, T; Oriuchi, N; Paudyal, B; Paudyal, P; Tsushima, Y | 1 |
| Ameye, L; Delatte, P; Flamen, P; Ghanem, G; Hendlisz, A; Van Den Eynde, M; Vanderlinden, B | 1 |
| Choi, JI; Kang, KW; Kim, CM; Kim, JH; Kim, SK; Lee, WJ; Nam, BH; Park, JW; Park, KW | 1 |
| He, C; Hu, JB; Sun, XN; Xu, J | 1 |
| Assumpcao, L; Buijs, M; Choti, MA; Gleisner, AL; Pawlik, TM; Schulick, RD; Vossen, JA | 1 |
| Chen, YL; Hung, GU; Lee, JK; Yeh, YH | 1 |
| D'souza, MM; Jaimini, A; Mishra, A; Mondal, A; Saw, SK; Sharma, R; Singh, D; Tripathi, M; Tripathi, RP | 1 |
| Barzilai, M; Domachevsky, L; Peled, N | 1 |
| Seto, J | 1 |
| Bailly, P; Daouk, J; Fin, L; Meyer, ME | 1 |
| Eisele, RM; Neuhaus, P; Schumacher, G | 1 |
| Fong, Y; Gulec, SA; Hall, M; Pennington, K | 1 |
| Arslan, N; Ataergin, S; Ozet, A; Ozguven, MA | 1 |
| Bärthel, E; Freesmeyer, M; Gottschild, D; Habrecht, O; Jandt, K; Katenkamp, K; Kornberg, A; Sappler, A; Settmacher, U; Steenbeck, J | 1 |
| Oyen, WJ; Ruers, TJ; Vogel, WV; Wiering, B | 1 |
| Choe, W; Hwang, KH; Jeon, IS; Kim, JE; Kwon, CG; Lee, MK; Tchah, H | 1 |
| Hiyama, A; Hori, K; Kawakami, Y; Suga, K | 1 |
| Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Kitamura, K; Nakajima, A; Nakamoto, Y; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Chung, JK; Kang, KW; Kwon, HW; Lee, DS; Lee, JW; Lee, MC; Paeng, JC; Suh, KS | 1 |
| Hamada, N; Jinnouchi, S; Matukita, S; Nakajo, M; Sueyoshi, K; Tanabe, H; Tateno, R | 1 |
| Chong, A; Jeong, SY; Min, JJ | 1 |
| Broccoli, P; D'Urso, S; Danieli, R; Fusco, N; Maurici, M; Orlacchio, A; Schillaci, O; Simonetti, G; Yamgoue, M | 1 |
| Brouwers, AH; de Vries, EG; Fiebrich, HB; Koopmans, KP | 1 |
| Bode, B; Dummer, R; Fischer, DR; Goldinger, S; Imhof, L; Steinert, HC; Strobel, K; Veit-Haibach, P; von Schulthess, GK | 1 |
| Basu, S; Rao, R | 1 |
| Dierckx, R; Maes, A; Peeters, M; Van De Wiele, C | 1 |
| Comans, EF; de Jong, KP; Dekker, HM; Krabbe, PF; Oyen, WJ; Pruim, J; Roumen, RM; Ruers, TJ; van der Sijp, JR; Wiering, B | 1 |
| Biron, P; Cimarelli, S; Deshayes, E; Desuzinges, C; Giammarile, F; Mognetti, T; Rivoire, M | 1 |
| Quon, A; Zissen, MH | 1 |
| Addeo, P; Bucci, L; Camera, L; D'Antonio, D; Mainenti, PP; Mainolfi, C; Manchia, A; Mancini, M; Maurea, S; Pace, L; Persico, F; Persico, G; Salvatore, M; Speranza, A; Tanga, M | 1 |
| Adie, S; Chu, F; Morris, DL; Yip, C | 1 |
| Hany, TF; Husmann, L; Schaefer, NG; Soyka, JD; Strobel, K; Treyer, V; Tschopp, A; Veit-Haibach, P | 1 |
| Bang, SH; Kim, JW; Kim, KS; Lee, JD; Park, JY; Yun, M | 1 |
| Lu, F; Meng, T; Qian, ZB; Wang, YT; Xu, YP; Zhu, F | 1 |
| Al-Nahhas, A; Banti, E; Bonciarelli, G; Cordiano, C; Del Favero, G; Fornasiero, A; Galeotti, F; Grassetto, G; Marzola, MC; Massaro, A; Minicozzi, AM; Pasini, F; Rampin, L; Rubello, D | 1 |
| Tzen, KY; Wang, LY; Wu, MZ; Yen, RF | 1 |
| Ahn, KJ; Bang, SH; Hwang, HS; Kang, WJ; Lee, JD; Park, JH; Yun, M | 1 |
| Bender, H; Biersack, HJ; Bucerius, J; Fischer, HP; Pauleit, D; Rabe, C; Risse, JH | 1 |
| Chen, JZ; Liao, WJ; Shi, M; Wang, QS; Wu, HB; You, CX | 1 |
| Desjardins, L; Levy-Gabriel, C; Lumbroso-le Rouic, L; Malhaire, C; Mariani, P; Petras, S; Piperno-Neumann, S; Plancher, C; Salmon, RJ; Servois, V | 1 |
| de Geus-Oei, LF; Heerschap, A; Krabbe, PF; Oyen, WJ; Punt, CJ; van Asten, JJ; van Laarhoven, HW; Visser, EP; Vriens, D | 1 |
| Hatano, E; Higashi, T; Ikai, I; Ishizu, K; Kamimoto, S; Kawashima, H; Kitamura, K; Nakamoto, Y; Nishii, R; Seo, S; Suga, T; Takada, Y; Togashi, K; Uemoto, S | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, M; Heusner, T; Peng, Z; Zhan, Y; Zhou, X | 1 |
| Adachi, E; Endoh, B; Esaka, N; Hashiba, M; Katsushima, S; Kitaoka, S; Komeda, T; Kuroda, E; Maekawa, T; Minamiguchi, S; Mizumoto, Y; Morimoto, H; Ohta, R; Ohta, Y; Shima, N; Tanaka, Y; Tomono, T; Watanabe, T | 1 |
| Bernardi, M; Boschi, S; Colecchia, A; Fanti, S; Farsad, M; Feletti, V; Franchi, R; Frigerio, M; Golfieri, R; Jovine, E; Lodi, F; Magini, G; Patti, C; Serra, C; Trevisani, F; Vivarelli, M | 1 |
| Luo, L; Tang, G; Tang, X | 1 |
| Kim, HK; Kim, YS; Park, JM; Park, SJ | 1 |
| Hitachi, S; Ishida, K; Kaneta, T; Katayose, Y; Rikiyama, T; Takahashi, S; Takanami, K; Unno, M; Yamada, S; Yamada, T | 1 |
| Chen, YK; Yeh, CL | 1 |
| Bako, F; Banfalvi, G; Hunyadi, J; Juhasz, T; Kertai, P; Marian, T; Pocsi, I; Trencsenyi, G | 1 |
| Amthauer, H; Denecke, T; Grabik, W; Grieser, C; Hamm, B; Hänninen, EL; Lüdemann, L; Ricke, J; Rühl, R; Schnapauff, D; Steffen, IG; Wust, P | 1 |
| Kim, YC; Park, MS | 1 |
| Buvat, I; Doyeux, K; Gardin, I; Grotus, N; Hapdey, S; Stute, S; Tylski, P; Vanderlinden, B | 1 |
| Adduci, AJ; Harvin, HJ | 1 |
| Goethals, I; Ham, H; Hanssens, S; Kortbeek, K; Smeets, P; Van Belle, S | 1 |
| Lencioni, R; Llovet, JM | 1 |
| Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T | 1 |
| Chen, F; De Keyzer, F; Feng, Y; Li, J; Marchal, G; Ni, Y; Nuyts, J; Wang, H; Yu, J | 1 |
| Donati, OF; Hany, TF; Marincek, B; Reiner, CS; Seifert, B; von Schulthess, GK; Weishaupt, D | 1 |
| Donati, OF; Fornaro, J; Hany, TF; Marincek, B; Reiner, CS; von Schulthess, GK; Weishaupt, D | 1 |
| Akkaş, BE; Gullu, I; Kitapci, MT; Sokmensuer, C | 1 |
| Campbell, J; Gates, VL; Ho, CL; Lewandowski, RJ; Qing, F; Salem, R; Savin, M; Tang, B; Thie, J; Wong, CY | 1 |
| Izuishi, K; Masaki, T; Sano, T; Suzuki, Y; Takebayashi, R; Yamamoto, Y | 1 |
| Brown, RK; Frey, KA; Hansen, N; Khan, A; Orringer, M | 1 |
| Chabrier, G; Detour, J; Goichot, B; Greget, M; Imperiale, A; Keomany, J; Pessaux, P; Rust, E | 1 |
| Li, J; Liu, Y; Wang, JW; Xu, LM; Zhao, S | 1 |
| Cho, SY; Han, SS; Kim, SH; Kim, SK; Kim, YK; Lee, KW; Park, SJ | 1 |
| Assenat, E; Aufort, S; Bacigalupo, L; Eberlé, MC; Gallix, B; Ychou, M | 1 |
| Chan, WS; Khong, PL; Zhang, J | 1 |
| Jung, SA; Kim, CG; Kim, DW; Park, SA; Yang, SH | 1 |
| Kim, SK; Kim, TS; Lee, JW; Lee, SM; Moon, SH | 1 |
| Choi, SK; Park, CH | 1 |
| Al-Nahhas, A; Gordon, F; Habib, N; Hodolic, M; Karunanithy, N; Tait, NP; Wasan, HS | 1 |
| Chen, CJ; Chen, HJ; Chen, HY; Chou, SC | 1 |
| Cheng, W; Li, F; Wu, C; Zhong, D; Zhu, Z; Zhuang, H | 1 |
| Chang, ZH; Guo, QY; Liu, ZY; Lu, ZM | 1 |
| Franzius, C | 1 |
| Dittmar, Y; Götz, M; Heise, M; Rauchfuss, F; Scheuerlein, H; Settmacher, U; Voigt, R | 1 |
| Bipat, S; Niekel, MC; Stoker, J | 1 |
| Adang, EM; Comans, EF; de Jong, KP; Dekker, HM; Krabbe, PF; Oyen, WJ; Pruim, J; Roumen, RM; Ruers, TJ; van der Sijp, JR; Wiering, B | 1 |
| Bomanji, J; Caplin, M; Desai, K; Quigley, AM; Toumpanakis, C; Watkins, J; Woodward, N | 1 |
| Bang, YJ; Han, SW; Im, SA; Kim, TY; Oh, DY; Shin, DY | 1 |
| Klarhöfer, M; Lenz, C; Scheffler, K; Sommer, G; Winter, L | 1 |
| Bakhshi, S; Karunanithi, S; Radhakrishnan, V; Tanveer, N; Thulkar, S | 1 |
| Jang, JY; Kim, BS; Kim, SG; Kim, YS; Koh, ES; Lee, MS; Moon, JH; Park, JM; Park, SK | 1 |
| Ananthasivan, R; Chandra, S; Kavindran, R; Seshadri, N; Srikanth, G | 1 |
| Ancel, D; Balogova, S; Fartoux, L; Grange, JD; Gutman, F; Huchet, V; Kerrou, K; Nataf, V; Rosmorduc, O; Talbot, JN | 1 |
| Ayala-Ramirez, M; Chuang, H; Habra, MA; Jimenez, C; Kyle, K; Núñez, R; Rich, T | 1 |
| Chen, S; Cheng, TK; Ho, CL; Leung, YL | 1 |
| Bonardel, G; Carette, MF; de Labriolle-Vaylet, C; Grahek, D; Housset, B; Lebeau, B; Mangiapan, G; Margery, J; Meignan, M; Milleron, B; Talbot, JN; Vaylet, F | 1 |
| Kim, HO; Kim, JS; Lee, SG; Lee, YS; Ryu, JS; Shin, YM | 1 |
| Corn, DJ; Kolthammer, JA; Kuang, Y; Lee, Z; Salem, N; Tian, H; Wang, F; Wang, Y; Wu, C | 1 |
| Dehdashti, F; Strasberg, SM | 1 |
| Arizono, S; Isoda, H; Nakamoto, Y; Saito, H; Shibata, T; Shimada, K; Togashi, K | 1 |
| Bleichrodt, R; Boerman, O; de Jong, G; Franssen, G; Hendriks, T; Oyen, W | 1 |
| Baum, RP; Daffner, W; Hommann, M; Kaemmerer, D; Katenkamp, K; Kaufmann, R; Petrovitch, A; Prasad, V; Sauerbrey, A; Settmacher, U | 1 |
| Han, A; Xue, J; Yu, J; Yue, J; Zheng, J; Zhu, D | 1 |
| Burbelko, M; Hundt, W; la Fougère, C; Steinbach, S; Tiling, R; Vogtmann, J | 1 |
| Buecher, B; Deleau, C; des Varannes, SB; Flamant, M; Frampas, E; Galmiche, JP; Kraeber-Bodéré, F; Matysiak-Budnik, T; Rousseau, C | 1 |
| Bartenstein, P; Bruns, CJ; Hacker, M; Haug, AR; Heinemann, V; Hoffmann, R; Jakobs, T | 1 |
| Chang, YT; Cheng, MF; Hsu, C; Liu, KL; Tzen, KY; Wang, HP; Wu, YM; Wu, YW; Yen, RF | 1 |
| Beer, AJ; Buck, AK; Eckel, F; Herrmann, K | 1 |
| Morrison, PR; Sainani, NI; Shyn, PB; Silverman, SG; Tatli, S; Tuncali, K | 1 |
| Altomonte, J; Braren, R; Ebert, O; Esposito, I; Neff, F; Rummeny, E; Schwaiger, M; Settles, M; Steingoetter, A | 1 |
| Bercich, L; Bertagna, F; Bosio, G; Fisogni, S; Giubbini, R; Grazioli, L; Orlando, E | 1 |
| Baur-Melnyk, A; Haug, A; Hoffmann, RT; Jakobs, TF; Nikolaou, K; Notohamiprodjo, M; Paprottka, P; Reiser, MF; Rist, C; Schmidt, GP | 1 |
| Apostolopoulos, DJ; Dimitrakopoulou-Strauss, A; Hohenberger, P; Roumia, S; Strauss, LG | 1 |
| Aldridge, M; Almuhaideb, A; Bomanji, JB; Gaze, MN; Papathanasiou, ND; Sullivan, K; Waddington, W | 1 |
| Fabregat, J; Gamez, C; Lladó, L; Martinez, L; Rafecas, A; Ramos, E; Ruiz, S; Serrano, T; Torras, J; Valls, C | 1 |
| Ahn, SH; Han, KH; Kang, WJ; Kim, BK; Kim, DY; Kim, JK; Lee, DY; Lee, JD; Lee, KH; Park, JY; Seong, J | 1 |
| Ersoy, H; Hsiao, E; Laury, A; Menard, MT; Rybicki, FJ | 1 |
| Bılgıç, S; Küçük, O; Laçın, S; Oz, I | 1 |
| Liu, S; Qiao, L; Tong, J; Wah Chan, K; Wang, B; Wang, Y | 1 |
| Abi-Hatem, N; Benard, F; Daube-Witherspoon, ME; El Fakhri, G; Karp, JS; Lim, R; Mankoff, D; Moussallem, E; Scheuermann, J; Surti, S | 1 |
| Bernstine, H; Braun, M; Carmi, R; Groshar, D; Lamash, Y; Sosna, J; Steinmetz, A; Stern, D; Yefremov, N | 1 |
| Cho, HJ; Han, KH; Kim, JW; Lee, IJ; Seong, J; Yoon, HI; Yun, M | 1 |
| Chung, WS; Kim, MJ; Kim, YE; Lee, JD; Seo, HJ | 1 |
| Anthony, MP; Ho, SL; Kwong, YL; Lam, C; Loong, F | 1 |
| Chiang, IP; Hsieh, CY; Hsieh, TC; Hsu, CN; Kao, CH; Sun, SS; Wu, YC; Yang, CF | 1 |
| de Geus-Oei, LF; Heerschap, A; Oyen, WJ; van Laarhoven, HW; Vriens, D | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Schmid, DT; Stoeckli, SJ | 1 |
| Chan, AC; Chan, SC; Cheung, TT; Chok, KS; Fan, ST; Ho, CL; Lo, CM; Ng, KK; Poon, RT; Sharr, WW | 1 |
| He, TT; Tian, JH | 1 |
| Belgers, HJ; Blom, RL; Oostenbrug, LE; Schreurs, WM; Sosef, MN; Vliegen, RF | 1 |
| Abi-Jaoudeh, N; Dalal, S; Glossop, N; Kadoury, S; Krücker, J; Levy, EB; Maass-Moreno, R; Venkatesan, AM; Wood, BJ; Xu, S | 1 |
| Ahn, SH; Choi, HJ; Han, KH; Kim, DY; Lee, JD; Lee, JH; Park, JY; Seo, HJ | 1 |
| Gong, G; Hong, SJ; Hwang, DW; Lee, AL; Lee, JH; Lee, SR; Lee, YM; Park, KM; Sung, TY; Yoon, JH | 1 |
| Chatburn, L; Mercier, G; Peller, PJ; Sacks, A; Subramaniam, RM; Surasi, DS | 2 |
| Hatano, E; Higashi, T; Iida, T; Kitamura, K; Nakamoto, Y; Seo, S; Taura, K; Uemoto, S; Yamanaka, K; Yasuchika, K | 1 |
| Büchler, P; Friess, H; Gottschild, D; Kornberg, A; Krause, B; Küpper, B; Tannapfel, A; Witt, U | 1 |
| Briggs, RH; Chowdhury, FU; Lodge, JP; Scarsbrook, AF | 1 |
| Mi, B; Wan, W; Xu, Q; You, X; Yu, C | 1 |
| De Haan, HA; Gambhir, SS; Iagaru, AH; Reid, TR; Sze, DY | 1 |
| Chen, JH; Jeng, LB; Kao, CH; Liang, JA; Lin, CC; Lin, CY | 1 |
| Ahn, SG; Cho, HJ; Choi, SB; Jeon, TJ; Kim, KS; Kim, SH; Lee, JD; Yun, MJ | 1 |
| Abulafi, M; Artho, G; Brown, G; Garant, A; Hunter, CJ; Lisbona, R; Tekkis, P; Vuong, T | 1 |
| Brock, KK | 1 |
| Delaloye, AB; Denys, A; Leyvraz, S; Orcurto, V; Prior, JO; Schalenbourg, A; Schnyder, P; Voelter, V; Zografos, L | 1 |
| Li, BY; Li, HS; Wang, QS; Wang, QY; Wu, HB; Zhou, WL | 1 |
| Dong, MJ; Ouyang, XB; Pan, JH | 1 |
| Choi, YY; Chung, HW; Jang, KS; Jang, SJ; Kim, JY; Kim, YH; Paik, SS; Song, SY | 1 |
| Cheng, CY; Hou, CH; Lin, LF; Shen, DH | 1 |
| Cui, L; Gao, J; Guan, Z; Shen, Z; Tian, J; Wang, H; Xu, B; Yao, S | 1 |
| Bagni, O; Cannas, P; Chiacchiararelli, L; Chiaramida, P; Cianni, R; D'Agostini, A; D'Arienzo, M; Salvatori, R; Scopinaro, F | 1 |
| Ell, PJ; Engledow, AH; Groves, AM; Imber, C; Pakzad, F; Skipworth, JR | 1 |
| Asakura, K; Kanemoto, H; Mizuno, T; Moriguchi, M; Sasaki, K; Sugiura, T; Sumiyoshi, T; Uesaka, K | 1 |
| Amanuma, M; Higuchi, T; Nakano, S; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Au-Yeung, AW; Lo, AX; Luk, WH | 1 |
| Bertagna, X; Bertherat, J; Dousset, B; Ghander, C; Groussin, L; Legmann, P; Ragazzon, B; Richard, B; Silvera, S; Tenenbaum, F; Tissier, F | 1 |
| Corbin, DJ; Ko, YH; Lee, MJ; Pedersen, PL; Verhoeven, HA; Vogl, TJ | 1 |
| Bartenstein, P; Hacker, M; Haug, AR; Heinemann, V; Laubender, RP; Michl, M; Tiega Donfack, BP; Trumm, C; Uebleis, C; Zech, CJ | 1 |
| Freesmeyer, M; Lopatta, E; Opfermann, T; Schierz, JH; Settmacher, U; Steenbeck, J | 1 |
| Antoch, G; Bölke, E; Budach, W; Gerber, PA; Hautzel, H; Kröpil, P; Matuschek, C; Scherer, A; Zinnmann, F | 1 |
| Chowdhury, FU; Culverwell, AD; Scarsbrook, AF | 1 |
| Goethals, I; Lambert, B; Mees, G; Mertens, K; Van de Wiele, C | 1 |
| Bailly, P; Chatelain, D; Daouk, J; Diouf, M; El Esper, I; Fin, L; Meyer, ME; Morvan, J; Régimbeau, JM; Slama, J | 1 |
| Ahn, BC; Gambhir, SS; Hofmann, LV; Katzenberg, R; Kim, YI; Paulmurugan, R; Ray, S; Ronald, JA; Singh, A | 1 |
| Aras, M; Dane, F; Dede, F; Erdil, TY; Inanir, S; Ones, T; Turoglu, HT | 1 |
| Dang, Y; Feng, R; Huo, L; Li, F; Zhuang, H | 1 |
| Buckens, CF; van den Bosch, MA; van Hillegersberg, R; van Kessel, CS; van Leeuwen, MS; Verkooijen, HM | 1 |
| Akgun, V; Alagoz, E; Battal, B; Ince, S; Karaman, B; Ustunsoz, B | 1 |
| Andratschke, N; Astner, ST; Brügel, M; Bundschuh, RA; Dinges, J; Duma, MN; Essler, M; Molls, M; Schwaiger, M; Ziegler, SI | 1 |
| Choi, BI; Eo, JS; Goo, JM; Han, JK; Han, SW; Im, SA; Kim, DH; Kim, SH; Lee, ES; Paeng, JC; Willmann, JK | 1 |
| Bleichrodt, RP; Boerman, OC; de Jong, GM; Dekker, HM; Gotthardt, M; Hendriks, T; Mus, RD; Oyen, WJ; Visser, EP | 1 |
| Chawla, M; Kumar, R; Malhotra, A; Sharma, P; Thulkar, S | 1 |
| Hsieh, TC; Kao, CH; Sun, SS; Wu, YC; Yen, KY | 1 |
| Dall'Angelo, S; Li, XG; O'Hagan, D; Schweiger, LF; Zanda, M | 1 |
| Diot, Q; Kavanagh, BD; Schefter, TE; Stinauer, MA; Westerly, DC | 1 |
| Balogova, S; Fartoux, L; Huchet, V; Kerrou, K; Nataf, V; Rosmorduc, O; Talbot, JN | 1 |
| Farlow, D; Gan, G; Hollands, M; Lam, VW; Laurence, JM; Pleass, HC; Richardson, A; Yao, J | 1 |
| Eaton, A; Evangelista, L; Fazio, M; Howard, J; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; McArthur, HL; Morris, PG; Park, JY; Patil, S; Serna-Tamayo, C; Ulaner, GA | 1 |
| Bonomo, L; Castaldi, P; De Gaetano, AM; Filograna, L; Gatto, AM; Giordano, A; Rufini, V | 1 |
| Chalian, H; Tochetto, SM; Töre, HG; Yaghmai, V | 1 |
| Ceelen, W; De Bruyne, S; Ferdinande, L; Geboes, K; Laurent, S; Libbrecht, L; Mertens, J; Peeters, M; Smeets, P; Troisi, R; Van Damme, N; Van de Wiele, C | 1 |
| Barron, BJ; Dhanasekaran, R; Kim, HS; Lawson, DH; Piduru, SM; Schuster, DM | 1 |
| Barot, TC; Gulec, SA; Hall, M; Pennington, K; Schwartzentruber, D; Suthar, RR; Wheeler, J | 1 |
| Jadvar, H | 1 |
| Bakir, B; Bilge, O; Gulluoglu, M; Kuyumcu, S; Mudun, A; Ozkan, ZG; Sanli, Y; Turkmen, C | 1 |
| Choi, YY; Jang, KS; Kim, JY; Kim, YH; Lee, JH; Lee, KG; Park, HK; Park, MH; Song, SY | 1 |
| D'Asseler, Y; Dobbeleir, A; Goethals, I; Ham, H; Mertens, J; Van de Wiele, C | 1 |
| Doxani, C; Poulou, LS; Thanos, L; Vakrinos, G; Voulgarelis, M; Xyla, V; Ziakas, PD; Ziogas, DC | 1 |
| Cha, SW; Cho, YD; Choi, DL; Jang, JY; Jeong, SW; Jin, SY; Kim, BS; Kim, HS; Kim, SG; Kim, YS; Lee, JE; Lee, SH | 1 |
| Onal, C; Parlak, C; Reyhan, M; Sonmez, S; Topkan, E | 1 |
| Cameron, AG; Gao, X; Ke, S; Li, M; Lin, J; Qiu, X; Wang, W; Zhang, F; Zhu, VF; Zou, C | 1 |
| Bae, SH; Choi, BG; Choi, JY; Chun, HJ; Jang, JW; Lee, HG; Park, CH; Song, MJ; Yoo, IeR; Yoon, SK | 1 |
| Christophi, C; Kwok, M; Lau, L; Lee, ST; Muralidharan, V; Scott, AM | 1 |
| Adjouadi, M; Bhatt, R; Goryawala, M; Gulec, SA; McGoron, AJ | 1 |
| Alvaro, PR; Atri Moises, M; Feregrino Rodrigo, R; Montell García, M; Moreno Manlio Gerardo, G; Romero Cabello, R; Romero Feregrino, R; Trejo Estrada, R | 1 |
| Freesmeyer, M; Lopatta, E; Schierz, JH; Settmacher, U | 1 |
| Badger, SA; Diamond, T; Jones, C; Lynch, TB; McKie, LD; Taylor, MA | 1 |
| Bresee, C; Friedman, M; Waxman, A; Yu, R; Zalom, M | 1 |
| Iagaru, A; Jeffrey, RB; McDougall, IR; Mosci, C | 1 |
| Bussink, J; de Geus-Oei, LF; de Wilt, JH; Hatt, M; Heijmen, L; Oyen, WJ; Punt, CJ; van Laarhoven, HW; Visser, EP; Visvikis, D | 1 |
| Chen, L; Li, F; Xiao, Y; Zhang, J; Zhuang, H | 1 |
| Dong, A; Dong, H; Gong, J; Lu, J; Wang, Y; Zuo, C | 1 |
| Alavi, A; Chen, W; Cheng, G; Torigian, DA; Zhuang, H | 1 |
| Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ | 1 |
| Allende-Riera, A; Cabello-García, D; Cárdenas-Negro, JC; De Sequera-Rahola, M; Martínez-Gimeno, E; Muñoz-Iglesias, J; Ochoa-Figueroa, MA; Uña-Gorospe, J | 1 |
| Kara Gedik, G; Kaya, B; Ozcan Kara, P; Sari, O; Varoglu, E | 1 |
| Han, SS; Kim, C; Kim, SH; Kim, SK; Kim, YK; Lee, SD; Park, SJ | 1 |
| Ito, T; Kawabata, K; Noguchi, A; Okano, S; Shimizu, T; Tani, N; Yamaguchi, M; Yamane, T | 1 |
| Andersson, R; Ansari, D; Keussen, I | 1 |
| Abe, Y; Chijiwa, T; Ishida, J; Kawai, K; Nagata, M; Nakamura, M; Sakata, I; Suemizu, H; Tamura, K; Tsukada, H | 1 |
| Chen, W; Chen, Z; Liang, H; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X | 1 |
| Knox, JJ; Zhu, AX | 1 |
| Breitenstein, S; Burger, IA; Hany, TF; Samarin, A; Schwarz, EI; Weber, A | 1 |
| Kim, HG; Kim, IY; Kim, SW; Kim, SY; Lee, SM; Park, JM; Shin, HC | 1 |
| Deroose, CM; George, J; Loeckx, D; Nuyts, J; Suetens, P; Tejpar, S; Van de Casteele, E; Vunckx, K | 1 |
| McCannel, TA; Sai, V; Straatsma, BR; Wen, JC | 1 |
| Chan, SC; Chen, S; Cheung, TT; Chok, KS; Fan, ST; Fung, JY; Ho, CL; Lo, CM; Poon, RT; Sharr, W; Yan Chan, AC; Yau, T | 1 |
| Han, JK; Ni, M; Pan, B; Wang, CS; Xu, SC; Zhan, LF | 1 |
| Couturier, O; Fosse, P; Girault, S; Hoareau, J; Morel, O; Testard, A | 1 |
| Beels, L; Brugman, E; D'Asseler, Y; De Spiegeleer, B; Maes, A; Mees, G; Stellamans, K; Van de Wiele, C | 1 |
| Martin, A; Sharma, B; Zerizer, I | 1 |
| Detry, R; Gigot, JF; Kartheuser, A; Lonneux, M; Pauwels, S; Reffad, AM | 1 |
| Higashiyama, S; Kawabe, J; Koyama, K; Ochi, H; Okamura, T; Ozawa, N; Yamada, R | 1 |
| Jörg, L; Langsteger, W | 1 |
| Clavien, PA; Hagge, R; Killius, J; Nelson, RC; Paulson, EK; Rohren, EM; Wong, TZ | 1 |
| Filice, C; Prati, U; Roveda, L; Trotta, F | 1 |
| Corstens, FH; Jager, GJ; Langenhoff, BS; Oyen, WJ; Ruers, TJ; Strijk, SP; Wobbes, T | 1 |
| Arrighi, JA; Fogarasi, MC; Kummar, S; Messana, SA; Seibyl, JP; Zelkowitz, RS | 1 |
| Clark, PA; Nakamoto, Y; Tatsumi, M; Wahl, RL | 1 |
| Choi, CY; Han, CJ; Im, SM; Jeong, SH; Kim, BI; Kim, J; Kim, YC; Lee, JO; Son, HB | 1 |
| Bingham, JB | 1 |
| Horaguchi, N; Imafuku, H; Kaihou, M; Kakiuchi, T; Kikkawa, H; Koike, C; Kuruto, R; Matsuura, N; Oku, N; Takada, Y; Takiguchi, A; Tsukada, H; Uchida, T; Yamazaki, Y | 1 |
| Ho, CL; Yeung, DW; Yu, SC | 1 |
| Delbeke, D; Pinson, CW | 1 |
| Cohade, C; Leal, JP; Marshall, LT; Nakamoto, Y; Osman, MM; Wahl, RL | 1 |
| Alavi, A; Anderson, GS; Brinkmann, F; Soulen, MC; Zhuang, H | 1 |
| Frick, MP; Karabulut, N; Martin, DR; Yang, M | 1 |
| Bomanji, J; Costa, DC; Croasdale, I; Ell, PJ; Gacinovic, S; Lonn, AH; Visvikis, D | 1 |
| Chapman, WC; Delbeke, D; Morris, D; Pinson, CW; Rice, M; Shyr, Y; Washington, MK; Wudel, LJ | 1 |
| Balan, A; Balan, KK | 1 |
| Dimitrakopoulou-Strauss, A; Rudi, J; Strauss, LG | 1 |
| Bourguet, P | 1 |
| Delos, M; Krug, B; Lacrosse, M; Martinet, JP; Vander Borght, T | 1 |
| Delbeke, D; Hopper, OW; Kikkawa, R; Ludwig, V; Martin, WH | 1 |
| Aizer-Dannon, A; Bar-Am, A; Even-Sapir, E; Flusser, G; Ron, IG | 1 |
| Lilien, DL; Reddy, MP; Reddy, P | 1 |
| Constable, CJ; Fulham, MJ; McCaughan, BC; Wilkinson, MD | 1 |
| Higashi, T; Imamura, M; Ishimori, T; Ishizu, K; Kobayashi, H; Konishi, J; Mamede, M; Nakamoto, Y; Saga, T; Sakahara, H; Sato, N | 1 |
| Annovazzi, A; Dierckx, R; Maenhout, A; Peeters, M; Signore, A; Van De Wiele, C | 1 |
| Erdi, Y; Larson, SM; Sarikaya, I; Yeung, HW | 1 |
| Bêlohlávek, O; Kantorová, I; Lipská, L; Schneiderová, M; Trubaĉ, M; Visokai, V | 1 |
| Chen, J; Li, QG; Liu, QW; Yao, SZ; Zhang, CQ | 1 |
| Jamar, F; Lonneux, M | 1 |
| Granov, AM; Kostenikov, NA; Ryzhkova, DV; Savello, VE; Stanzhevskiĭ, AA; Tiushin, LA; Tlostanova, MS | 1 |
| Alvarez, E; Arranz, JA; Calvo, FA; Carreras, JL; Desco, M; Domper, M; Martínez-Lázaro, R; Matute, R | 1 |
| Donckier, V; Feron, P; Gelin, M; Goldman, S; Ickx, B; Van Gansbeke, D; Van Laethem, JL; Wikler, D | 1 |
| Böhm, B; Geoghegan, J; Gottschild, D; Hellfritzsch, H; Petrovich, A; Scheele, J; Voth, M | 1 |
| Arulampalam, TH; Ell, PJ; Francis, DL; Taylor, I; Visvikis, D | 1 |
| Koumanis, DJ; Meterissian, S; Tzimas, GN | 1 |
| Cistaro, A; Fazio, F; Giraldi, E; Landoni, C; Messa, C; Provenzi, M; Sironi, S; Sonzogni, A | 1 |
| Bozzetti, F; Crippa, F; Gavazzi, C; Mariani, L | 1 |
| Fukuda, K; Koh, T; Kunishima, S; Taniguchi, H; Yamagishi, H | 1 |
| Bertagna, X; Bertherat, J; Dousset, B; Foehrenbach, H; Gouya, H; Groussin, L; Legmann, P; Richard, B; Tenenbaum, F; Tissier, F | 1 |
| Fuse, H; Hisada, K; Kamisaki, Y; Kato, H; Matsunari, I; Noguchi, K; Seto, H; Shimizu, M; Watanabe, N | 1 |
| Chen, Y; He, XF; Li, YH; Liu, FY; Shang, JB; Wang, JY; Zeng, QL | 1 |
| Oyen, WJ; Ruers, TJ; Wiering, B | 1 |
| Choi, Y; Choi, YH; Han, KH; Kim, JS; Kim, KS; Kim, SJ; Lee, JD; Lee, JM; Lee, WJ; Lim, SM; Park, JH; Park, YN; Yang, WI; Yoo, N; Yun, M | 1 |
| Alavi, A; Chiang, S; Fuster, D; Johnson, G; Schuchter, LM; Zhuang, H | 1 |
| Chin, VT; Costello, SP; Court, FG; Kirkwood, ID; Maddern, GJ; Morrison, CP; Teague, BD | 1 |
| Bumm, R; Dresel, S; Hahn, K; Meimarakis, G; Rosa, F; Stahl, A; Tatsch, K | 1 |
| Dehdashti, F; Drebin, JA; Fernandez, FG; Linehan, DC; Siegel, BA; Strasberg, SM | 1 |
| Basu, S; Nair, N | 2 |
| Gharib, AM; Li, KC; Thomasson, D | 1 |
| Rummeny, E; Schwaiger, M; Stollfuss, J; Wieder, H | 1 |
| Barker, D; Dworkin, HJ; Gates, V; Hill, EA; Lewandowski, R; Nagle, C; Qing, F; Salem, R; Wong, CY; Wong, KT | 1 |
| Nguyen, BD | 2 |
| Futatsubashi, M; Kanno, T; Nakamura, F; Nakamura, S; Sakahara, H; Sugiyama, M; Torizuka, T | 1 |
| Kashiwagi, T | 1 |
| Hashimoto, D; Hoshino, T; Ishida, H; Nakada, H; Ohsawa, T; Okada, N; Ozawa, F; Takeuchi, I; Yokoyama, M | 1 |
| Dai, JZ; Dong, MJ; Guan, YH; Lin, XT; Yu, DF; Zhao, J; Zuo, CT | 1 |
| Matsumoto, K; Matsuura, H; Minota, E; Nakamoto, Y; Sakamoto, S; Senda, M | 1 |
| Clavien, PA; Hany, TF; Kadry, Z; McCormack, L; Selzner, M; Wildbrett, P | 1 |
| Amesur, N; Avril, N; Bienert, M; Carr, BI; Geller, DA; McCook, B; Sheetz, M | 1 |
| Kula, Z; Pietrzak, T; Romanowicz, G; Szefer, J; Zuchora, Z | 1 |
| Cheon, GJ; Choi, CW; Han, CJ; Jeong, SH; Ki, SS; Kim, J; Kim, MJ; Kim, YC; Kong, YH; Lee, JO; Lee, SD; Lim, SM; Sohn, WS | 1 |
| Liu, SW; Xing, LG; Yu, JM | 1 |
| Amir, R; Bourgeot, B; Liehn, JC; Marcus, C; Papathanassiou, D | 1 |
| Bueno, JG; Domínguez Grande, ML; Fernández, JP; Kosvintseva, O; Oromendía, AO; Pozo, MA; Suárez, AM; Zomeño, M | 1 |
| Ernst, O; Hebbar, M; Huglo, D; Pruvot, FR; Steinling, M; Truant, S | 1 |
| de Geus, LF; de Waal, RM; Oyen, WJ; Peeters, CF; Ruers, TJ; Ruiter, DJ; Westphal, JR; Wobbes, T | 1 |
| Blokhuis, TJ; Comans, EF; Manoliu, RA; van den Tol, MP; van der Schaaf, MC; van der Sijp, JR | 1 |
| Hung, GU; Lin, WY; Tsai, SC | 1 |
| Amesur, N; Avril, N; Bienert, M; Carr, BI; Geller, DA; McCook, B; Sheetz, M; Tutor, C | 1 |
| Barker, DW; Kavanagh, PV; Morton, KA; Shen, P; Zagoria, RJ | 1 |
| Hirota, T; Kato, T; Nishimura, T; Tanaka, O; Yamagami, T | 1 |
| Howman-Giles, R; McCowage, G; Philip, I; Shun, A | 1 |
| Altehoefer, C; Ghanem, N; Högerle, S; Kotter, E; Langer, M; Lohrmann, C; Nitzsche, E; Schäfer, O | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Kuehl, H; Stergar, H; Veit, P | 1 |
| Helmberger, T; Jacobs, TF; Münzing, W; Pöpperl, G; Schmid, R; Tatsch, K | 1 |
| Blankenberg, FG; Kuge, Y; Sato, M; Strauss, HW; Tait, JF; Takei, T; Tamaki, N; Zhao, S | 1 |
| Kurtovic, J; Riordan, SM; Van Der Wall, H | 1 |
| Chen, YK; Kao, CH | 1 |
| Adusumilli, P; Fong, Y; Song, TJ | 1 |
| Blake, M; Fischman, AJ; Hahn, PF; Kadavigere, R; Kalva, SP; Sahani, DV; Saini, S | 1 |
| Finger, PT; Kurli, M; Pavlick, AC; Reddy, S; Tena, LB | 2 |
| Collins, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H | 1 |
| Malde, S; Mody, RJ; Pohlen, JA; Shulkin, BL; Strouse, PJ | 1 |
| Khandani, AH; Wahl, RL | 1 |
| Bipat, S; Bossuyt, PM; Comans, EF; Pijl, ME; Stoker, J; van Leeuwen, MS; Zwinderman, AH | 1 |
| Aparici, F; Aznar, DL; Flores, D; Garcia, EU; Martínez, C; Ojeda, R; Sánchez, PA; Sopena, R | 1 |
| Campbell, J; Gates, VL; Lewandowski, RJ; Nagle, C; Qing, F; Salem, R; Savin, M; Sherpa, KM; Wong, CY | 1 |
| Fischman, AJ; Hahn, PF; Kalva, SP; Mueller, P; Ryan, D; Sahani, DV; Saini, S | 1 |
| Alison, ME; Balan, KK; Beadsmoore, CJ; Cheow, HK; Gibbs, P; Lomas, DJ; Sala, E; Save, V | 1 |
| Baker, JG; Bednarczyk, EM; Nabi, HA; Zubeldia, JM | 1 |
| Amir, R; Becker, S; Liehn, JC; Menéroux, B; Papathanassiou, D | 1 |
| Fan, WJ; Gu, YK; Huang, JH; Lin, YE; Tan, ZB; Wu, PH; Zeng, YX; Zhang, FJ; Zhang, L; Zhao, M | 1 |
| Figarola, MS; McQuiston, SA; Powell, R; Wilson, F | 1 |
| Khandani, AH; Semelka, RC | 1 |
| de Geus-Oei, LF; Heerschap, A; Kaanders, JH; Krabbe, PF; Lok, J; Oyen, WJ; Punt, CJ; Rijpkema, M; Ruers, T; van der Kogel, AJ; van Laarhoven, HW; Wiering, B | 1 |
| Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Satoh, K; Tsutsui, K; Yamamoto, Y; Yokoe, K | 1 |
| Habu, D; Hayashi, T; Kawabe, J; Kawamura, E; Kotani, J; Oe, A; Sakaguchi, H; Shiomi, S; Torii, K | 1 |
| Hanajiri, K; Kondo, Y; Maruyama, T; Mitsui, H; Nakagawa, K; Omata, M; Shiina, S | 1 |
| Akhurst, T; Chessin, DB; Guillem, JG; Kiran, RP | 1 |
| Akhurst, T; Blumgart, L; Burt, BM; Fong, Y; Jarnagin, W; Kates, TJ; Larson, SM; Mazumdar, M; Riedel, ER; Yeung, H | 1 |
| Jager, GJ; Krabbe, PF; Oyen, WJ; Ruers, TJ; Wiering, B | 1 |
| Arveux, P; Bedenne, L; Bey, P; Bismuth, MJ; Conroy, T; Faivre, J; Guillemin, F; Lejeune, C; Zanni, C | 1 |
| Gupta, C; Gupta, V; Malani, AK; Rangineni, S | 1 |
| Gates, VL; Geschwind, JF; Goin, JE; Lewandowski, RJ; Salem, R; Thurston, KG; Van Buskirk, M; Wong, CY | 1 |
| Bandou, H; Ishiguro, K; Kinoshita, S; Koizumi, H; Kotake, M; Murakami, N; Yamada, T | 1 |
| Aderka, D; Davidson, T; Goshen, E; Zwas, ST | 1 |
| Erturk, SM; Fujii, H; Ichikawa, T; Ros, PR; Yasuda, S | 1 |
| Bybel, B; Guglielmi, AN; Kim, BY; Slifkin, N | 1 |
| Guest, P; Isaac, J; John, A; Khan, S; Mirza, DF; Singhvi, S; Tan, YM | 1 |
| Connolly, LP; Gauger, PG; Hurwitz, CA; Kunter, G; Mackie, GC; Mody, RJ; Ribeiro, RC; Rodriguez-Galindo, C; Schteingart, DE; Shulkin, BL; Wallis, JW; Worden, FP | 1 |
| Chen, X; Hadway, J; Lee, TY; Stewart, EE | 1 |
| de Bruin, PC; Koelemij, R; Oreel, MA; Tiel-van Buul, MM; Verzijlbergen, JF | 1 |
| De Renzo, A; Mainolfi, C; Pace, L; Perna, F; Persico, M | 1 |
| Batra, K; Chhabra, A; Makler, PT | 1 |
| Hisada, K; Kageyama, M; Kamisaki, Y; Kato, H; Kawabe, H; Matsunari, I; Murakami, J; Seto, H; Shimizu, M; Watanabe, N | 1 |
| Bawa, M; Galt, JR; Halkar, RK; Schuster, DM; Sidhu, G | 1 |
| Kohlfürst, S; Lind, P | 1 |
| Francken, AB; Fulham, MJ; Millward, MJ; Thompson, JF | 1 |
| Fartoux, L; Ganne, N; Grahek, D; Grange, JD; Gutman, F; Kerrou, K; Montravers, F; Poupon, R; Rosmorduc, O; Talbot, JN | 1 |
| Fujii, H; Hatano, E; Higashi, T; Ikai, I; Saga, T; Shimahara, Y; Teramukai, S; Torizuka, T | 1 |
| Chang, TH; Cheng, CY; Huang, WS; Lin, MH; Liu, CH; Shen, DH | 1 |
| Li, H; Wang, QS; Wang, XL; Zhang, XL | 1 |
| Amthauer, H; Denecke, T; Gutberlet, M; Hänninen, EL; Hildebrandt, B; Langrehr, J; Miersch, A; Nicolaou, A; Plotkin, M; Ricke, J; Riess, H; Ruf, J; Rühl, R; Stroszczynski, C | 1 |
| Cho, EH; Cho, JY; Cho, YB; Lee, HW; Lee, KU; Suh, KS; Yang, SH; Yi, NJ | 1 |
| Keith, C; Miles, K | 1 |
| Plukker, JT; van Westreenen, HL | 1 |
| Arii, S; Ishiwata, K; Kawamura, K; Liu, HY; Oda, K; Teramoto, K | 1 |
| Albertini, AF; Devaux, JY; Ech-Charraq, I; Hindié, E; Weinmann, P; Zanotti-Fregonara, P | 1 |
| Chan, AT; Chan, SL; Hui, EP; Leung, SF; Ma, BB | 1 |
| Danno, K; Fukunaga, H; Gu, J; Hatazawa, J; Ikeda, M; Monden, M; Nishimura, T; Sekimoto, M; Takemasa, I; Tatsumi, M; Yamamoto, H | 1 |
| Dekker, HM; Krabbe, PF; Oyen, WJ; Ruers, TJ; Wiering, B | 2 |
| Hicks, RJ; Lau, EW; Ware, RE | 1 |
| Corstens, FH; de Geus-Oei, LF; Leer, JW; Oyen, WJ; Punt, CJ; Ruers, TJ | 1 |
| Al-Nahhas, A; Canelo, R; Habib, N; Jiao, L; Pagou, M; Szyszko, T; Tait, P; Wasan, H | 1 |
| An, M; Choi, JI; Hong, EK; Kim, CM; Kim, SH; Kim, SK; Lee, WJ; Park, JW; Park, SJ; Shin, JA | 1 |
| Hara, T; Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Chen, X; Dai, JZ; Dong, MJ; Guan, YH; Jiang, BD; Lin, XT; Zhao, J; Zuo, CT | 1 |
| Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N | 1 |
| Collins, CD; Duffy, GJ; Malone, DE; Ridge, CA; Sheehan, JJ; Skehan, SJ; Ward, EV | 1 |
| Hayasaka, K; Ishigaki, T; Ito, K; Itou, T; Kato, R; Nihashi, T; Okae, T | 1 |
| Beppu, Y; Kawai, A; Kobayashi, E; Seki, K; Tateishi, U | 1 |
| Ben-Haim, M; Even-Sapir, E; Figer, A; Geva, R; Klausner, JM; Lubezky, N; Metser, U; Nakache, R; Shmueli, E | 1 |
| Akaki, S; Iguchi, T; Kanazawa, S; Matsuoka, J; Mifune, H; Okumura, Y; Omori, M; Sato, S | 1 |
| AL-Nahhas, A; Canelo, R; Gishen, P; Stamp, G; Tait, P; Tehranipour, N; Woo, K | 1 |
| Berthelsen, AK; Hillingsoe, J; Kirkegaard, P; Larsen, PN; Loft, A; Mogensen, AM; Rappeport, ED; Rasmussen, A; Thomsen, C; von der Recke, P; Wettergren, A | 1 |
| Dicken, V; Hoffmann, AL; Karssemeijer, N; Oyen, WJ; Ruers, TJ; van Dalen, JA; Vogel, WV; Wiering, B | 1 |
| Akhurst, T; Bhargava, A; Fong, Y; Hricak, H; Klimstra, D; Larson, S; Riedl, CC; Stanziale, SF; Tuorto, S | 1 |
| Chen, S; Cheng, TK; Ho, CL; Yeung, DW | 1 |
| Arai, Y; Hasegawa, T; Maeda, T; Ojima, H; Sugimura, K; Tateishi, U | 1 |
| van den Hoff, J | 1 |
| Fleshman, JW; Strasberg, SM; Yang, YY | 1 |
| Klippenstein, DL; Lamonica, DM | 1 |
| Al-Nahhas, A; Carnaghi, C; Chiti, A; Doci, R; Luttmann, F; Rimassa, L; Rodari, M; Rubello, D; Santoro, A; Tondulli, L; Torzilli, G; Tronconi, MC; Zuradelli, M | 1 |
| Altmann, A; Bonaterra, GA; Dimitrakopoulou-Strauss, A; Eisenhut, M; Haberkorn, U; Hoffend, J; Kinscherf, R; Schmidt, K; Strauss, LG | 1 |
| Bomanji, JB; Chua, SC; Du, Y; Ell, PJ; Gacinovic, S; Groves, AM; Kayani, I; Menezes, L | 1 |
| Guan, YS; Pan, WM; Sun, L; Wu, H | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Chami, L; Dromain, C; Giraudet, AL; Hartl, D; Lassau, N; Leboulleux, S; Lumbroso, J; Ny Tovo, N; Schlumberger, M; Travagli, JP; Vanel, D | 1 |
| Kawashima, H; Kohanawa, M; Kuge, Y; Seki, K; Takahashi, T; Takei, T; Tamaki, N; Temma, T; Zhao, S; Zhao, Y | 1 |
| Berdel, WE; Bremer, C; Brunnberg, U; Mesters, RM; Müller-Tidow, C; Schleicher, C; Schliemann, C; Schmidt, E; Staebler, A; Stegger, L; Thoennissen, NH | 1 |
| Cheng, MF; Huang, YH; Tzen, KY; Wu, YW; Yen, RF | 1 |
| Chen, GB; Guan, YS; Luo, ZM; Pan, WM; Sun, L; Wu, H | 1 |
| Amthauer, H; Denecke, T; Hänninen, EL; Hildebrandt, B; Langrehr, J; Lehmkuhl, L; Ricke, J; Rühl, R; Steffen, I; Streitparth, F | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Fronz, U; Heusner, TA; Jentzen, W; Verhagen, R | 1 |
| Bassi, MC; Brambilla, M; Cannillo, B; Inglese, E; Krengli, M; La Mattina, P; Loi, G; Sacchetti, G; Turri, L | 1 |
| Clavien, PA; Fried, M; Gerlach, T; Gubler, C; Hany, T; Jochum, W; Mullhaupt, B; Petrowsky, H; Wildi, SM | 1 |
| Dimitrakopoulou-Strauss, A; Strauss, LG | 1 |
| Antoch, G; Barkhausen, J; Blechschmid, N; Bockisch, A; Diersch, O; Freudenberg, LS; Kuehl, H; Veit, P; Vogt, FM | 1 |
| Calvo, BF; Jorgenson, J; Khandani, AH; Mauro, MA; O'Neil, BH | 1 |
| Høyer, M; Keiding, S; Mortensen, FV; Sørensen, M; Vilstrup, H | 1 |
| Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Miyakubo, M; Oriuchi, N; Paudyal, B; Paudyal, P; Takano, A; Tsushima, Y | 1 |
| Dresel, S; Schlag, PM | 1 |
| Balan, KK; Gibbs, P; Huguet, EL; Jamieson, NV; Old, S; Praseedom, RK | 1 |
| Guan, YS; Sun, L; Wu, H; Ye, HY; Zhang, YH | 1 |
| Kim, J; Kim, S; Kostakoglu, L; Machac, J; Mocherla, B; Roayaie, S | 1 |
| Agoff, N; Lin, E | 1 |
| Avila-Rodriguez, MA; Converse, AK; Hampel, JA; Jaskowiak, CJ; McDermott, JC; Nickles, RJ; Selwyn, RG; Thomadsen, BR; Warner, TF | 1 |
| Kanegae, K; Kohanawa, M; Kuge, Y; Seki, K; Takahashi, T; Tamaki, N; Yi, M; Zhao, S; Zhao, Y | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, JK; Lee, JD; Rha, SY; Yoon, KT; Yun, M | 1 |
| Antoch, G; Barkhausen, J; Bockisch, A; Frilling, A; Kuehl, H; Rosenbaum-Krumme, S; Stergar, H; Veit-Haibach, P; Vogt, F | 1 |
| Amthauer, H; Denecke, T; Grieser, C; Hildebrandt, B; Lopez Hänninen, E; Plotkin, M; Podrabsky, P; Ricke, J; Rühl, R; Stelter, L; Stiepani, H; Werk, M | 1 |
| Endo, K; Higuchi, T; Ishikita, T; Miyakubo, M; Nakajima, T; Oriuchi, N; Paudyal, B; Paudyal, P; Tsushima, Y | 1 |
| Banzo, I; Barragan, J; Carril, JM; Jimenez-Bonilla, J; Martinez-Rodriguez, I; Portilla-Quattrociocchi, H; Quirce, R; Sainz-Esteban, A | 1 |
| Lin, E | 1 |
| Chen, GB; Guan, YS; Luo, ZM; Pan, WM; Sun, L; Wei, JH; Wu, H | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lazúrová, I; Ling, A; Pacak, K; Reynolds, JC; Timmers, HJ; Whatley, MA; Widimsky, J; Zelinka, T | 1 |
| Bonomo, G; Chiappa, A; Della Vigna, P; Ferrari, M; Mallia, A; Monfardini, L; Orsi, F; Paganelli, G; Ravasi, L; Travaini, LL; Trifirò, G | 1 |
| Baboï, L; Beuf, O; Langlois, JB; Lartizien, C; Milot, L; Pilleul, F; Roche, C; Scoazec, JY | 1 |
| Brown, G; Cook, GJ; Cunningham, D; Jackson, C; Koh, DM; Kong, G; Lewington, V; Sharma, B | 1 |
| Ahmad, MN; Nadeem, N; Zafar, AM | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Kuehl, H | 1 |
| Buchmann, I; Ganten, TM; Haberkorn, U | 1 |
| Ichinose, Y; Maruyama, R; Nishiyama, K; Okamoto, T; Seto, T; Suemitsu, R; Wataya, H | 1 |
| Castaldo, ET; Chari, RS; Delbeke, D; Gao, F; Hawkins, WG; Linehan, DC; Pinson, CW; Siegel, BA; Strasberg, SM; Tan, MC; Wright, JK | 1 |
| Al-Nahhas, A; Khan, S; Khodjibekova, M; Nijran, K; Szyszko, T; Tait, P | 1 |
| Funada, H; Kameda, K; Kamisaki, Y; Kato, H; Murakami, J; Noguchi, K; Seto, H; Watanabe, N | 1 |
| Carrasquillo, JA; Larson, SM | 1 |
| Welch, MJ | 1 |
| Benua, RS; Brill, AB; Christman, DR; Fowler, JS; Kemeny, NE; MacGregor, RR; Som, P; Stamm, R; Wolf, AP; Yeh, SD; Yonekura, Y | 1 |
| Inokuma, T; Konishi, J; Magata, Y; Sasayama, S; Tamaki, N; Tanaka, A; Torizuka, T; Yamamoto, K; Yamaoka, Y; Yonekura, Y | 1 |
| Ball, D; Bohdiewicz, PJ; Dworkin, H; Juni, JE | 1 |
| Bohdiewicz, PJ; Dworkin, HJ; Fink-Bennett, D; Juni, JE; Nagle, C; Scott, GC; Wilner, F | 1 |
| Ahlström, H; Bergh, J; Jansson, T; Långström, B; Lilja, A; Westlin, JE | 1 |
| Hosokawa, C; Ikeda, H; Kamino, T; Kawabe, J; Ochi, H; Okamura, T; Onoyama, Y | 1 |
| Aerts, R; Beets, G; De Roo, M; Filez, L; Kerremans, R; Mortelmans, L; Penninckx, F; Schiepers, C | 1 |
| Choi, Y; Hawkins, RA; Hoh, CK; Huang, SC; Wu, HM | 1 |
| Inokuma, T; Konishi, J; Magata, Y; Tamaki, N; Tanaka, A; Torizuka, T; Yamamoto, K; Yamaoka, Y; Yonekura, Y | 1 |
| Alpert, NM; Fischman, AJ; Goldberg, MA; Lee, MJ; Mueller, PR; Thrall, JH | 1 |
| Campbell, MG; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
| Fischman, AJ | 1 |
| Cronin, B; Cunningham, D; Findlay, M; Flower, M; Hickish, T; Husband, J; Iveson, A; Ott, R; Pratt, B; Young, H | 1 |
| Chu, KM; Fulham, M; Lai, DT; Sheldon, DM; Solomon, M; Stephen, MS; Storey, DW; Thompson, JF | 1 |
| Hawkins, RA; Hoh, CK; Huang, SC; Phelps, ME; Wu, HM; Yao, WJ | 1 |
| Bishop, AF; Smith, SM; Young, CS | 1 |
| Delbeke, D; Mazer, MJ; Meranze, SG; Pinson, CW; Vitola, JV | 1 |
| Dimitrakopoulou-Strauss, A; Doll, J; Gutzler, F; Irngartinger, G; Oberdorfer, F; Strauss, LG; Stremmel, W; van Kaick, G | 1 |
| Ali, A; Alibazoglu, H; Fordham, E; LaMonica, G; Patel, PM | 1 |
| Arildsen, RC; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
| Jadvar, H; Segall, GM | 1 |
| Belani, CP; Ferson, PF; Keenan, RJ; Landreneau, RJ; Luketich, JD; Meltzer, CC; Schauer, PR; Townsend, DW; Urso, GK | 1 |
| Belani, CP; Cidis Meltzer, C; Ferson, PF; Keenan, RJ; Luketich, JD; Schauer, P; Townsend, DW; Urso, K | 1 |
| Birnbaum, EH; Dehdashti, F; Flanagan, FL; Fleshman, JW; Kodner, IJ; Ogunbiyi, OA; Philpott, GW; Read, TE; Siegel, BA; Trask, DD | 1 |
| Bangerter, M; Ellenrieder, V; Griesshammer, M; Hafner, M; Heimpel, H; Merkle, E; Moog, F; Reske, SN | 1 |
| Abdel-Nabi, H; Carbone, GM; Cronin, VR; Doerr, RJ; Galantowicz, PJ; Lamonica, DM; Spaulding, MB | 1 |
| Dimitrakopoulou-Strauss, A; Doll, J; Hohenberger, P; Irngartinger, G; Oberdorfer, F; Schlag, P; Strauss, LG; van Kaick, G | 1 |
| Chapman, WC; Delbeke, D; Martin, WH; Pinson, CW; Sandler, MP; Wright, JK | 1 |
| Bury, T; Hustinx, R; Jacquet, N; Jerusalem, G; Paulus, P; Rigo, P | 1 |
| Dimitrakopoulou-Strauss, A; Gutzler, F; Moehler, M; Raeth, U; Strauss, LG; Stremmel, W | 1 |
| Shohtsu, A; Tomioka, K; Yasuda, S | 1 |
| Baum, RP; Dietrich, C; Hör, G; Kirchner, J; Rink, T; Schröder, O; Zeuzem, S | 1 |
| Cook, GJ; Mason, R; Rankin, SC; Taylor, H | 1 |
| Couper, GW; McAteer, D; Nicolson, M; Norton, M; Park, KG; Wallis, F; Welch, A | 1 |
| Blair, T; Blanke, C; Chapman, WC; Debelak, JP; Delbeke, D; Pinson, CW; Rose, AT; Rose, DM; Wright, JK | 1 |
| Baum, RP; Schröder, O; Trojan, J; Zeuzem, S | 1 |
| Ali, A; Alibazoglu, B; Alibazoglu, H; La Monica, G | 1 |
| Beger, HG; Diederichs, CG; Fröhlich, A; Reske, SN; Staib, L; Vogel, J | 1 |
| Hadfield, JA; Hastings, DL; McGown, AT; Moore, JV; Pettit, GR; Waller, ML; Zhao, S | 1 |
| Higashi, T; Imamura, M; Kogire, M; Konishi, J; Nakamoto, Y; Sakahara, H; Tamaki, N | 1 |
| Bangard, M; Bangard, N; Bender, H; Biersack, HJ; Metten, N; Mezger, J; Schomburg, A | 1 |
| Fukuda, T; Jomura, H; Kawabe, J; Kawashima, D; Koyama, K; Kuroki, T; Ochi, H; Sasaki, N; Shiomi, S | 1 |
| Bicik, I; Engel, H; Krestin, GP; von Schulthess, GK; Wiesner, W | 1 |
| Brink, I; Moser, E; Nitzsche, EU; Schumacher, T | 1 |
| Jomura, H; Kawabe, J; Kubo, S; Kuroki, T; Morikawa, H; Nishiguchi, S; Ochi, H; Sakaguchi, H; Sasaki, N; Seki, S; Shiomi, S | 1 |
| Collins, BT; Dunphy, FR; Lowe, VJ | 1 |
| Ishida, H; Kimura, T; Makuuchi, H; Mukai, M; Sadahiro, S; Shohtsu, A; Tajima, T; Tokunaga, N; Yasuda, S | 1 |
| Aloj, L; Caracó, C; Eckelman, WC; Jagoda, E; Neumann, RD | 1 |
| Delbeke, D | 1 |
| Baum, RP; Herrmann, G; Jacobi, V; Raedle, J; Schroeder, O; Trojan, J; Zeuzem, S | 1 |
| Akhurst, T; Blumgart, LH; Cohen, A; Finn, RD; Fong, Y; Kemeny, N; Larson, SM; Macapinlac, H; Saldinger, PF; Yeung, H | 1 |
| Aultman, DF; Boykin, KN; Lilien, DL; McDonald, JC; McMillan, RW; Zibari, GB | 1 |
| Beger, HG; Brambs, HJ; Diederichs, CG; Glasbrenner, B; Glatting, G; Reske, SN; Staib, L; Vogel, J | 1 |
| Bender, H; Biersack, HJ; Caselmann, WH; Grünwald, F; Kersjes, W; Palmedo, H; Risse, JH; Strunk, H | 1 |
| Camargo, EE; Etchebehere, EC; Grigolon, MV; Lima, MC; Pin, CA; Ramos, CD; Santos, AO | 1 |
| Baier, P; Dingeldey, A; Einert, A; Farthmann, EH; Imdahl, A; Mix, M; Nitzsche, EU; Reinhardt, MJ | 1 |
| Hansen, SB; Keiding, S; Munk, OL; Schiøtt, KM | 1 |
| Iwata, Y; Jomura, H; Kawabe, J; Nishiguchi, S; Ochi, H; Sasaki, N; Seki, S; Shiomi, S | 1 |
| Czernin, J; Gambhir, SS; Huebner, RH; Park, KC; Phelps, ME; Schwimmer, J; Shepherd, JE | 1 |
| Delbeke, D; Patton, JA; Sandler, MP | 1 |
| Amthauer, H; Beier, J; Felix, R; Herbel, A; Hosten, N; Kreissig, R; Lemke, AJ; Puls, R; Rohlfing, T; Stroszczynski, C | 1 |
| Dietlein, M; Gossmann, A; Groth, W; Krug, B; Lackner, K; Psaras, T; Scheidhauer, K; Schicha, H; Stützer, H | 1 |
| Beger, HG; Reske, SN; Schirrmeister, H; Staib, L | 1 |
| Bangard, M; Bender, H; Biersack, HJ; Decker, P; Grünwald, F; Willkomm, P | 1 |
| Alavi, A; Duarte, PS; Pourdehnad, M; Sinha, P; Yamamoto, AJ; Zhuang, H | 1 |
| Carreras, JL; Domper, M; Expósito, R; Jiménez-Vicioso, A; Montz, R; Ortega, A; Pérez-Castejón, MJ | 1 |
| Imamoto, E; Kondo, M; Kou, T; Kuchide, M; Kunishima, S; Naito, Y; Taniguchi, H; Tomatsuri, N; Yoshida, N; Yoshikawa, T | 1 |
| Graham, MM; Hayward, RM; Peterson, LM | 1 |
| Neumann, MC; Schober, O | 1 |
| Arulampalam, TH; Costa, DC; Ell, PJ; Loizidou, M; Taylor, I; Visvikis, D | 1 |
| Becherer, A; Dudczak, R; Kaserer, K; Kletter, K; Kurtaran, A; Müller, C; Pfeffel, F; Raderer, M; Schima, W; Schmaljohann, J; Traub, T; Virgolini, I | 1 |
| Cachin, F; Lumbroso, J; Maublant, J; Raoul, JL; Syrota, A; Vuillez, JP | 1 |
| Dehdashti, F; Drebin, JA; Linehan, D; Siegel, BA; Strasberg, SM | 1 |
| Czernin, JR; Gambhir, SS; Park, KC; Phelps, ME; Schiepers, C; Schwimmer, J; Shepherd, JE | 1 |
| Andersson, LC; Capdeville, R; Demetri, GD; Dimitrijevic, S; Druker, B; Joensuu, H; Roberts, PJ; Sarlomo-Rikala, M; Silberman, S; Tervahartiala, P; Tuveson, D | 1 |
| Aerts, R; D'Hoore, A; Filez, L; Flamen, P; Mortelmans, L; Penninckx, F; Topal, B; Van Cutsem, E | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Bomanji, JB; Costa, DC; Ell, PJ; Le Rest, C; Townsend, CE; Visvikis, D | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Füzy, M; Kásler, M; Lengyel, Z; Perner, F; Repa, I; Szakáll, S; Szavcsur, P; Szentirmay, Z; Trón, L | 1 |
| Braga, FJ; Flamen, P; Homans, F; Maes, A; Mortelmans, L; Stroobants, S | 1 |
| Habu, D; Ishizu, H; Iwata, Y; Kubo, S; Nishiguchi, S; Ochi, H; Sasaki, N; Shiomi, S; Takeda, T; Tamori, A | 1 |
| Ishizu, H; Iwata, Y; Minamitani, S; Nishiguchi, S; Ochi, H; Ofuji, S; Sasaki, N; Shiomi, S | 1 |
| Habu, D; Ishizu, H; Iwata, Y; Kawabe, J; Kurooka, H; Minamitani, S; Nishiguchi, S; Ochi, H; Shiomi, S | 1 |
| Higashiyama, S; Inoue, Y; Kawabe, J; Koyama, K; Ochi, H; Ohachi, Y; Okamura, T; Sakamoto, H; Shakudo, M; Yamada, R | 1 |
| Gerber, E; Knoll, P; Köhn, H; Kumpan, W; Mirzaei, S; Raderer, M; Schiessel, R; Schratter-Sehn, AU | 1 |
| Amthauer, H; Felix, R; Schlag, PM; Stroszczynski, C | 1 |
| Coates, G; Nahmias, C; Rawlinson, J; Skehan, SJ; Somers, S; Zealley, IA | 1 |
| Nishiguchi, S; Shiomi, S | 1 |
| Corstens, FH; Jager, GJ; Langenhoff, BS; Neeleman, N; Oyen, WJ; Ruers, TJ; Strijk, S; Wobbes, T | 1 |
| Arulampalam, TH; Bomanji, JB; Costa, DC; Ell, PJ | 1 |
| Dehdashti, F; Gordon, BA; Rydzewski, B; Siegel, BA; Strasberg, SM; Teefey, SA | 1 |
| Siegal, BA; Strasberg, SM | 1 |
| Conte, PF; Dani, D; Donati, S; Gennari, A; Giorgetti, A; Landucci, E; Mariani, G; Pisani, P; Poli, M; Puccini, G; Salvadori, B; Salvadori, PA; Sorace, O | 1 |
| de Man, RA; Krenning, EP; Valkema, R; Verhoef, C; Yzermans, JN | 1 |
| Cabrera Villegas, A; Ciria Santos, JP; Martín Urreta, JC | 1 |
| Dworkin, HJ; Gates, VL; Raman, S; Salem, R; Wong, CY | 1 |
| Ito, K; Kato, T | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Miklovicz, T; Repa, I; Sinkovics, I; Szakáll, S | 1 |
| Asano, T; Enomoto, K; Hayashi, H; Isono, K; Kikuchi, T; Okazumi, S; Ozaki, M; Ryu, M; Yamamoto, H | 1 |
| Eremin, O; Evans, NT; Gvozdanovic, D; Heys, SD; Mallard, JR; Roeda, D; Smith, FW | 1 |
| Cho, BJ; Chung, SK; Haynie, TP; Kim, CG; Kim, EE; Moser, RP; Podoloff, DA; Tilbury, RS; Yang, DJ; Yung, WK | 1 |
| Asano, T; Enomoto, K; Fukunaga, T; Imazeki, K; Isono, K; Itoh, H; Kikuchi, T; Nagashima, T; Okazumi, S; Yamamoto, H | 1 |
| Fukuda, H | 1 |
| Abe, Y; Enomoto, K; Imazeki, K; Isono, K; Okazumi, S; Ozaki, M; Takayama, W; Yamada, S; Yamamoto, H; Yoshida, M | 1 |
| Ahonen, A; Nordman, E; Paul, R; Roeda, D | 1 |
| Fukuda, H; Ido, T; Ito, M; Maeda, S; Matsuzawa, T; Takahashi, H; Wakui, A; Yamaguchi, K; Yang, PK | 1 |
107 review(s) available for fluorodeoxyglucose f18 and Liver Neoplasms
| Article | Year |
|---|---|
Effect of metformin on
Topics: Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Colonic Neoplasms; Diabetes Mellitus, Type 2; Energy Intake; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Kidney; Liver Neoplasms; Metformin; Mice; Myocardium; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Thyroid Neoplasms; White Matter | 2022 |
The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fatty Liver; Fibroblasts; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Increased 18 F-FAPI-04 Uptake in Vertebral Hemangioma.
Topics: Biological Transport; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hemangioma; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the Liver.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Quality Improvement; Radiology, Interventional; Radiopharmaceuticals; Role | 2019 |
Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response.
Topics: Bone Neoplasms; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Liver Neoplasms; Male; Monitoring, Physiologic; Neoplasms; Patient Care Planning; Positron-Emission Tomography; Quality Improvement; Radiation Oncology; Radiology, Interventional | 2019 |
Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Microenvironment | 2019 |
The Unique Role of Fluorodeoxyglucose-PET in Radioembolization.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2019 |
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Molecular and Metabolic Imaging of Hepatic Neuroendocrine Tumors Following Radioembolization with 90Y-microspheres.
Topics: Brachytherapy; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Microspheres; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Liver involvement in pediatric Hodgkin lymphoma: A systematic review by an international collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL).
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Liver; Liver Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Young Adult | 2020 |
Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography; Young Adult | 2021 |
Image-Guided Thermal Ablation for Colorectal Liver Metastases.
Topics: Biopsy; Clinical Decision-Making; Colorectal Neoplasms; Cryosurgery; Fluorodeoxyglucose F18; Humans; Laser Therapy; Liver Neoplasms; Margins of Excision; Metastasectomy; Microwaves; Patient Selection; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiofrequency Ablation; Radiopharmaceuticals; Surgery, Computer-Assisted; Treatment Outcome; Tumor Burden | 2020 |
Radiomics in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Clinical Decision-Making; Early Detection of Cancer; Fluorodeoxyglucose F18; Genomics; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Prognosis; Risk Assessment; Survival Rate; Tomography, X-Ray Computed | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
PET/MRI of the hepatobiliary system: Review of techniques and applications.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Prognostic Significance of Pretreatment 18F-FDG PET/CT Volumetric Parameters in Patients With Colorectal Liver Metastasis: A Systematic Review and Meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis.
Topics: Carcinoma, Hepatocellular; Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2018 |
Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2018 |
18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
Topics: Acetates; Adult; Aged; Biomarkers, Tumor; Carbon; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed | 2019 |
Diagnostic performance of [
Topics: Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Emerging role of
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2019 |
The use of PET/MRI for imaging rectal cancer.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2019 |
Simultaneous positron emission tomography and magnetic resonance imaging for the detection and characterisation of liver lesions in patients with colorectal cancer: A pictorial review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2019 |
Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Imaging appearance of sarcomas of the prostate.
Topics: Adenocarcinoma; Bone Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
[Clinical use of 18F-FDG PET/CT in colorectal carcinoma].
Topics: Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
FDG PET/CT in the liver: lesions mimicking malignancies.
Topics: Adenoma; Cryptococcosis; Fluorodeoxyglucose F18; Hemangioendothelioma; Humans; Liver; Liver Abscess; Liver Diseases; Liver Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Whole Body Imaging | 2014 |
Potential role of FDG PET/CT in evaluating patients with hepatic incidentalomas.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysis.
Topics: Ablation Techniques; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neoplasm, Residual; Positron-Emission Tomography; Radiofrequency Therapy; Tomography, X-Ray Computed | 2014 |
Functional imaging biomarkers for assessing response to treatment in liver and lung metastases.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Yttrium-90 radioembolization of liver tumors: what do the images tell us?
Topics: Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Liver Abscess; Liver Neoplasms; Multimodal Imaging; Pleural Effusion, Malignant; Positron-Emission Tomography; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2014 |
The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.
Topics: Carcinoma, Hepatocellular; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multidrug Resistance-Associated Proteins; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2014 |
Meta-analysis of diagnosis of liver metastatic cancers: comparison of (18) FDG PET-CT and gadolinium-enhanced MRI.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.
Topics: Algorithms; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thrombosis | 2015 |
Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians.
Topics: Bevacizumab; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2015 |
[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
[18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Prognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.
Topics: alpha-Fetoproteins; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Patient Selection; Positron-Emission Tomography; Prognosis; Protein Precursors; Prothrombin; RNA, Messenger | 2016 |
Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2016 |
Neuroendocrine Tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chromogranin A; Digestive System Surgical Procedures; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Magnetic Resonance Imaging; Malignant Carcinoid Syndrome; Metastasectomy; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Serotonin; Tomography, X-Ray Computed | 2016 |
Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature.
Topics: Abdominal Wall; Adenocarcinoma, Clear Cell; Adult; Antibiotics, Antineoplastic; Biopsy, Fine-Needle; Cell Transformation, Neoplastic; Cesarean Section; Cicatrix; Doxorubicin; Endometrial Neoplasms; Endometriosis; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Laparoscopy; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Ovariectomy; Pelvis; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Pregnancy; Rectus Abdominis; Salpingectomy | 2016 |
Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Radiography; Tomography, Emission-Computed; Ultrasonography | 2008 |
Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Topics: Biopsy, Needle; Catheter Ablation; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cryosurgery; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Diagnostic Imaging; Drug Delivery Systems; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; Fatal Outcome; Fluorodeoxyglucose F18; Gastrectomy; Gastroscopy; Granulocyte Colony-Stimulating Factor; Humans; Leukocytosis; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Stomach Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
FDG-PET/CT in pediatric solid tumors.
Topics: Bone Neoplasms; Brain Neoplasms; Child; Fluorodeoxyglucose F18; Hepatoblastoma; Histiocytosis, Langerhans-Cell; Humans; Liver Neoplasms; Neoplasms; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2010 |
Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Assessing extracranial tumors using diffusion-weighted whole-body MRI.
Topics: Adenoma, Liver Cell; Blood Glucose; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature.
Topics: Adult; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Young Adult | 2011 |
Application of positron emission tomography molecular probes in hepatocellular carcinoma biological imaging.
Topics: Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography | 2011 |
Value of PET/CT in the management of liver metastases, part 1.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
Topics: Acetates; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Imaging and image-guided radiation therapy in liver cancer.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Tomography, X-Ray Computed | 2011 |
Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
Topics: Carcinoembryonic Antigen; Colonography, Computed Tomographic; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
Topics: Adenocarcinoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers.
Topics: Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Stomach Neoplasms | 2012 |
FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis.
Topics: Area Under Curve; Catheter Ablation; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; ROC Curve; Tomography, X-Ray Computed | 2012 |
Angiosarcoma of the liver as a cause of fulminant liver failure.
Topics: Aged; Fatal Outcome; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Immunohistochemistry; Liver Failure, Acute; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Positron emission tomography in malignancies of the liver, pancreas and biliary tract - indications and potential pitfalls.
Topics: Biliary Tract Neoplasms; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Positron emission tomography-computed tomography in liver imaging.
Topics: Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
Topics: Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
Fused functional-anatomic images of metastatic cancer of cervix obtained by a combined gamma camera and an X-ray tube hybrid system with an illustrative case and review of the 18F-fluorodeoxyglucose literature.
Topics: Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract.
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Pancreatic Neoplasms; Tomography, Emission-Computed | 2003 |
The role of nuclear medicine in the staging and management of liver metastases.
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed | 2003 |
Positron emission tomography and colorectal carcinoma: an update.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mass Screening; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Patient Care Planning; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT.
Topics: Catheter Ablation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Applications of PET in liver imaging.
Topics: Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2005 |
The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.
Topics: Carcinoembryonic Antigen; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2005 |
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2005 |
PET imaging for evaluation of metastatic colorectal cancer of the liver.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Topics: Adenocarcinoma, Follicular; Biomarkers, Tumor; Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiometry; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Staging in oesophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Endosonography; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
PET in colorectal cancer.
Topics: Adult; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; History, 18th Century; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Selective internal radiation therapy with Yttrium-90 for unresectable liver tumours.
Topics: Brachytherapy; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes | 2007 |
Nuclear oncology 1984.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bleomycin; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Liver Neoplasms; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Neoplasm Proteins; Neoplasms; Tomography, Emission-Computed | 1984 |
New Radiopharmaceuticals for studying liver function.
Topics: Albumins; Animals; Cricetinae; Deoxyglucose; Dogs; Fluorine; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Mice; Organotechnetium Compounds; Rabbits; Radioisotopes; Radionuclide Imaging; Rats; Rhamnose; Technetium | 1982 |
Oncological applications of FDG PET imaging.
Topics: Breast Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Pelvic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
[Nuclear medicine diagnosis of the liver].
Topics: Biliary Tract; Diagnosis, Differential; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Humans; Liver; Liver Circulation; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Positron emission tomography and colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Nuclear medicine in oncology: new diagnostic and therapeutic methods].
Topics: Carcinoma, Hepatocellular; Contraindications; Contrast Media; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Lymphatic Metastasis; Medical Oncology; Neoplasms; Nuclear Medicine; Radioimmunotherapy; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
[Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer].
Topics: Adult; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Selection; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Nuclear medicine(FDG-PET)].
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2001 |
The clinical application of positron emission tomography to colorectal cancer management.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Colorectal cancer].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
64 trial(s) available for fluorodeoxyglucose f18 and Liver Neoplasms
| Article | Year |
|---|---|
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung; Middle Aged; Prospective Studies; Radiosurgery | 2022 |
Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms; Urea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
F-18 FDG perfusion PET: intraprocedural assessment of the liver tumor ablation margin.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study.
Topics: Aged; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques | 2018 |
Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Serum Albumin; Survival Rate | 2018 |
Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iopamidol; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Prognostic importance of 18F-FDG uptake pattern of hepatocellular cancer patients who received SIRT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Lung; Male; Middle Aged; Prognosis; Radionuclide Imaging; Survival Rate; Yttrium Radioisotopes | 2013 |
Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours.
Topics: Aged; Aged, 80 and over; Embolization, Therapeutic; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Starch; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2014 |
The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
Topics: Catheter Ablation; Colorectal Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2014 |
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; New York City; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Topics: Ablation Techniques; Aged; Colorectal Neoplasms; Electroporation; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Tomography, X-Ray Computed | 2015 |
The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; ROC Curve; Stomach Neoplasms; Treatment Outcome; Young Adult | 2016 |
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Netherlands; Patient Selection; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals; Survival Analysis; Survival Rate; Treatment Outcome | 2009 |
Additional value of FDG-PET/CT in management of "solitary" liver metastases: preliminary results of a prospective multicenter study.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2010 |
Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Survival Rate; Treatment Outcome | 2009 |
Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Costs and Cost Analysis; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Quality-Adjusted Life Years; Sensitivity and Specificity; Treatment Outcome | 2010 |
Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
Topics: Biological Transport; Carcinoma, Hepatocellular; Cell Differentiation; Choline; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed | 2010 |
[Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Decision Making; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Palliative Care; Patient Care Planning; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Response to intra-arterial oncolytic virotherapy with the herpes virus NV1020 evaluated by [18F]fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Oncolytic Virotherapy; Oncolytic Viruses; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Simplexvirus; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uveal Neoplasms; Young Adult | 2012 |
Intermodality comparison between 3D perfusion CT and 18F-FDG PET/CT imaging for predicting early tumor response in patients with liver metastasis after chemotherapy: preliminary results of a prospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Imaging, Three-Dimensional; Leucovorin; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Perfusion Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Topics: Aged; Carcinoma, Hepatocellular; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Organoplatinum Compounds; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Camptothecin; Chemoradiotherapy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Quantitative p retreatment VOI analysis of liver metastases. (99m)Tc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
The usefulness of 18F-FDG PET images obtained 2 hours after intravenous injection in liver tumor.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2002 |
Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET.
Topics: Body Mass Index; Body Surface Area; Body Weights and Measures; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Quality Control; Radiometry; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
PET-FDG as predictor of therapy response in patients with colorectal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Radiopharmaceuticals; Risk Assessment; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
[F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Topics: Breast Neoplasms; Catheter Ablation; Colonic Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver; Liver Neoplasms; Neoplasm Recurrence, Local; Postoperative Period; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using (15)O and (18)F-deoxyglucose.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose; Humans; Liver; Liver Neoplasms; Middle Aged; Neovascularization, Pathologic; Oxygen; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Statistics as Topic | 2004 |
Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tissue Distribution | 2004 |
Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Topics: Abdominal Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glass; Humans; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Trauma Severity Indices; Treatment Outcome; Yttrium Radioisotopes | 2004 |
[Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Topics: Adult; Carcinoma; Colon; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectum; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2005 |
Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Melanins; Melanoma; Middle Aged; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iohexol; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole-Body Counting | 2005 |
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution | 2006 |
Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Cesium Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Movement; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory Mechanics; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2005 |
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
A novel iterative method for lesion delineation and volumetric quantification with FDG PET.
Topics: Aged; Calibration; Colorectal Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Middle Aged; Models, Biological; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden | 2007 |
18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; New York; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2007 |
A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases.
Topics: Adult; Aged; Catheter Ablation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2007 |
FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Laparotomy; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2007 |
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Methionine; Tomography, Emission-Computed | 1995 |
Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Necrosis; Tomography, Emission-Computed | 1994 |
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
Topics: Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
Topics: Colorectal Neoplasms; Deoxyglucose; Double-Blind Method; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Radiography; Tomography, Emission-Computed | 1996 |
Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases.
Topics: Adult; Aged; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1998 |
Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer.
Topics: Adenocarcinoma; Aged; Animals; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Intraarterial HCC therapy with I-131-Lipiodol.
Topics: Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Germany; Hepatic Artery; Humans; Injections, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Missouri; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2001 |
Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma.
Topics: Adult; Aged; Angiography; Calcitonin; Carcinoma, Medullary; Diagnosis, Differential; Diarrhea; Female; Fluorodeoxyglucose F18; Flushing; Humans; Liver; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cell Division; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Liver Neoplasms; Male; Middle Aged; Survival Rate; Tomography, Emission-Computed | 2001 |
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Topics: Adult; Aged; Colorectal Neoplasms; Decision Making; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2002 |
885 other study(ies) available for fluorodeoxyglucose f18 and Liver Neoplasms
| Article | Year |
|---|---|
Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
Topics: Adult; Aged; Aged, 80 and over; China; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Diagnostic performance of the FDG-PET/CT in patients with resected mucinous colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Value of
Topics: Animals; Catheter Ablation; Fluorodeoxyglucose F18; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals | 2022 |
Undetectable Brain Metastasis of Hepatocellular Carcinoma by PET-CT After Liver Transplantation: a Case Report.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Extrahepatic metastases of hepatocellular carcinoma on
Topics: Carcinoma, Hepatocellular; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Survival after liver resection and liver transplantation for colorectal liver metastases: a comparative analysis stratified by metabolic tumor volume assessed by
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Tumor Burden | 2022 |
Port-Site Metastases in Incidentally Detected Carcinoma Gall Bladder: Role of 18F-FDG PET/CT and Patient Outcome.
Topics: Carcinoma; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
Dynamic chaotic gravitational search algorithm-based kinetic parameter estimation of hepatocellular carcinoma on
Topics: Algorithms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
The value of 18F-FDG PET/MRI in prediction of microvascular invasion in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Retrospective Studies | 2022 |
Steatotic Hepatitis Presenting as a Huge Hypermetabolic Liver Mass.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2022 |
PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Mice; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; TOR Serine-Threonine Kinases | 2022 |
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
18F-FDG PET/CT Imaging in Sarcomatoid Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence: A New Pitfall?
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Thrombosis; Umbilical Veins; Venous Thrombosis; Yttrium Radioisotopes | 2022 |
Hepatic Angiosarcoma With Diffuse Increased 18 F-FDG Uptake on PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Liver Failure, Acute; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden; Yttrium Radioisotopes | 2022 |
Preoperative clinical-radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using [Formula: see text]F-FDG PET/CT.
Topics: Carcinoma, Hepatocellular; China; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
Primary Hepatic Angiosarcoma Having FDG Uptake at the Similar Level of the Normal Liver Parenchyma.
Topics: Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases.
Topics: Carcinoma, Hepatocellular; Drugs, Investigational; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Muscle, Skeletal; Skull; Sorafenib; Tegafur | 2022 |
Budd-Chiari syndrome secondary to tumor thrombus of hepatocellular carcinoma detected by
Topics: Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Thrombosis | 2022 |
[Hypermetabolic multifocal steatohepatitis: a rare case of [18F]FDG PET/CT false positive mimicking a metastatic carcinomatosis].
Topics: Aged; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Multicystic Biliary Hamartoma With Xanthogranulomatous Inflammation on 18F-FDG PET/CT.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cysts; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Hamartoma; Humans; Inflammation; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2022 |
FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
What is the effect of tumor diameter, lymph node metastases, and SUVmax value on prognosis in limited-stage small cell lung cancer?
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Progression or Response: New Liver Lesions in a Patient with Responding Hodgkin Lymphoma.
Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
Topics: Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2022 |
Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Choline; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies | 2023 |
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colonic Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Different 18F-FDG imaging: A rare case of liver multiple carcinomas.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals | 2023 |
Kinetic parameter estimation of hepatocellular carcinoma on
Topics: Bayes Theorem; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
The Role of FDG Positron Emission Tomography/Contrast--Enhanced Computed Tomography in Preoperative Staging and Postoperative Follow-up in Rectal Cancer Surgery.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rectal Neoplasms; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Hot Gloved Finger Sign in Endobronchial Metastasis From Hepatocellular Carcinoma on FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
[
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2023 |
Detection of liver metastasis by 18F-FAPI PET/CT in the background of fatty liver.
Topics: Fatty Liver; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2023 |
Mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver.
Topics: Aged; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Respiratory-gated PET imaging with reduced acquisition time for suspect malignancies: the first experience in application of total-body PET/CT.
Topics: Deoxyglucose; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Tomography, X-Ray Computed | 2023 |
Dynamic PET/CT scan of
Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2023 |
Disappearing colorectal liver metastases in the era of state-of-the-art triple-modality diagnostic imaging.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
68 Ga-FAPI PET/MRI and 18 F-FDG PET/CT in a Case With Extensive Portal Vein Tumor Thrombus.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Solitary Accessory Spleen-Like Metastasis Coexisted With Splenic Infarction Reveled on 18F-FDG PET/CT in a Hepatocellular Carcinoma Patient.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Splenic Infarction | 2023 |
Complete Metabolic Response by 18 F-FDG PET/CT to Atezolizumab Plus Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.
Topics: Aged; Bevacizumab; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2023 |
Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study.
Topics: Carcinoma, Hepatocellular; Choline; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
SUVmax-to-HU ratio in diagnosis of hepatic metastases of colon cancer on FDG PET/CT. A new semiquantitative parameter.
Topics: Adenocarcinoma; Adult; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Role of textural analysis parameters derived from FDG PET/CT in differentiating hepatocellular carcinoma and hepatic metastases.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Microenvironment | 2023 |
99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2023 |
Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Role of 68 Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies : A Prospective Pilot Study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
Prognostic value of TLR from FDG PET/CT in patients with margin-negative stage IB and IIA non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
FAPI PET Positivity in Fibrolamellar Hepatocellular Carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Primary Pancreatic Choriocarcinoma With Hepatic Metastases on 18 F-FDG PET/CT.
Topics: Choriocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Pregnancy; Radiopharmaceuticals | 2023 |
The added value of
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Keratin-19; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
Topics: B7-H1 Antigen; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
18 F-FDG PET/MRI of Primary Hepatic Malignancies: Differential Diagnosis and Histologic Grading
Topics: Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Retrospective Studies | 2024 |
Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Uveal Neoplasms | 2023 |
The role of
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Programmed Cell Death 1 Receptor | 2023 |
Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Thrombosis; Tomography, X-Ray Computed; Young Adult | 2023 |
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation.
Topics: Aged; B7-H1 Antigen; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; T-Lymphocytes, Cytotoxic | 2023 |
[Primary α-fetoprotein positive hepatoid adenocarcinoma of the lung: a case report].
Topics: Adenocarcinoma; Aged, 80 and over; alpha-Fetoproteins; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung; Male; Positron Emission Tomography Computed Tomography | 2023 |
PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines | 2023 |
PET imaging of tumor vascular normalization in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography | 2023 |
Primary Hepatocellular Carcinoma Revealed on 68 Ga-DOTATATE in a Patient With Nasopharyngeal Carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
Differentiation of Discordant Lesions on Dual-Tracer PET/CT (
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Neoplasms, Second Primary; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms | 2023 |
A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
Topics: Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Pulmonary Cryptococcosis: Intense Uptake on Both 18 F-FDG and 68 Ga-FAPI PET/CT.
Topics: Abdominal Pain; Biological Transport; Cryptococcosis; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
68 Ga-PSMA-Avid Liver Metastases From Colon Cancer, Not Visualized on FDG PET Scan.
Topics: Aged; Colonic Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms | 2023 |
Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumors.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity | 2023 |
68 Ga-PSMA PET/CT in Hepatic Metastasis From Pancreatic Neuroendocrine Tumor.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Comparison of 18 F-FDG and 68 Ga-FAPI PET/CT in a Patient With Hepatic Perivascular Epithelioid Cell Neoplasm.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Perivascular Epithelioid Cell Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Hepatic Cavernous Hemangioma Mimicking Malignancy on 18 F-FDG PET/CT Imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Hemangioma; Hemangioma, Cavernous; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Multiple Intrahepatic Inflammatory Myofibroblastic Tumor on 68 Ga-FAPI and 18 F-FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasms, Muscle Tissue; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Unusual Case of Primary Hepatic Squamous Carcinoma on 18F-FDG PET/CT.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Minimal-activity PET/CT for efficacy control after SIRT (MAPECSI) - clinical implementation of a resource-saving, liver-focused protocol.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Health Resources; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Dosage | 2019 |
Commentary on "FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study".
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Positron-Emission Tomography; Retrospective Studies; Transplant Recipients | 2019 |
Selective Internal Radiation Therapy for Liver Metastasis of Papillary Thyroid Carcinoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Yttrium Radioisotopes | 2020 |
A case report of rectal adenocarcinoma with intrahepatic cholangiocarcinoma of the liver.
Topics: Adenocarcinoma; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Rectal Neoplasms | 2019 |
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carrier Proteins; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hepatectomy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms; Male; Membrane Proteins; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2020 |
Acne vulgaris with false-positive signals on
Topics: Acne Vulgaris; Endodermal Sinus Tumor; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Testicular Neoplasms; Young Adult | 2020 |
Complete Spontaneous Regression of Hepatosplenic T-Cell Lymphoma After Surgical Biopsy.
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, T-Cell; Male; Neoplasm Regression, Spontaneous; Positron Emission Tomography Computed Tomography; Spleen | 2020 |
Improving patient selection in Living-Donor Liver transplantation: Prognostication with pre-transplant 18-fluoro-deoxyglucose Positron Emission Tomography.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Patient Selection; Positron-Emission Tomography; Retrospective Studies; Transplant Recipients | 2019 |
Ectopic Corticotropin-Releasing Hormone-Secreting Pancreatic Neuroendocrine Tumor: Excellent Response of Liver Metastases to Peptide Receptor Radionuclide Therapy as Demonstrated by 68Ga-DOTATOC and 18F-FDG PET/CT Imaging.
Topics: Corticotropin-Releasing Hormone; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2020 |
FDG PET Findings of Hyperprogression During Immunotherapy in a Patient With Hepatocellular Carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Disease Progression; Fluorodeoxyglucose F18; Humans; Immunotherapy; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Hypoxia-induced modulation of glucose transporter expression impacts
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia; Liver Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Comparison of different kinetic models for dynamic
Topics: Algorithms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Image Processing, Computer-Assisted; Kinetics; Liver Neoplasms; Male; Middle Aged; Models, Biological; Positron Emission Tomography Computed Tomography | 2020 |
Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2020 |
Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Membrane Glycoproteins; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the diagnosis and follow-up of primary hepatic diffuse large B-cell Lymphoma: A clinical case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia.
Topics: Adult; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Hep G2 Cells; Humans; Hypoxia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Middle Aged; Positron Emission Tomography Computed Tomography; Tumor Microenvironment | 2020 |
Hepatic hemangioendothelioma: CT, MR, and FDG-PET-CT in 67 patients-a bi-institutional comprehensive cancer center review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2020 |
Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Sensitivity and Specificity; Tumor Burden | 2020 |
Mass-forming hepatic cryptococcosis: a mimicker of metastatic tumors.
Topics: Aged, 80 and over; Cryptococcosis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2020 |
Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis; Von Hippel-Lindau Tumor Suppressor Protein | 2020 |
Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Young Adult | 2020 |
The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Addition of [
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Successful treatment of combined thymic epithelial tumor with hepatic metastasis: a long disease-free survival case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thymectomy; Thymoma; Thymus Neoplasms | 2020 |
Alpha-fetoprotein and
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Portal Vein; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Risk Factors; Survival Rate; Tumor Burden | 2020 |
18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
Topics: Aged; Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Omentum; Palliative Care; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival; Tomography, X-Ray Computed | 2020 |
FDG Hepatic Superscan Due to Metastatic Infiltration of Prostate Cancer.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2020 |
[
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2020 |
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Choline; Contrast Media; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2020 |
Reply: [
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2020 |
Hepatic Schwannoma on 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neurilemmoma; Positron Emission Tomography Computed Tomography; Postoperative Period | 2020 |
Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Period; Retrospective Studies | 2020 |
Primary Inferior Vena Cava Leiomyosarcoma With Hepatic Metastases on FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Vascular Neoplasms; Vena Cava, Inferior | 2021 |
Prognostic value of
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiofrequency Ablation; Radiopharmaceuticals | 2020 |
Concurrent Liver and Mesentery Primary Extraosseous Multiple Myeloma on 18F-FDG PET/CT.
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mesentery; Middle Aged; Multiple Myeloma; Neoplasms, Multiple Primary; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Tumor heterogeneity for differentiation between liver tumors and normal liver tissue in 18F-FDG PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Inflammatory Myofibroblastic Tumor of the Liver Mimicking Metastasis on 18F-FDG PET/CT.
Topics: Diagnosis, Differential; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Myofibroblasts; Positron Emission Tomography Computed Tomography | 2021 |
Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microwaves; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
New Data-Driven Gated PET/CT Free of Misregistration Artifacts.
Topics: Artifacts; Body Mass Index; Data Science; Exhalation; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Lung Neoplasms; Organ Motion; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Exposure; Radiotherapy Dosage; Respiratory Mechanics; Time Factors; Tomography, X-Ray Computed | 2021 |
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Quinolines; Retrospective Studies; Treatment Outcome | 2021 |
Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
Digital versus analog PET/CT in patients with known or suspected liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Computers; Computers, Analog; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2021 |
Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
18-FDG PET/CT provides solid evidence of microvascular invasion and is correlated with prognosis in patients with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Investigating the value of pre-treatment
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Porta Hepatic Schwannoma on FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neurilemmoma; Positron Emission Tomography Computed Tomography | 2021 |
Follicular Thyroid Carcinoma Metastases on Round Ligament of Liver.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Round Ligament of Liver; Thyroid Neoplasms; Thyroidectomy; Whole Body Imaging | 2021 |
Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
The superiority of [
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Extrahepatic metastases from hepatocellular carcinoma: multimodality image evaluation.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
FDG PET/CT to Detect Incidental Findings in Patients With Hepatocellular Carcinoma-Additional Benefit for Patients Considered for Liver Transplantation?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Ultrasonography | 2021 |
18F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: A case report.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lumbar Vertebrae; Neurilemmoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spinal Neoplasms; Spinal Nerve Roots | 2021 |
Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2.
Topics: Animals; Colorectal Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Liver Neoplasms; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Micro-positron emission tomography imaging of angiogenesis based on
Topics: Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Ki-67 Antigen; Liver Neoplasms; Mice; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2021 |
Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver Metastases.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Topics: Antibodies, Monoclonal, Humanized; Calcium; Cinacalcet; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immune System; Immunotherapy; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Molecular Biology; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior.
Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neck Dissection; Pancreatic Neoplasms; Phenylurea Compounds; Positron-Emission Tomography; Quinolines; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Whole Body Imaging | 2021 |
Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from
Topics: Animals; Biomarkers; Carcinoma, Hepatocellular; Energy Metabolism; Fluorodeoxyglucose F18; Gluconeogenesis; Glycolysis; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Metabolic Networks and Pathways; Metabolomics; Mice; Positron-Emission Tomography | 2021 |
Dynamic
Topics: Adult; Aged; Aorta, Thoracic; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Feasibility of perfusion and early-uptake
Topics: Carcinoma, Hepatocellular; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Quinolines; Radiopharmaceuticals; Survival Rate; Treatment Outcome | 2021 |
Radiomics analysis of [
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Liver metastases from medullary thyroid carcinoma detected on
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Thyroid Neoplasms | 2021 |
Lateral Hepatic Fissure Peritoneal Carcinomatosis as a Pitfall for Hepatic Metastasis of Advanced Ovarian Cancer.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Identifying Patients Who May Benefit from Liver Resection Compared to Living Donor Liver Transplantation for Hepatocellular Carcinoma Using
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2021 |
Diagnostic challenges in primary cardiac lymphoma, the opportunity of
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Peritoneal carcinomatosis from signet-ring cell adenocarcinoma of the appendix.
Topics: Appendiceal Neoplasms; Carcinoma, Signet Ring Cell; Colonoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Ultrasonography | 2017 |
Thymoma metastatic to liver and pancreas: case report and review of the literature.
Topics: Aged; Brachiocephalic Veins; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Neoadjuvant Therapy; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiotherapy, Adjuvant; Thymectomy; Thymus Neoplasms; Treatment Outcome; Vena Cava, Superior | 2017 |
Response to: "Consideration of KRAS Mutation Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET, in Patients With Colorectal Liver Metastases".
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Mutation; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins p21(ras); Retrospective Studies | 2018 |
Consideration of KRAS Mutational Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET Scan, in Patients With Colorectal Liver Metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins p21(ras); Retrospective Studies | 2018 |
Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Monte Carlo Method; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiosurgery; Retrospective Studies; Survival Rate; Treatment Outcome | 2017 |
The value of [
Topics: Acetates; Aged; Arteries; Bevacizumab; Carbon; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Treatment Outcome | 2017 |
The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies.
Topics: Adult; Aged; Algorithms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Role of [
Topics: Adult; Carcinoma, Hepatocellular; Clinical Decision-Making; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography | 2017 |
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
Topics: Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2017 |
Is FCH PET able to identify foci of infection superiorly to FDG PET?
Topics: Anti-Bacterial Agents; Brain Abscess; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Streptococcal Infections; Streptococcus milleri Group | 2017 |
Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT.
Topics: Bone Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Recurrence; Scapula | 2017 |
Fluorine-18-fluorodeoxyglucose positron emission tomography as an objective substitute for CT morphologic response criteria in patients undergoing chemotherapy for colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2018 |
The uptake exploration of 68Ga-labeled NGR in well-differentiated hepatocellular carcinoma xenografts: Indication for the new clinical translational of a tracer based on NGR.
Topics: Animals; Carcinoma, Hepatocellular; CD13 Antigens; Cell Line, Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; HT29 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Transplantation; Oligopeptides; Positron Emission Tomography Computed Tomography; Tissue Distribution | 2017 |
Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT.
Topics: Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Venous Thrombosis | 2017 |
Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the
Topics: Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Rectal Neoplasms; Tomography, Spiral Computed | 2017 |
Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature review.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Injuries; Retrospective Studies | 2018 |
Combining
Topics: Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Preoperative Care; Retrospective Studies; Treatment Outcome | 2017 |
Small Bowel Metastasis From Hepatocellular Carcinoma Detected by 18F-FDG PET/CT But Not by 11C-Acetate PET/CT.
Topics: Acetates; Adult; Carbon Radioisotopes; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Liver Neoplasms; Positron Emission Tomography Computed Tomography | 2017 |
18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma.
Topics: Aged; Aged, 80 and over; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2018 |
Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; C-Reactive Protein; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Vessels; Lymphocyte Count; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Neutrophils; Platelet Count; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Rate; Tumor Burden | 2018 |
Topics: Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sorafenib; Treatment Outcome | 2018 |
Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Artifactual Hepatic Metastasis on FDG PET/CT Secondary to Cryoablation for Adrenal Metastasis.
Topics: Adrenal Gland Neoplasms; Aged; Artifacts; Cryosurgery; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2018 |
18F-FDG PET/CT in Primary Hepatic Neuroendocrine Tumors.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography | 2018 |
Primary Spleen Angiosarcoma With Concomitant Hepatic Hemangiomas on 18F-FDG PET/CT.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Splenic Neoplasms | 2018 |
Automatic liver detection and standardised uptake value evaluation in whole-body Positron Emission Tomography/Computed Tomography scans.
Topics: Algorithms; Cohort Studies; Electronic Data Processing; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Liver; Liver Neoplasms; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Standards; Reference Values; Reproducibility of Results; Whole Body Imaging | 2018 |
18F-FDG PET/CT for Molecular Imaging of Hepatoblastoma in Beckwith-Wiedemann Syndrome.
Topics: Beckwith-Wiedemann Syndrome; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Primary Hepatic Malignant Fibrous Histiocytoma on PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
18F-FDG PET/CT Equivalent of the Hepatic Hot Spot Sign With CT Correlation.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Tomography, X-Ray Computed | 2018 |
Anal Malignant Melanoma Manifesting Hepatic Metastases Shown on FDG PET/CT.
Topics: Adult; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiopharmaceuticals; Reproducibility of Results | 2018 |
Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on 18F-FDG PET/CT: A case report.
Topics: Carcinoma, Hepatocellular; Castleman Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
FDG-Avid Focal Liver Reaction From Proton Therapy in a Patient With Primary Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Proton Therapy; Radiopharmaceuticals | 2018 |
Three Primary Carcinomas on 18F-FDG PET/CT: Intrahepatic Cholangiocarcinoma, Papillary Renal Cell Carcinoma, and Clear Cell Renal Cell Carcinoma.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Immunohistochemistry; Ki-67 Antigen; Linear Models; Liver Neoplasms; Mice, Nude; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Vascular Endothelial Growth Factor A | 2018 |
Hepatic Epithelioid Angiomyolipoma and 18F-FDG PET/CT.
Topics: Adult; Angiomyolipoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tumor Burden | 2018 |
Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case report.
Topics: Antineoplastic Agents, Phytogenic; Biopsy; Cytotoxins; Etoposide; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Splenic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2018 |
Pedunculated Hepatocellular Carcinoma Mimicking Right Adrenal Tumor on FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Peliosis Hepatis Simulating Metastatic Liver Disease on FDG PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Peliosis Hepatis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2018 |
Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation.
Topics: Adult; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Survival Analysis | 2018 |
Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Stereotactic body radiation therapy for liver oligometastases: predictive factors of local response by
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Treatment Outcome | 2018 |
"Hepatic Superscan" in a Patient With Hepatosplenic Alphabeta T-cell Lymphoma: 18F-FDG PET/CT Findings.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, T-Cell; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Splenic Neoplasms | 2018 |
Diffuse hepatic epithelioid hemangioendothelioma with multiple splenic metastasis and delayed multifocal bone metastasis after liver transplantation on FDG PET/CT images: A case report.
Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Hospitalization; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Spleen; Splenic Neoplasms; Tomography, X-Ray Computed | 2018 |
Quantitative biomarkers for liver metastases: comparison of MRI diffusion-weighted imaging heterogeneity index and fluorine-18-fluoro-deoxyglucose standardised uptake value in hybrid PET/MR.
Topics: Biomarkers, Tumor; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Metastasizing pleomorphic adenoma in the multiple organs: A case report on FDG-PET/CT imaging.
Topics: Adenoma, Pleomorphic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteolysis; Parotid Gland; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Salivary Glands; Tomography, X-Ray Computed | 2018 |
Diffuse Liver Metastasis From Nasopharyngeal Carcinoma Found by 18F-FDG PET/CT Scans.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography | 2018 |
Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Treatment Outcome | 2018 |
[
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Relationship between KRAS mutations and dual time point
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; Retrospective Studies | 2019 |
11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Treatment Outcome | 2018 |
Dual-time 18F-FDG PET/CT for the detection of liver metastases in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Time Factors; Whole Body Imaging | 2018 |
A Case of Liver Injury Mimicking Metastasis After Gamma Knife Therapy for Lung Cancer: Evaluating by 18F-FDG PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiopharmaceuticals; Radiosurgery | 2018 |
Thyroid Metastasis From Hepatocellular Carcinoma Visualized by 18F-FDG PET/CT Imaging.
Topics: Adult; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
Incidentally detected PET-avid liver adenomatosis: MRI and 18F-FDG PET-CT findings.
Topics: Adenoma; Adult; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Colorectal Neoplasms; Decision Support Techniques; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2018 |
ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis | 2018 |
Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Indazoles; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Pyrimidines; Radiopharmaceuticals; Sulfonamides; Treatment Outcome | 2018 |
Change in standardized uptake values in delayed 18F-FDG positron emission tomography images in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Spleen; Young Adult | 2018 |
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Positron-Emission Tomography | 2018 |
18F-FDG PET/CT of Internal Mammary Lymph Node Hepatocellular Carcinoma Metastases.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mammary Glands, Human; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Primary Hepatic Neuroendocrine Tumor: Pretherapy and Posttherapy FDG PET/CT Finding.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microvessels; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Vascular Neoplasms | 2019 |
Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines.
Topics: Aged; Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Chemoradiotherapy; DNA Mutational Analysis; Epithelial Cells; Female; Fluorodeoxyglucose F18; Glucose; Humans; Liver; Liver Neoplasms; Mice; Mice, Nude; Middle Aged; Mutation; Radiation Tolerance; Rectal Neoplasms; Rectum; Treatment Outcome; Xenograft Model Antitumor Assays | 2018 |
FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
Topics: Bile Duct Neoplasms; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Thrombosis | 2019 |
Telbivudine-Induced Myopathy Incidentally Detected by FDG PET/CT Imaging in a Patient With History of Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Neoplasms; Male; Muscular Diseases; Positron Emission Tomography Computed Tomography; Telbivudine | 2019 |
Heterogeneous Uptake of 18F-FDG and 68Ga-PSMA-11 in Hepatocellular Carcinoma.
Topics: Aged, 80 and over; Biological Transport; Biopsy; Carcinoma, Hepatocellular; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Liver Neoplasms; Male; Oligopeptides; Positron Emission Tomography Computed Tomography | 2019 |
Primary lymphoma of the liver: a diagnostic surprise.
Topics: Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Liver; Liver Neoplasms; Lymphoma; Male; Middle Aged; Radiopharmaceuticals; Ultrasonography, Interventional | 2019 |
Evaluation of Iodine-125 Interstitial Brachytherapy Using Micro-Positron Emission Tomography/Computed Tomography with 18F-Fluorodeoxyglucose in Hepatocellular Carcinoma HepG2 Xenografts.
Topics: Animals; Brachytherapy; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorodeoxyglucose F18; Hep G2 Cells; Heterografts; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed; Xenograft Model Antitumor Assays | 2019 |
18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Injections, Subcutaneous; Liver Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Split-Dose
Topics: Ablation Techniques; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microwaves; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Dosage; Recurrence; Surgery, Computer-Assisted | 2019 |
Concurrent Pancreatic Metastasis From Lung Adenocarcinoma and Primary Cholangiocarcinoma on FDG PET/CT Imaging.
Topics: Adenocarcinoma of Lung; Adult; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Response Evaluation Criteria in Solid Tumors; Yttrium Radioisotopes | 2019 |
Hepatic paraganglioma hiding as a slowly growing lesion for 24 years: a diagnostic conundrum.
Topics: Aged; alpha-Fetoproteins; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Paraganglioma; Positron-Emission Tomography | 2019 |
Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tumor Burden; Young Adult | 2019 |
Value of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Venous Thrombosis; Young Adult | 2019 |
Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Combined Modality Therapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Palliative Care; Positron Emission Tomography Computed Tomography; Radionuclide Imaging | 2019 |
The clinical utility of phase-based respiratory gated PET imaging based on visual feedback with a head-mounted display system.
Topics: Aged; Biliary Tract Neoplasms; Equipment Design; Feedback, Sensory; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Retrospective Studies; Sensitivity and Specificity; User-Computer Interface | 2019 |
Prognostic value of
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2019 |
Diffusion-weighted MRI and
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Macrophages; Male; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; RAW 264.7 Cells; Tumor Microenvironment | 2019 |
Hepatic Angiomyolipoma Having FDG Uptake at the Similar Level of the Normal Liver Parenchyma.
Topics: Angiomyolipoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Rapidly Lethal Ruptured Hepatocellular Carcinoma With Disseminated Peritoneal Carcinomatosis on FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Fatty Liver; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Adult Pancreatoblastoma With Liver Metastasis Diagnosed by 18F-FDG PET/CT and 2 Years' Postoperative Follow-up.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Postoperative Period | 2020 |
Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors.
Topics: Biomarkers, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2019 |
A Rapidly Progressing Polycystic Liver Disease?
Topics: Biopsy; Cysts; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Liver; Liver Diseases; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Nasal Cavity; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Time Factors | 2020 |
FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Arteries; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2013 |
The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
FDG PET/CT findings in 3 cases of solitary necrotic nodule of the liver.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Eosinophilic infiltration in the colon and liver mimicking primary colon cancer with hepatic metastases on (18)F-FDG PET/CT.
Topics: Aged; Colon; Colonic Neoplasms; Colonoscopy; Diagnosis, Differential; Eosinophils; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Multimodal Imaging; Radionuclide Imaging; Tomography, X-Ray Computed | 2013 |
Multiple primary hepatic malignant mesotheliomas mimicking cystadenocarcinomas on enhanced CT and FDG PET/CT.
Topics: Cystadenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Invited editorial: Response to therapy assessment of colorectal liver metastasis.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iopamidol; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Education and imaging. Hepatobiliary and pancreatic: intrahepatic biliary cystadenocarcinoma.
Topics: Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cystadenocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.
Topics: Adult; Aged; Blood Circulation; Carcinoma, Hepatocellular; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Whole Body Imaging | 2013 |
A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Disseminated Intravascular Coagulation; Docetaxel; Fatal Outcome; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Treatment Failure | 2013 |
PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.
Topics: Age Distribution; Aging; Body Mass Index; Boston; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Organ Specificity; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Distribution; Tissue Distribution | 2013 |
Therapeutic effect of sunitinib malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma.
Topics: Aged; Antineoplastic Agents; Blood Glucose; Fluorodeoxyglucose F18; Humans; Indoles; Insulinoma; Liver Neoplasms; Male; Positron-Emission Tomography; Pyrroles; Sunitinib; Tomography, Emission-Computed | 2013 |
Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
Topics: Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorodeoxyglucose F18; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Positron-Emission Tomography; Protons; Radiopharmaceuticals; Rats | 2013 |
Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Standardized added metabolic activity (SAM) IN ¹⁸F-FDG PET assessment of treatment response in colorectal liver metastases.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease.
Topics: Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18 F-FDG versus 68 Ga-DOTATOC in hepatic NET metastasis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2014 |
Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Biological Transport; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Comparing respiratory gated with delayed scans in the detection of colorectal carcinoma hepatic and pulmonary metastases with 18F-FDG PET-CT.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Time Factors; Tomography, X-Ray Computed | 2014 |
Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Topics: Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Meglumine; Middle Aged; Multimodal Imaging; Observer Variation; Organometallic Compounds; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Treatment Outcome | 2013 |
Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasis.
Topics: Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting.
Topics: Carbon Radioisotopes; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Test-retest variability of various quantitative measures to characterize tracer uptake and/or tracer uptake heterogeneity in metastasized liver for patients with colorectal carcinoma.
Topics: Area Under Curve; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Reply: Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting.
Topics: Carbon Radioisotopes; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation.
Topics: Aged; Catheter Ablation; Cholagogues and Choleretics; Cholecystokinin; Dissection; Female; Fluorodeoxyglucose F18; Gallbladder; Humans; Liver; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Observations on the effects of lithium on carcinoid tumors.
Topics: Bone Neoplasms; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lithium Compounds; Liver Neoplasms; Male; Mood Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2013 |
A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2013 |
Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan.
Topics: Adenoma; Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hysterectomy; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
¹⁸F-FDG PET metabolic parameters and MRI perfusion and diffusion parameters in hepatocellular carcinoma: a preliminary study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Perfusion Imaging; Positron-Emission Tomography; Retrospective Studies | 2013 |
Aggressive strategy for the treatment of synchronous metastatic anal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mitomycin; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiosurgery; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Topics: Contrast Media; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI.
Topics: Adult; Aged; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2013 |
A comparison between ¹⁸F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients.
Topics: Child; Child, Preschool; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Improvement of hepatic lesion characterization by 18F-FDG PET/CT with the use of the lesion to background liver activity ratio.
Topics: Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
FDG PET/CT and enhanced CT imaging of tumor heterogeneity in hepatocellular carcinoma: imaging-pathologic correlation.
Topics: Adult; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
68Ga-dotatate avid medullary thyroid cancer with occult liver metastases.
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Thyroid Neoplasms | 2014 |
Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
Topics: Adult; Aged; Embolization, Therapeutic; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Melanoma; Middle Aged; Monte Carlo Method; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2014 |
FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Interdisciplinary Communication; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Care Team; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Registries; Retrospective Studies; Tomography, X-Ray Computed; United Kingdom | 2014 |
Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucose-6-Phosphatase; Glucose-6-Phosphate; Hepatectomy; Hexokinase; Humans; Liver; Liver Neoplasms; Male; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; RNA, Messenger | 2014 |
Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Non-local means denoising of dynamic PET images.
Topics: Analysis of Variance; Animals; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Liver Neoplasms; Mice; Phantoms, Imaging; Positron-Emission Tomography; Signal-To-Noise Ratio | 2013 |
Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
Topics: Aged; Area Under Curve; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microvessels; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Protein Precursors; Prothrombin; Radiopharmaceuticals; Risk Factors; ROC Curve; Tumor Burden | 2014 |
18F-fluorocholine may be taken-up by brown adipose tissue.
Topics: Adenoma; Adipose Tissue, Brown; Adult; Artifacts; Choline; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2013 |
PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Boston; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Inhalation; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiography, Interventional; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Respiratory-gated PET/CT versus delayed images for the quantitative evaluation of lower pulmonary and hepatic lesions.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Melanoma; Microspheres; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Uveal Neoplasms; Young Adult; Yttrium Radioisotopes | 2016 |
Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2013 |
Pathology-confirmed granuloma mimicking liver metastasis of breast cancer.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Tomography, X-Ray Computed | 2014 |
A comparison of diagnostic imaging modalities for colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Respiratory trace feature analysis for the prediction of respiratory-gated PET quantification.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Models, Statistical; Positron-Emission Tomography; Respiration; Respiratory-Gated Imaging Techniques; Signal-To-Noise Ratio; Tomography, X-Ray Computed | 2014 |
Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1.
Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Child; Child, Preschool; Demography; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma | 2014 |
Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Italy; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Rate; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2014 |
FDG-PET predicts outcomes of treated bone metastasis following palliative radiotherapy in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Treatment Outcome | 2014 |
Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Endpoint Determination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Risk Factors; Survival Analysis | 2014 |
Inflammatory myofibroblastic tumours of the liver: gadoxetic acid-enhanced and diffusion-weighted MRI findings with 18F-FDG PET/CT and clinical significance of regression on follow-up.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gadolinium DTPA; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Female; Fluoroacetates; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Time Factors | 2015 |
Imaging findings of primary malignant gastrointestinal stromal tumor of the liver.
Topics: Aged; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Gadolinium DTPA; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Iohexol; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
(18)F-FDG PET/CT imaging of malignant hepatic solitary fibrous tumor.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Solitary Fibrous Tumors; Tomography, X-Ray Computed | 2014 |
Relative role of motion and PSF compensation in whole-body oncologic PET-MR imaging.
Topics: Aged; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Respiration; Sarcoma; Whole Body Imaging | 2014 |
The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.
Topics: Aged; Algorithms; Carcinoma, Hepatocellular; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
[Comparison analysis of multi-modalities images in 158 patients with hepatic tumor].
Topics: Adult; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2014 |
Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Analysis; Tomography, Emission-Computed | 2014 |
Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Yttrium Radioisotopes | 2014 |
The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Multimodal Imaging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
A case of multiple hepatic angiomyolipomas with high (18) F-fluorodeoxyglucose uptake.
Topics: Adult; Angiomyolipoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Inflammatory pseudotumor of the liver diagnosed as metastatic liver tumor in a patient with a gastrointestinal stromal tumor of the rectum: report of a case.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Inflammation; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2014 |
Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Hepatocellular; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
Topics: Catheter Ablation; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Iohexol; Liver Neoplasms; Metastasectomy; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Child; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thrombosis; Tomography, X-Ray Computed; Veins; Vena Cava, Inferior; Venous Thromboembolism; Young Adult | 2014 |
[Value of (18)F-FDG PET in preoperative TACE of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Survival Rate | 2014 |
Detection of a liver metastasis by breath-hold FDG-PET/CT not visible on standard PET/CT.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Multiple hepatic lesions in a case of isolated hepatic tuberculosis simulating metastases on 18F-FDG PET/CT imaging.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis, Hepatic | 2014 |
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Middle Aged; Phosphorylation; Radionuclide Imaging; STAT3 Transcription Factor | 2014 |
CT, MRI, and 18F-FDG PET/CT in a patient with nested stromal epithelial tumor of the liver.
Topics: Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography | 2014 |
A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT.
Topics: Adult; Aged; Algorithms; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden | 2014 |
Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors.
Topics: Adult; Aged; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Muscles; Neoplasm Grading; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Assessing and accounting for the impact of respiratory motion on FDG uptake and viable volume for liver lesions in free-breathing PET using respiration-suspended PET images as reference.
Topics: Ablation Techniques; Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Motion; Movement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Respiration; Respiration, Artificial; Signal Processing, Computer-Assisted; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2014 |
[Synchronous hepatocellular carcinoma and B-cell non-Hodgkin's lymphoma in chronic hepatitis C patient].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gadolinium DTPA; Genotype; Hepatitis B virus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microvessels; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neovascularization, Pathologic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET.
Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cell Survival; Disease Models, Animal; Fluorodeoxyglucose F18; Hep G2 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunohistochemistry; Liver Neoplasms; Male; Mice; Neoplasm Transplantation; Positron-Emission Tomography; Vorinostat | 2015 |
F-18 FDG hypermetabolism in mass-forming focal pancreatitis and old hepatic schistosomiasis with granulomatous inflammation misdiagnosed by PET/CT imaging.
Topics: Biopsy; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Granuloma; Humans; Liver Diseases, Parasitic; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Schistosomiasis; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2015 |
[Feasibility study of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in proposing selection criteria for patients with hepatocellular carcinoma in liver transplantation].
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Disease-Free Survival; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Multimodal Imaging; Patient Selection; Positron-Emission Tomography; Risk Factors; ROC Curve; Tomography, X-Ray Computed | 2014 |
[A case of malignant perivascular epithelioid cell tumor of the retroperitoneum with multiple metastases].
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Perivascular Epithelioid Cell Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Combined PET/CT by 18F-FDOPA, 18F-FDA, 18F-FDG, and MRI correlation on a patient with Carney triad.
Topics: Adult; Chondroma; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
¹⁸F-FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Solitary splenic metastasis from hepatocellular carcinoma detected on (18)F-FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed | 2015 |
Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Retrospective Studies | 2015 |
Subdiaphragmatic gallstone mimicking hepatic malignancy on FDG PET/CT.
Topics: Aged; Carcinoma; False Positive Reactions; Fluorodeoxyglucose F18; Gallstones; Humans; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Cold Ischemia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reperfusion Injury; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Warm Ischemia | 2015 |
The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
Topics: Autoradiography; Biopsy; Bone Neoplasms; Calibration; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Logistic Models; Lung Neoplasms; Needles; Positron-Emission Tomography; Probability; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
[A case report of surgical treatment for hepatocellular carcinoma with a Hugely swollen lymph node that showed high FDG uptake].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2014 |
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Incidental Detection of Solitary Hepatic Metastasis by 99mTc-MDP and 18F-NaF PET/CT in a Patient With Osteosarcoma of the Tibia.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Neoplasms; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tibia; Tomography, X-Ray Computed | 2015 |
Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy.
Topics: Age Factors; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Serum Albumin; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2015 |
[Diagnostic value of ¹⁸F-fluorodexyglucose positron emission tomography combined with contrast enhanced computed tomography in colorectal cancer liver metastasis].
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Treatment Outcome | 2015 |
18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The role of 18F-FDG accumulation and arterial enhancement as biomarkers in the assessment of typing, grading and staging of hepatocellular carcinoma using 18F-FDG-PET/CT with integrated dual-phase CT angiography.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Pretransplant serum levels of C-reactive protein predict prognoses in patients undergoing liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; C-Reactive Protein; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2015 |
Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
Topics: Blood Glucose; Brain; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Microcirculation; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Topics: Acetates; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Carbon; Carcinoma, Hepatocellular; Disease Models, Animal; Fluorodeoxyglucose F18; Liver Neoplasms; Mice; Mice, Knockout; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG PET/CT of Liver Lymphoepithelioma-like Carcinoma.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Lean body mass correction of standardized uptake value in simultaneous whole-body positron emission tomography and magnetic resonance imaging.
Topics: Adult; Aged; Body Composition; Body Mass Index; Brain Neoplasms; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Obesity; Positron-Emission Tomography; Prospective Studies; Whole Body Imaging | 2015 |
18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
18F-FDG PET/CT in Hepatosplenic Gamma-Delta T-Cell Lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, T-Cell; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed | 2015 |
FDG-PET/CT Manifestation of Tumor Seeding Along Percutaneous Biliary Drainage Catheter Tract.
Topics: Catheterization; Colonic Neoplasms; Drainage; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Seeding; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
Topics: Adult; Algorithms; Artifacts; Bayes Theorem; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Signal-To-Noise Ratio; Tomography, X-Ray Computed | 2015 |
Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Unnecessary Procedures | 2015 |
Important factors determining prognosis based on SUVmax in PET imaging.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Mammography; Mastectomy; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Bone Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging; Young Adult | 2015 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2015 |
Liver and bone metastases from breast cancer: Eovist magnetic resonance and diffusion weighted imaging, 18F-FDG positron emission/computed tomography.
Topics: Adult; Breast Neoplasms; Carcinoma; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed | 2016 |
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Performance of tumor growth kinetics as an imaging biomarker for response assessment in colorectal liver metastases: correlation with FDG PET.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Biomarkers; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2015 |
A Case of Oral Metastasis From Hepatocellular Carcinoma Displayed on 18F-FDG PET/CT Imaging.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Predictors of Microvascular Invasion in Hepatocellular Carcinoma.
Topics: Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microvessels; Neoplasm Invasiveness; Positron-Emission Tomography; Protein Precursors; Prothrombin; Radiopharmaceuticals | 2015 |
Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Klatskin Tumor; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Feasibility Studies; Fluorodeoxyglucose F18; Liver Cirrhosis; Liver Neoplasms; Male; Metabolic Clearance Rate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Standardized Added Metabolic Activity Predicts Survival After Intra-arterial Resin-Based 90Y Radioembolization Therapy in Unresectable Chemorefractory Metastatic Colorectal Cancer to the Liver.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Yttrium Radioisotopes | 2016 |
Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers.
Topics: Adult; Aged; Aged, 80 and over; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Dyspnoea in a 72-year-old woman.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Dyspnea; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Positron-Emission Tomography | 2015 |
Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vascular Surgical Procedures | 2015 |
18F-FDG PET in Liver Transplantation Setting of Hepatocellular Carcinoma: Predicting Histology?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2016 |
Total Lesion Glycolysis and Sequential (90)Y-Selective Internal Radiation Therapy in Breast Cancer Liver Metastases: Preliminary Results.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Yttrium Radioisotopes | 2015 |
Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer.
Topics: Aged; Aged, 80 and over; Algorithms; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2016 |
Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients.
Topics: Angiogenesis Inhibitors; Breast Neoplasms; Embolization, Therapeutic; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Liver Function Tests; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2016 |
Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aging; Carcinoma, Hepatocellular; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2016 |
Increased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Perfusion Imaging; Portal System; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Metabolic activity of breast cancer metastatic lesions on positron emission tomography/computed tomography: comparison with histological and biological characteristics of primary tumor.
Topics: Bone Neoplasms; Breast Neoplasms; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ki-67 Antigen; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2016 |
PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions.
Topics: Adenoma, Liver Cell; Adult; Biomarkers, Tumor; Biopsy; Databases, Factual; Diagnostic Errors; DNA Mutational Analysis; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hepatocyte Nuclear Factor 1-alpha; Humans; Incidental Findings; Liver Neoplasms; Male; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
Topics: Acetates; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiometry; Retrospective Studies; Risk; Whole Body Imaging | 2016 |
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
Topics: Ablation Techniques; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Waiting Lists | 2016 |
Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Image-Guided Biopsy; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2015 |
18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Treatment Outcome | 2016 |
18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
Topics: Aged; Biological Transport; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Damage; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hep G2 Cells; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2; Quercetin; Sorafenib; Tumor Suppressor Protein p53 | 2016 |
A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microvessels; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Neoplasms | 2016 |
Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Treatment Outcome; Young Adult | 2016 |
CT, MRI, and 18F-FDG PET/CT Findings in Untreated Pulmonary and Hepatic B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Over a Five-Year Period: A Case Report.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2016 |
Extraosseous Osteosarcoma of the Liver Demonstrated on 18F-FDG PET/CT Imaging.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Whole Body Imaging | 2016 |
Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms | 2016 |
(18)F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Analysis; Tumor Burden; Yttrium Radioisotopes | 2016 |
FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases.
Topics: Adenocarcinoma; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vulvar Neoplasms | 2016 |
Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation.
Topics: Adenoma, Liver Cell; Adult; Antiporters; Female; Fluorodeoxyglucose F18; Hepatocyte Nuclear Factor 1-alpha; Humans; Liver Neoplasms; Middle Aged; Monosaccharide Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
18F-FDG PET/CT and primary hepatic MALT: a case series.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Primary Liver Carcinosarcoma and 18F-FDG PET/CT.
Topics: Abdominal Neoplasms; Carcinosarcoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; Decision Support Techniques; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2016 |
Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Survival Rate; Treatment Outcome | 2016 |
Cholangiolocellular Carcinoma of the Liver Exhibiting High F-18 FDG Uptake.
Topics: Aged; Cholangiocarcinoma; Diagnosis, Differential; Duodenal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2016 |
The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
Topics: Adult; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2016 |
Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.
Topics: Adult; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Survival Rate | 2016 |
Unusual Presentation of Bone Metastasis from Hepatocellular Carcinoma Mimicking as Breast Lump.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed | 2016 |
A Lesion-Based Response Prediction Model Using Pretherapy PET/CT Image Features for Y90 Radioembolization to Hepatic Malignancies.
Topics: Adult; Aged; Disease Progression; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary.
Topics: Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Middle Aged; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Hepatopulmonary Shunt Reduction With 177Lu-DOTATATE Therapy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
High Uptake of FDG Along a Biliary Stent.
Topics: Aged; Biliary Tract; Biliary Tract Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stents | 2016 |
Dual-Tracer PET/CT Using 18F-FDG and 11C-Acetate in Gastric Adenocarcinoma With Liver Metastasis.
Topics: Acetates; Adenocarcinoma; Aged; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2016 |
Primary Maligant Melanoma of the Oesophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Female; Fluorodeoxyglucose F18; Humans; Interferons; Liver Neoplasms; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
FDG DOTANOC Mismatch in In Vivo Characterization and Grading of Neuroendocrine Tumor.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Venous Thrombosis | 2017 |
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
Hepatic radiation injury mimicking metastasis in distal esophageal cancer
Topics: Adenocarcinoma; Adult; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Hepatitis; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiopharmaceuticals | 2017 |
Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Assessment; Survival Analysis; Young Adult | 2017 |
Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cause of Death; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hospital Mortality; Humans; Japan; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Tissue Donors; Treatment Outcome | 2017 |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Topics: Bone Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Survival Rate | 2017 |
Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2016 |
Prognostic Importance of the Presence of Early Metabolic Response and Absence of Extrahepatic Metastasis After Selective Internal Radiation Therapy in Colorectal Cancer Liver Metastasis.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis | 2016 |
Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Evaluation of a New Motion-correction Algorithm Using On-rigid Registration in Respiratory-gated PET/CT Images of Liver Tumors.
Topics: Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Motion; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Signal-To-Noise Ratio | 2016 |
[Surgery of colorectal lung metastases : Results of a survey in Germany].
Topics: Colorectal Neoplasms; Contraindications; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Metastasectomy; Pneumonectomy; Positron-Emission Tomography; Prognosis; Surveys and Questionnaires; Tomography, X-Ray Computed; United Kingdom | 2017 |
Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2017 |
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Florida; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals | 2017 |
FDG PET/CT Findings of Primary Hepatic Leiomyosarcoma in an Immunocompetent Pediatric Patient.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Pati
Topics: Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; South Australia; Survival Rate | 2018 |
Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
Topics: Animals; Dog Diseases; Dogs; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Hemangiosarcoma; Liver Neoplasms; Male; Neoplasm Staging; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Splenectomy; Splenic Neoplasms; Ultrasonography | 2017 |
Comparison of Contrast-Enhanced CT and [
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2017 |
90Y Liver Radioembolization Imaging Using Amplitude-Based Gated PET/CT.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Yttrium Radioisotopes | 2017 |
Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Prognosis; Recurrence; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome | 2017 |
Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before Liver Transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2017 |
Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Liver Neoplasms; Male; Neovascularization, Pathologic; Nitroimidazoles; Oxygen Consumption; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits | 2017 |
Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
Topics: Adult; Aged; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
18F-Fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma.
Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyridines; Radiopharmaceuticals; Receptors, Vascular Endothelial Growth Factor; Sorafenib | 2008 |
Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Fourier Analysis; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Time Factors; Tomography, X-Ray Computed | 2008 |
Clinical case report and literature review: metachronous colorectal splenic metastases.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Splenectomy; Splenic Neoplasms | 2008 |
Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
Topics: Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2008 |
Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Time Factors; Young Adult | 2008 |
Focal fat spared area in the liver masquerading as hepatic metastasis on F-18 FDG PET imaging.
Topics: Biopsy; Colorectal Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Image Enhancement; Iopamidol; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
[Current possibilities of radiodiagnosis in liver tumors].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2008 |
[Use of 18F-FDG PET scan in the diagnosis of large liver neoplasms and in the evaluation of therapeutic effectiveness].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome | 2008 |
Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Topics: Aged; Blotting, Western; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 2; Hexokinase; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Treatment Outcome | 2008 |
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Topics: Aged; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Liver Neoplasms; Microspheres; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiation Dosage; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Topics: Acetates; Adult; Carbon; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Incidence; Korea; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Survival Analysis; Survival Rate; Tomography, X-Ray Computed | 2008 |
Port site and distant metastases of gallbladder cancer after laparoscopic cholecystectomy diagnosed by positron emission tomography.
Topics: Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cholecystectomy, Laparoscopic; Cholecystitis; Cholelithiasis; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Incidental Findings; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Seeding; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Catheter Ablation; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Duodenal metastasis from hepatocelluar carcinoma demonstrated on FDG PET/CT imaging.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Duodenal Neoplasms; Duodenoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiography, Abdominal; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
Sonography of multifocal Brucella orchitis.
Topics: Adult; Antineoplastic Agents; Benzamides; Brucellosis; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Hemangioma; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Piperazines; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography | 2009 |
Respiratory-gated positron emission tomography and breath-hold computed tomography coupling to reduce the influence of respiratory motion: methodology and feasibility.
Topics: Artifacts; Contrast Media; Equipment Design; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Tomography, X-Ray Computed | 2009 |
Radiofrequency ablation of liver tumors using a novel bipolar device.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections.
Topics: Carcinoma, Squamous Cell; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Portal Vein; Positron-Emission Tomography; Preoperative Care; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Yttrium Radioisotopes | 2009 |
Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculous lymphadenitis.
Topics: Antitubercular Agents; Breast Neoplasms; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tuberculosis, Lymph Node | 2009 |
18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Recurrence; Survival Rate | 2009 |
F-18 FDG PET/CT findings in a case of undifferentiated embryonal sarcoma of the liver with lung and adrenal gland metastasis in a child.
Topics: Adrenal Gland Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT monitoring of radiation therapeutic effect in hepatic epithelioid hemangioendothelioma.
Topics: Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Differentiation; Disease Progression; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucose-6-Phosphatase; Hexokinase; Humans; Liver Neoplasms; Models, Biological; Radionuclide Imaging; Tumor Cells, Cultured; Verapamil | 2009 |
FDG PET/CT findings of mesenchymal hamartoma of the liver in an adult.
Topics: Adult; Fluorodeoxyglucose F18; Hamartoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Mesoderm; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Inflammatory pseudotumours resembling multiple hepatic metastases and their complete regression, as revealed by 18F-FDG PET/CT.
Topics: Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Liver Neoplasms; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed | 2009 |
Role of PET/CT in the detection of liver metastases from colorectal cancer.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Topics: Adenocarcinoma; Aged; Carcinoid Tumor; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2009 |
Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Nerve Growth Factors; Positron-Emission Tomography; Prognosis; Retrospective Studies; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, X-Ray Computed; Uveal Neoplasms | 2009 |
Fluorodeoxyglucose-positron emission tomography imaging characteristics of unusual cystic metastasis on the liver surface arising from gallbladder carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2009 |
FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Prognosis; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Outcome | 2009 |
F-18 FDG PET/CT imaging in a case of primary choriocarcinoma in the retroperitoneum.
Topics: Adult; Choriocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed | 2009 |
Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging.
Topics: Breast Neoplasms; Carcinoma, Ductal; Diagnosis, Differential; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Dextrans; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Patient Care Planning; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Iohexol; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Perfusion Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, X-Ray Computed | 2010 |
The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.
Topics: Acetate-CoA Ligase; Acetates; Adult; Aged; Carbon; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Fatty Acid Synthases; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
Primary hepatic tuberculoma appears similar to hepatic malignancy on F-18 FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculoma | 2009 |
Asymptomatic thymic carcinoma with solitary hepatic metastasis detected by fluorodeoxyglucose positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms | 2009 |
Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Hexokinase; Humans; Liver Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2009 |
[Clinical value of (18)F-FDG positron emission tomography-computed tomography in local liver neoplasm ablation].
Topics: Ablation Techniques; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Uveal Neoplasms | 2010 |
FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Analysis of Variance; Biological Transport; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Time Factors | 2010 |
Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; Tumor Burden | 2010 |
[A case of epithelioid hemangioendothelioma of the liver: detection by FDG-PET].
Topics: Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography | 2009 |
C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
Topics: Acetates; Adenoma, Liver Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carbon; Carbon Isotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2009 |
[Automated synthesis of 2-[(18)F]-fluoro-2-deoxy-D-glucose by on-column hydrolysis].
Topics: Adult; Aged; Automation; Fluorodeoxyglucose F18; Humans; Hydrolysis; Kidney Neoplasms; Liver Neoplasms; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2009 |
[A case of eosinophilic abscess mistaken for metastasis due to FDG uptake in PET-CT].
Topics: Diagnostic Errors; Eosinophilia; Fluorodeoxyglucose F18; Humans; Liver Abscess; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT findings in two patients with hepatic angiomyolipoma with and without intratumoral hemorrhage.
Topics: Aged; Angiomyolipoma; Female; Fluorodeoxyglucose F18; Hemorrhage; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Interesting image. Utility of FDG metabolism to differentiate synchronous metastatic liver lesions from synchronous colon cancer: nonmucinous versus mucinous adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Comparison of the tumorigenic potential of liver and kidney tumors induced by N-nitrosodimethylamine.
Topics: Analysis of Variance; Animals; Autoradiography; Biomarkers, Tumor; Blotting, Western; Carcinogenicity Tests; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Dimethylnitrosamine; Flow Cytometry; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Immunohistochemistry; Kidney; Kidney Neoplasms; Liver; Liver Neoplasms; Mesenchymoma; Microscopy, Fluorescence; Radionuclide Imaging; Rats; Transforming Growth Factor beta1 | 2010 |
Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Primary hepatic schwannoma mimicking malignancy on fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Monte Carlo Method; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Software | 2010 |
Posterior parahepatic cyst as an incidental finding--review of 40 cases.
Topics: Aged; Aged, 80 and over; Cysts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Support for Warburg's hypothesis using dynamic (18)F-FDG PET in oncology.
Topics: Anaerobiosis; Cell Hypoxia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Biomarkers; Fluorodeoxyglucose F18; Injections, Intravenous; Liver Neoplasms; Male; Organophosphorus Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Treatment Outcome | 2010 |
Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed | 2010 |
18F-FDG-PET and MRI in patients with malignancies of the liver and pancreas. Accuracy of retrospective multimodality image registration by using the CT-component of PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Body Size; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature.
Topics: Biological Transport; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2010 |
Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Yttrium Radioisotopes | 2010 |
Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
False positive diagnosis of metastatic esophageal carcinoma on positron emission tomography: a case report of cholecystitis simulating a hepatic lesion.
Topics: Aged; Cholecystitis; Diagnosis, Differential; Esophageal Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Solitary hepatic metastasis from medullary thyroid carcinoma mimicking atypical hemangioma: insights from multimodality diagnostic approach by MRI, F-18 FDG and F-18 FDOPA PET/CT.
Topics: Diagnosis, Differential; Diagnostic Imaging; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
[Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions].
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Whole Body Imaging; Young Adult | 2010 |
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Republic of Korea; Time Factors; Tomography, Spiral Computed; Treatment Outcome | 2010 |
Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Contrast Media; Dermatitis, Contact; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
18F-FDG-PET-CT imaging findings of recurrent intracranial haemangiopericytoma with distant metastases.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiopericytoma; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Metabolic super scan in F-FDG PET/CT imaging.
Topics: Carcinoma, Small Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hemoptysis; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2011 |
[A case of pancreatic neuroendocrine tumor with multiple hepatic metastasis].
Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
Topics: Adult; Aged; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Solitary necrotic nodule with larval infestation in the liver on F-18 FDG PET/CT.
Topics: Animals; Female; Fluorodeoxyglucose F18; Humans; Larva; Liver Neoplasms; Necrosis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Hepatic paragonimiasis revealed by FDG PET/CT.
Topics: Aged; Animals; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Paragonimiasis; Paragonimus westermani; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
[Hepatocellular carcinoma and cholangiocarcinoma].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Combined Modality Therapy; Contrast Media; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Use of molecular imaging to differentiate liver metastasis of colorectal cancer metastasis from neuroendocrine tumor origin.
Topics: Biopsy; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography | 2011 |
Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Palliative Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2011 |
Nasopharyngeal carcinoma with splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings.
Topics: Adolescent; Carcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed | 2010 |
Detection of distant metastasis to skeletal muscle by 18F-FDG-PET in a case of intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Abscess; Liver Neoplasms; Lymphoma, Large-Cell, Immunoblastic; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Vincristine | 2010 |
Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemia; Liver Neoplasms; Male; Pheochromocytoma; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tumor Burden; Young Adult | 2010 |
PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate | 2011 |
Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Contrast Media; Embolization, Therapeutic; Ethiodized Oil; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2010 |
Imaging lipid synthesis in hepatocellular carcinoma with [methyl-11c]choline: correlation with in vivo metabolic studies.
Topics: Animals; Betaine; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Choline Kinase; Choline-Phosphate Cytidylyltransferase; Fluorodeoxyglucose F18; Lipids; Liver Neoplasms; Marmota; Phosphatidylcholines; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
FDG PET for giant cavernous hemangioma: important clue to differentiate from a malignant vascular tumor in the liver.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography | 2010 |
Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Liver Neoplasms; Lutetium; Male; Octreotide; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Rats; Reproducibility of Results; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2011 |
Nested stromal epithelial tumor of the liver--liver transplantation and follow-up.
Topics: Adolescent; Epithelial Cells; Fatal Outcome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Multimodal Imaging; Neoplasms, Complex and Mixed; Positron-Emission Tomography; Radiopharmaceuticals; Stromal Cells; Tomography, X-Ray Computed | 2011 |
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Evaluation of contrast medium enhancement and [(18)F]-FDG uptake of liver metastasis in PET/CT prior to therapy.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Serum Albumin; Survival Analysis; Technetium Tc 99m Aggregated Albumin; Tin Compounds; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diagnostic Imaging; Endemic Diseases; Female; Fluorodeoxyglucose F18; Hepatitis, Viral, Human; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Taiwan; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2011 |
Pancreatic and hepatobiliary cancers.
Topics: Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
Topics: Adult; Aged; Biopsy; Boston; Case-Control Studies; Catheter Ablation; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Embolization, Therapeutic; Extravasation of Diagnostic and Therapeutic Materials; Fluorodeoxyglucose F18; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multivariate Analysis; Necrosis; Positron-Emission Tomography; Predictive Value of Tests; Rats; Rats, Inbred BUF; Tumor Burden | 2011 |
Incremental diagnostic value of F-18 FDG PET/CT over MRI in a pediatric patient with suspected hepatoblastoma and histologic diagnosis of focal nodular hyperplasia.
Topics: Female; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy.
Topics: Adult; Aged; Algorithms; Angiography; Contrast Media; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Software; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Treatment Outcome; Triage; Whole Body Imaging; Yttrium Radioisotopes | 2012 |
Parametric images via dynamic 18F-fluorodeoxyglucose positron emission tomographic data acquisition in predicting midterm outcome of liver metastases secondary to gastrointestinal stromal tumours.
Topics: Adult; Aged; Cohort Studies; Discriminant Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Image Interpretation, Computer-Assisted; Linear Models; Liver Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2011 |
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival; Survival Analysis; Tomography, Emission-Computed; Young Adult | 2011 |
Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2011 |
18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
Topics: Adult; Aged; Analysis of Variance; Carcinoma, Hepatocellular; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Research Design; Treatment Outcome | 2011 |
Images in vascular medicine . Metastatic aortic intimal sarcoma: the use of PET/CT in diagnosing and staging.
Topics: Aged; Angiography; Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed; Tunica Intima; Vascular Neoplasms | 2011 |
Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma.
Topics: Adult; Fatal Outcome; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Positron-Emission Tomography; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Impact of time-of-flight PET on whole-body oncologic studies: a human observer lesion detection and localization study.
Topics: Body Size; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Positron-Emission Tomography; ROC Curve; Time Factors; Whole Body Imaging | 2011 |
FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed | 2011 |
Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Treatment Outcome | 2012 |
Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2011 |
F-18 Fluorodeoxyglucose non-avid hepatosplenic T cell lymphoma: a diagnostic pitfall.
Topics: Fluorodeoxyglucose F18; Humans; Immunophenotyping; Liver Neoplasms; Lymphoma, T-Cell; Multimodal Imaging; Positron-Emission Tomography; Splenic Neoplasms; Tomography, X-Ray Computed | 2012 |
Hepatic macronodular tuberculoma mimics liver metastasis in a patient with locoregional advanced tongue cancer.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mycobacterium tuberculosis; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tongue Neoplasms; Tuberculoma; Tuberculosis, Hepatic; Tuberculosis, Pulmonary | 2011 |
Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Colorectal Neoplasms; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2011 |
Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Hong Kong; Humans; Liver Neoplasms; Liver Transplantation; Male; Microvessels; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome | 2011 |
The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2011 |
Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.
Topics: Aged; Aged, 80 and over; Biopsy; Catheter Ablation; Computer Systems; Electromagnetic Fields; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Surgery, Computer-Assisted | 2011 |
Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Protein Kinase Inhibitors; Pyridines; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Sorafenib; Survival Rate; Time Factors; Treatment Outcome; Young Adult | 2011 |
Hepatocellular carcinoma eats medullary thyroid carcinoma, a case of tumor-in-tumor metastasis.
Topics: Carcinoma, Hepatocellular; Carcinoma, Medullary; Fluorodeoxyglucose F18; Histocytochemistry; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Ultrasonography | 2011 |
Preoperative FDG-PET predicts recurrence patterns in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2012 |
Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiography; Retrospective Studies; Survival Rate; Treatment Outcome | 2012 |
Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Unnecessary Procedures | 2011 |
Sarcomatoid hepatocellular carcinoma diagnosed by FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed; Ultrasonography | 2011 |
The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2011 |
Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
Topics: Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Rectal Neoplasms; Risk Assessment; Tomography, X-Ray Computed | 2012 |
F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
A hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma detected by F-18 FDG PET/CT imaging.
Topics: Adenocarcinoma; Aged; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
F-18 FDG uptake in focal fatty infiltration of liver mimicking hepatic malignancy on PET/CT images.
Topics: Adolescent; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lipids; Liver; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Unusual Tc-99m methylene diphosphonate uptake by clinically suspected adrenal metastases from hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2011 |
Characterization of adrenal metastatic cancer using FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Carcinoma; China; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Hyperplasia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy.
Topics: Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2012 |
The role of 18FDG PET/CT in the management of colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case.
Topics: Adenoma, Liver Cell; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Imaging features of colorectal liver metastasis in FDG PET-CT: a retrospective correlative analysis between CT attenuation and FDG uptake.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis.
Topics: 19-Iodocholesterol; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2012 |
A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.
Topics: Adolescent; Ammonia; Antineoplastic Agents, Alkylating; Carcinoma, Hepatocellular; Energy Metabolism; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Molecular Structure; Positron-Emission Tomography; Pyruvates; Translational Research, Biomedical; Urea; Uric Acid | 2012 |
18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tomography, X-Ray Computed; Young Adult; Yttrium Radioisotopes | 2012 |
Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Pitfalls in radiation oncology. "Myocardial metastasis" in PET-CT after palliative radiation treatment of the left 5th rib.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Diagnostic Errors; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Myocardium; Neoplasm Staging; Palliative Care; Positron-Emission Tomography; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Ribs; Tomography, X-Ray Computed | 2012 |
In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations.
Topics: Brain Neoplasms; Carcinoma, Hepatocellular; Cell Count; Cell Proliferation; Colorectal Neoplasms; Culture Media; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tumor Cells, Cultured | 2012 |
Improved imaging of intrahepatic colorectal metastases with 18F-fluorodeoxyglucose respiratory-gated positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.
Topics: Adenoviridae; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Feasibility Studies; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, Reporter; Genetic Therapy; Genetic Vectors; Inhibitor of Apoptosis Proteins; Injections, Intralesional; Injections, Intravenous; Liver Neoplasms; Luciferases, Firefly; Luminescent Measurements; Positron-Emission Tomography; Promoter Regions, Genetic; Radiopharmaceuticals; Rats; Rats, Inbred BUF; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Transcription, Genetic; Transduction, Genetic | 2012 |
99mTc-MDP- and 18F-FDG-avid metastatic liver lesion: the similarities and differences between 2 modalities.
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Hepatocelluar carcinoma in an accessory lobe of the liver revealed by 11C-acetate PET with a negative finding on FDG imaging.
Topics: Acetates; Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Complete disappearance of uptake of FDG in the multifocal liver hemangioendothelioma after radioembolization therapy using yttrium-90 microspheres.
Topics: Biological Transport; Embolization, Therapeutic; Fluorodeoxyglucose F18; Hemangioendothelioma; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy, Image-Guided; Respiratory-Gated Imaging Techniques; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.
Topics: Animals; Artifacts; Colorectal Neoplasms; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Rats; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT in evaluation of radiofrequency ablation of liver metastasis.
Topics: Adult; Catheter Ablation; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Bilateral breast uptake demonstrated on FDG PET/CT scans in 3 male patients with hepatocellular carcinomas.
Topics: Breast; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
[18F]-5-Fluoro-5-deoxyribose, an efficient peptide bioconjugation ligand for positron emission tomography (PET) imaging.
Topics: Carcinoma, Hepatocellular; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hydrogen-Ion Concentration; Ligands; Liver Neoplasms; Oximes; Peptides; Positron-Emission Tomography; Receptor, PAR-2 | 2012 |
Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Regeneration; Male; Middle Aged; Multimodal Imaging; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cystadenoma, Serous; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Liver Neoplasms; Male; Microspheres; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT.
Topics: Adenoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Inflammatory pseudotumor of the kidney mimicking malignancy on 18F-FDG PET/CT in a patient with diabetes and hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Diabetes Complications; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Kidney Diseases; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Reference Standards; Reproducibility of Results | 2012 |
Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
CT- versus coregistered FDG-PET/CT-based radiation therapy plans for conformal radiotherapy in colorectal liver metastases: a dosimetric comparison.
Topics: Adult; Aged; Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Multiple target-specific molecular imaging agents detect liver cancer in a preclinical model.
Topics: Animals; Benzenesulfonates; Carbocyanines; Cell Line, Tumor; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Indoles; Liver Neoplasms; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Multimodal Imaging; Neoplasm Transplantation; Oligopeptides; Optical Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Single-Cell Analysis; Tissue Distribution; Tomography, X-Ray Computed | 2012 |
Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
Topics: Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
Prognostic ability of 18F-FDG PET/CT in the assessment of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2012 |
An algorithm for PET tumor volume and activity quantification: without specifying camera's point spread function (PSF).
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Early dynamic F18-FDG-PET shows a hypervascular pattern with central scar in a liver mass.
Topics: Female; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Humans; Liver; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2012 |
PET-CT accurately predicts the pre-operative characteristics of colorectal hepatic metastases.
Topics: Colectomy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2012 |
FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease.
Topics: Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Topics: Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
Topics: Antigens, CD34; Antigens, Neoplasm; Bayes Theorem; Carbonic Anhydrase IX; Carbonic Anhydrases; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Recurrent and metastatic osteoclast-like giant cell tumor of the liver revealed by FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Osteoclasts; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2013 |
Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors.
Topics: Ablation Techniques; Adult; Aged; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiofrequency Therapy; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2012 |
Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Brain Neoplasms; Carcinoembryonic Antigen; Chemoradiotherapy; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2012 |
Intramedullary metastasis detected with 18F FDG-PET/CT.
Topics: Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, X-Ray Computed | 2012 |
(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[A case of hepatocellular carcinoma with multiple lymph node metastases detected by FDG-PET].
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2Rγ(null) (NOG) mice by (18)F-FDG PET/CT.
Topics: Analysis of Variance; Animals; Colonic Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Multimodal Imaging; Neoplasms, Experimental; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
Topics: Adenocarcinoma; Adult; alpha-Fetoproteins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Biopsy; CA-125 Antigen; Capecitabine; Carcinoembryonic Antigen; Carrier Proteins; CDX2 Transcription Factor; Chemotherapy, Adjuvant; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cytokines; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Glycoproteins; Hepatectomy; Homeodomain Proteins; Humans; Immunohistochemistry; Keratin-20; Keratins; Liver; Liver Neoplasms; Lymph Node Excision; Magnetic Resonance Imaging; Membrane Transport Proteins; Phenotype; Portal Vein; Pregnancy; Receptors, Estrogen; Receptors, Progesterone | 2012 |
Correlation between therapy response assessment using FDG PET/CT and histopathologic tumor regression grade in hepatic metastasis of colorectal carcinoma after neoadjuvant therapy.
Topics: Biological Transport; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location.
Topics: Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Fuzzy multi-class statistical modeling for efficient total lesion metabolic activity estimation from realistic PET images.
Topics: Algorithms; Biomarkers; Computer Simulation; Diagnostic Imaging; Fluorodeoxyglucose F18; Fuzzy Logic; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Models, Statistical; Positron-Emission Tomography; Reproducibility of Results; Software; Stochastic Processes | 2012 |
Radiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanoma.
Topics: Adult; Aged; Body Burden; Choroid Neoplasms; Epidemiological Monitoring; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Monte Carlo Method; Multimodal Imaging; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiation Dosage; Radiometry; Radiopharmaceuticals; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Whole Body Imaging; Whole-Body Irradiation; Young Adult | 2013 |
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; Contrast Media; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Medical Oncology; Middle Aged; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
¹⁸F-fluorodeoxyglucose PET/CT findings of a solitary primary hepatic lymphoma: a case report.
Topics: Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Unusual uptake of 18FDG by a hepatic adenoma.
Topics: Adenoma; Adult; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole-Body Counting | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2002 |
The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Preoperative Care; Radiopharmaceuticals; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Ultrasonography | 2002 |
Intraoperative sonography still the standard technique in hepatic surgery.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Monitoring, Intraoperative; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography | 2002 |
Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Topics: Aged; Carcinoembryonic Antigen; Catheter Ablation; Cryosurgery; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
Positron emission tomography for the evaluation of patients with colorectal cancer.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Carcinoembryonic Antigen; Cecal Neoplasms; Colectomy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radioimmunodetection; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Evaluation of various hepatic lesions with positron emission tomography].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Where can FDG-PET contribute most to anatomical imaging problems?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses.
Topics: Animals; Cell Adhesion; Cell Line; Cells, Cultured; CHO Cells; Cricetinae; Endothelium, Vascular; Extracellular Matrix; Fluorodeoxyglucose F18; Green Fluorescent Proteins; Humans; Integrin alphaVbeta3; Kinetics; Liver Neoplasms; Luminescent Proteins; Mice; Microcirculation; Microscopy, Fluorescence; Pulmonary Circulation; Radiopharmaceuticals; Recombinant Fusion Proteins; Tomography, Emission-Computed; Transfection | 2002 |
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients.
Topics: Adult; Aged; Breast Neoplasms; Colonic Neoplasms; Diagnostic Errors; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germanium; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Catheter Ablation; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting | 2003 |
Comparison of MR and PET imaging for the evaluation of liver metastases.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.
Topics: Algorithms; Artifacts; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Mediastinal Neoplasms; Neoplasms; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Carcinoma, Hepatocellular; Decision Trees; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Detection of duplex kidney on a whole-body F-18 FDG positron emission tomographic scan.
Topics: Aged; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney; Liver Neoplasms; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
A well-differentiated hepatocellular carcinoma detected only by F-18 FDG positron emission tomography.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
[18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
Topics: Carcinoma; Catheter Ablation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
F-18 FDG PET imaging in gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Benzamides; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Piperazines; Pyrimidines; Radiopharmaceuticals; Stromal Cells; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Differentiation of synchronous tumors using FDG positron emission tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Respiratory artefact causing malpositioning of liver dome lesion in right lower lung.
Topics: Aged; Aged, 80 and over; Artifacts; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung; Male; Radiopharmaceuticals; Respiration; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[Clinical evaluation of 18F-FDE PET-CT in detecting malignant liver tumors].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Medical Oncology; Neoplasms; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Tomography, Emission-Computed | 2004 |
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.
Topics: Adenoma, Liver Cell; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
FDG-PET for the pre-operative evaluation of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Spiral Computed | 2004 |
Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG positron emission tomography.
Topics: Child, Preschool; Contrast Media; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 2004 |
Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours.
Topics: Adult; Aged; Blood Glucose; Colorectal Neoplasms; Fasting; Female; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Male; Middle Aged; Parenteral Nutrition, Total; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Female; Fluorodeoxyglucose F18; History, 18th Century; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
A case of renal pelvic tumor visualized by 18F-FDG-PET imaging.
Topics: Aged; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
[18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein].
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 2004 |
Role of FDG-PET in surgical management of patients with colorectal liver metastases.
Topics: Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2004 |
Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Radiopharmaceuticals; Risk Factors; Survival Rate; Tomography, Emission-Computed | 2004 |
Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin's disease: hepatic 'superscan'.
Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Liver; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Molecular imaging of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Messenger; Sensitivity and Specificity | 2004 |
[PET/CT for colorectal and hepatic tumors].
Topics: Adult; Aged; Colon; Colorectal Neoplasms; Disease Progression; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Epithelioid hemangioendothelioma of the liver with F-18 FDG PET imaging.
Topics: Abdominal Pain; Adult; Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases | 2004 |
18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
FDG-PET and hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
[Usefulness of F-18-fluorodeoxyglucose positron emission tomography for evaluating the efficacy of transient hepatic arterial chemoembolization for liver metastases of rectal cancer--a case report].
Topics: Chemoembolization, Therapeutic; Cholecystectomy; Doxorubicin; Fluorodeoxyglucose F18; Hepatectomy; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Mitomycin; Positron-Emission Tomography; Rectal Neoplasms; Starch | 2004 |
[Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
[Evaluation of optimized injection dose and acquisition time using body mass index for three-dimensional whole-body FDG-PET].
Topics: Body Mass Index; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Injections; Liver Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2004 |
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Topics: Colorectal Neoplasms; Contrast Media; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2004 |
Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microspheres; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
[Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2004 |
[Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
Cesium attenuation correction of the liver dome revealing hepatic lesion missed with computed tomography attenuation correction because of the respiratory motion artifact.
Topics: Aged; Artifacts; Cesium; Colorectal Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Male; Movement; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Mechanics; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Invasiveness; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.
Topics: Aged; Angiostatins; Colorectal Neoplasms; Endostatins; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiofrequency Therapy; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Radiofrequency ablation therapy of remnant colorectal liver metastases after a course of hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Catheter Ablation; Catheters, Indwelling; Colonic Neoplasms; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Remission Induction; Tomography, Spiral Computed; Treatment Outcome | 2005 |
Positron emission tomography in recurrent hepatoblastoma.
Topics: Child; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
Topics: Adult; Aged; Angiography; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclophosphamide; Deoxycytidine; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Liver Neoplasms; Male; Metabolic Clearance Rate; Organ Specificity; Organotechnetium Compounds; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Statistics as Topic; Tissue Distribution | 2005 |
FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy.
Topics: Adult; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Patient Selection; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Thrombosis | 2005 |
Metastatic hepatic lesions are detected better by delayed imaging with prolonged emission time.
Topics: Adenocarcinoma; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2005 |
[Prognostic factors in the evaluation of colorectal liver metastases].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver; Liver Neoplasms; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Survival Analysis | 2005 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
FDG PET for the study of primary hepatic malignancies in children.
Topics: Child, Preschool; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma, Embryonal; Sensitivity and Specificity | 2006 |
Focal nodular hyperplasia (FNH): a potential cause of false-positive positron emission tomography.
Topics: Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging.
Topics: Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Lung; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging.
Topics: Carcinoma, Hepatocellular; Catheterization; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Umbilical Veins; Venous Thrombosis | 2005 |
The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2005 |
[Evaluating efficacy of transcatheter arterial chemo-embolization combined with radiofrequency ablation on patients with hepatocellular carcinoma by 18FDG-PET/CT].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Whole body PET/CT for initial staging of choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Tomography, X-Ray Computed | 2005 |
Recurrent hepatoblastoma with localization by PET-CT.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; Child, Preschool; Contrast Media; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Can the relation between gadopentetate dimeglumine and FDG uptake in colorectal liver metastases be used clinically?
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Radiography; Radiopharmaceuticals | 2005 |
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
Topics: Adult; Aged; Cell Hypoxia; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET.
Topics: Aged; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Hepatic Veno-Occlusive Disease; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Thrombosis | 2005 |
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prospective Studies; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2005 |
Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Thyroid metastasis from colorectal cancer: role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Rectal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2005 |
[A case of focal fatty liver occurring after gastrectomy with difficulty in distinction from metastatic liver cancer ].
Topics: Aged; Diagnosis, Differential; Fatty Liver; Fluorodeoxyglucose F18; Gastrectomy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Postoperative Complications; Stomach Neoplasms; Ultrasonography | 2005 |
MRI better than FDG-PET at detecting liver tumors.
Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2005 |
PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
False-positive uptake of FDG in hepatic sarcoidosis.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Diseases; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Whole Body Imaging | 2006 |
An audit of fusion CT-PET in the management of colorectal liver metastases.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Medical Audit; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Child; Child, Preschool; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2006 |
Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model.
Topics: Animals; Aorta; Blood Volume; Capillary Permeability; Carcinoma; Cell Line, Tumor; Cineradiography; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Hepatic Artery; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Portal Vein; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Regional Blood Flow; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2006 |
Hürthle cell carcinoma with a giant cystic liver metastasis imaged with 18F-labeled fluorodeoxyglucose-positron emission tomography.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Obscured bone metastases after administration of hematopoietic factor on FDG-PET.
Topics: Artifacts; Bone and Bones; Bone Neoplasms; Cholangiocarcinoma; Diagnostic Errors; False Negative Reactions; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
F-18 FDG PET imaging in gastric neuroendocrine carcinoma.
Topics: Aged; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2006 |
Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.
Topics: Aged; Choroid Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Detection of metastatic disease in patients with uveal melanoma using positron emission tomography.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Uveal Neoplasms | 2006 |
PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
Topics: Carcinoma, Hepatocellular; Choline; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2006 |
"Cold" vertebrae on F-18 FDG PET: Causes and characteristics.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioma; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spine | 2006 |
Dual-time-point PET/CT to differentiate fluorodeoxyglucose-avid hiatal hernia from mediastinal malignancy.
Topics: Aged; Carcinoma, Hepatocellular; Diagnosis, Differential; Esophageal Diseases; Fluorodeoxyglucose F18; Hernia, Hiatal; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Perioperative Care; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2006 |
Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisions.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Lasers; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
Topics: Adult; Aged; alpha-Fetoproteins; Blood Vessels; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2006 |
Gadopentetate dimeglumine and FDG uptake in liver metastases.
Topics: Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Radiopharmaceuticals | 2006 |
Tumor viability evaluation by positron emission tomography with [18F]FDG in the liver metastasis rat model.
Topics: Animals; Cell Survival; Colonic Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Liver; Liver Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Time Factors | 2006 |
(18)F-FDG PET/CT visualisation of tumor seeding after percutaneous radiofrequency ablation of metastases.
Topics: Catheter Ablation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Seeding; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; DNA, Viral; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Liver Neoplasms; Male; Nasopharyngeal Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Treatment Outcome | 2006 |
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
The role of FDG-PET in the selection of patients with colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis | 2007 |
PET/CT: will it change the way that we use CT in cancer imaging?
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoembryonic Antigen; Case Management; Colorectal Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Probability; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG-PET in colorectal cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Intraoperative Period; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2007 |
Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
Topics: Adult; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
F-18 FDG PET imaging of disseminated sarcoidosis.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Sarcoidosis | 2007 |
[Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Differentiation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk | 2007 |
[Malignant tumor with false negative 18F-FDG PET image].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Signet Ring Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
FDG PET in preoperative assessment of colorectal liver metastases combining "evidence-based practice" and "technology assessment" methods to develop departmental imaging protocols: should FDG PET be routinely used in the preoperative assessment of patient
Topics: Colorectal Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Technology Assessment, Biomedical | 2007 |
Findings of fluorine-18-FDG PET in extranodal origin lymphoma--in three cases of diffuse large B cell type lymphoma.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Stomach Neoplasms | 2006 |
Bilateral adrenal gland metastasis from malignant fibrous histiocytoma: value of [F-18]FDG PET-CT for diagnosis of occult metastases.
Topics: Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Liver Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology.
Topics: Drug Delivery Systems; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Topics: Abdominal Neoplasms; Adult; Aged; Colonic Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iron; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Topics: Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Primary hepatic angiosarcoma on coregistered FDG PET and CT images.
Topics: Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Blood flow quantification with permeable contrast agents: a valid technique?
Topics: Animals; Aorta; Blood Volume; Capillary Permeability; Carcinoma; Cell Line, Tumor; Cineradiography; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Hepatic Artery; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Portal Vein; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Regional Blood Flow; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Liver Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Recombinant Proteins | 2007 |
The impact of 18F-FDG PET/CT in patients with liver metastases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thrombosis | 2007 |
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diagnosis, Differential; Disease Models, Animal; Fluorodeoxyglucose F18; Glucocorticoids; Granuloma; Liver Neoplasms; Male; Metabolic Clearance Rate; Prednisolone; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar | 2007 |
Chemotherapy in metastatic malignant triton tumor: report on two cases.
Topics: Adult; Antineoplastic Agents; Cecal Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Neoadjuvant Therapy; Neurilemmoma; Neurofibromatosis 1; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms | 2007 |
Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment.
Topics: Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2007 |
Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Tomography, Emission-Computed | 2007 |
Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Diagnostic Errors; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperthermia, Induced; Laser Therapy; Liver Neoplasms; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity | 2007 |
[The effect of different chemoembolization materials on CT-based attenuation correction in PET/CT].
Topics: Chemoembolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Iodized Oil; Liver Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Retrospective Studies; Tantalum; Tomography, X-Ray Computed; Tungsten | 2007 |
FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
Topics: Adult; Aged; Body Burden; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Rectal Neoplasms; Tomography, X-Ray Computed | 2008 |
Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Can PET-CT with FDG replace contrast enhanced CT for imaging of liver metastases?
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT.
Topics: Animals; Catheter Ablation; Fluorodeoxyglucose F18; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Necrosis; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Swine; Swine, Miniature; Tomography, X-Ray Computed; Ultrasonography | 2007 |
Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2007 |
F18-FDG-PET evaluation of patients for resection of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Endostatins; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Recombinant Proteins; Stomach Neoplasms | 2007 |
FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contraindications; Diagnosis, Differential; Eligibility Determination; Fluorodeoxyglucose F18; Granuloma, Respiratory Tract; Humans; Immune Tolerance; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study.
Topics: Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microspheres; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Yttrium Radioisotopes | 2007 |
Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Diagnosis, Differential; Dideoxynucleosides; Fluorodeoxyglucose F18; Granuloma; Inflammation; Liver Neoplasms; Male; Methionine; Mycobacterium bovis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Turpentine | 2008 |
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques.
Topics: Algorithms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Liver Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
F-18 FDG PET/CT assessment of gastrointestinal stromal tumor response to sunitinib malate therapy.
Topics: Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Indoles; Liver Neoplasms; Middle Aged; Pyrroles; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sunitinib | 2008 |
Apparent posterior misregistration of a liver lesion on PET/CT: pitfall secondary to partial hepatectomy.
Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Portal Vein; Positron-Emission Tomography; Thrombosis; Tomography, X-Ray Computed | 2008 |
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iron-Sulfur Proteins; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Retrospective Studies; Succinate Dehydrogenase; Tomography, Emission-Computed | 2008 |
Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.
Topics: Ablation Techniques; Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron-Emission Tomography; Radiofrequency Therapy; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2008 |
Multimodal imaging for the detection and characterization of liver lesions in a mouse model of neuroendocrine tumor.
Topics: Animals; Autoradiography; Biopsy; Cell Line, Tumor; Chromogranin A; Diagnostic Imaging; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Injections; Liver Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Nude; Neuroendocrine Tumors; Radiopharmaceuticals; Time Factors | 2008 |
The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Where there is no PET/CT.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Where there is no PET/CT.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Pulmonary typical carcinoid tumor and liver metastasis with hypermetabolism on 18-fluorodeoxyglucose PET: a case report.
Topics: Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2008 |
A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Viloxazine | 2008 |
F-18 FDG-PET imaging in adult T-cell leukemia lymphoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Leukemia, T-Cell; Liver Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed | 1982 |
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Glucose-6-Phosphatase; Hexokinase; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1995 |
Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Krukenberg Tumor; Liver Neoplasms; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Tomography, Emission-Computed | 1995 |
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Topics: Aged; Antibodies, Monoclonal; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Ovarian Neoplasms; Pentetic Acid; Tomography, Emission-Computed | 1995 |
[Usefulness of 99mTc-PMT SPECT and 18F-FDG PET in diagnosing orbital metastasis of hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Orbital Neoplasms; Organotechnetium Compounds; Predictive Value of Tests; Pyridoxal; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tryptophan | 1994 |
Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
Topics: Confidence Intervals; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver; Liver Neoplasms; Models, Biological; Monte Carlo Method; Tomography, Emission-Computed | 1995 |
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
Topics: Abdominal Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Tomography, Emission-Computed | 1993 |
Positron emission tomography in the clinical evaluation of metastatic cancer.
Topics: Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Models, Biological; Tomography, Emission-Computed | 1996 |
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Body Weight; Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Recombinant Proteins; Tomography, Emission-Computed | 1996 |
Quantification of serial tumor glucose metabolism.
Topics: Computer Simulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Models, Biological; Reproducibility of Results; Tomography, Emission-Computed | 1996 |
Adenocarcinoma of a foregut cyst: detection with positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Adult; Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lymphatic Metastasis; Mediastinal Cyst; Mediastinal Neoplasms; Tomography, Emission-Computed | 1996 |
Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization.
Topics: Adenocarcinoma; Chemoembolization, Therapeutic; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1996 |
[PET studies with C-11 ethanol in intratumoral therapy of hepatocellular carcinomas].
Topics: Aged; Blood Glucose; Brain; Brain Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Deoxyglucose; Ethanol; Female; Fluorodeoxyglucose F18; Humans; Injections, Intralesional; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed | 1996 |
'False-positive' uptake of FDG in a hepatic adenoma.
Topics: Adenoma; Adult; Breast Neoplasms; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Staging recurrent metastatic colorectal carcinoma with PET.
Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Portography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
False-negative fluorine-18-FDG PET in metastatic carcinoid.
Topics: Carcinoid Tumor; Deoxyglucose; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Role of positron emission tomography in staging esophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparoscopy; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Video Recording | 1997 |
Minimally invasive surgical biopsy confirms PET findings in esophageal cancer.
Topics: Adenocarcinoma; Aged; Biopsy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Laparoscopy; Liver Neoplasms; Lumbar Vertebrae; Lymphatic Metastasis; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Radiopharmaceuticals; Sacroiliac Joint; Spinal Neoplasms; Tomography, Emission-Computed | 1997 |
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Usefulness of FDG-PET in diagnosing primary lymphoma of the liver.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma.
Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Injections, Intra-Arterial; Injections, Intravenous; Liver Neoplasms; Oxygen Radioisotopes; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Water | 1998 |
Evaluation of benign vs malignant hepatic lesions with positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.
Topics: Aged; Antidotes; Antimetabolites, Antineoplastic; Carcinoma; Colorectal Neoplasms; Drug Interactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
F-18 fluorodeoxyglucose positron emission tomography imaging in ectopic nonfunctioning glucagonoma.
Topics: Choristoma; Female; Fluorodeoxyglucose F18; Glucagonoma; Humans; Ligaments; Liver Neoplasms; Middle Aged; Pancreas; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Long-term follow-up and therapeutic control of a hepatic metastatic acinar cell carcinoma of the pancreas using FDG PET].
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Acinar Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Ultrasonography | 1998 |
Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.
Topics: Esophageal Neoplasms; Esophagectomy; Esophagus; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Selection; Prospective Studies; Radiopharmaceuticals; Stomach; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Hepatocellular carcinoma outcomes based on indicated treatment strategy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tennessee; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hepatitis C, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography | 1998 |
False-negative FDG PET imaging in a patient with metastatic melanoma and ileal intussusception.
Topics: Adult; Animals; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Ileal Diseases; Intestinal Neoplasms; Intestine, Small; Intussusception; Liver Neoplasms; Melanoma; Tomography, Emission-Computed | 1999 |
Detection of liver metastases from pancreatic cancer using FDG PET.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4.
Topics: Animals; Antineoplastic Agents, Phytogenic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Liver Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Radiopharmaceuticals; Stilbenes; Tomography, Emission-Computed | 1999 |
Contribution of PET in the detection of liver metastases from pancreatic tumours.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid.
Topics: Adenoma, Oxyphilic; Aged; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Neoplasms, Multiple Primary; Radiopharmaceuticals; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
[Imaging of an adrenal cortex carcinoma and its metastasis with FDG-PET].
Topics: Adrenal Cortex Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1999 |
Hepatocellular carcinoma monitored by F-18 fluorodeoxyglucose positron emission tomography after laparoscopic microwave coagulation therapy.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microwaves; Middle Aged; Tomography, Emission-Computed | 1999 |
Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities.
Topics: Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver; Liver Neoplasms; Lymphoma, Non-Hodgkin; Melanoma; Tomography, Emission-Computed | 1999 |
Peritoneal recurrence of colon cancer detected by positron emission tomography: report of a case.
Topics: Aged; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Peritoneal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Topics: Biological Transport; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Membrane; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Glucose Transporter Type 1; Hexokinase; Humans; Isoenzymes; Kinetics; Liver Neoplasms; Monosaccharide Transport Proteins; Radiopharmaceuticals; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tumor Suppressor Protein p53; Ultrasonography; Whole-Body Counting | 1999 |
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Peritoneal Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.
Topics: Adult; Aged; Carcinoma; Colonic Neoplasms; Contraindications; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Laparotomy; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Patient Care Planning; Radiopharmaceuticals; Rectal Neoplasms; Reoperation; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses.
Topics: Area Under Curve; Blood Glucose; Cholangiopancreatography, Endoscopic Retrograde; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Preoperative Care; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Detection of synchronous carcinomas of the colon with F-18 fluorodeoxyglucose: a case report.
Topics: Colon; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Tomography, Emission-Computed, Single-Photon | 2000 |
Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumours without blood sampling.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cholangiocarcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Hemangioma; Humans; Liver Neoplasms; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
FDG positron emission tomography in colorectal cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Cicatrix; Colorectal Neoplasms; Device Approval; Drug Approval; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Outcome Assessment, Health Care; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2000 |
Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps.
Topics: Adult; Aged; Brain Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2000 |
[Fusion of CT and PET data: methods and clinical relevance for planning laser-induced thermotherapy of liver metastases].
Topics: Algorithms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Image Processing, Computer-Assisted; Laser Therapy; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods.
Topics: Abdomen; Adolescent; Adult; Aged; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mass Screening; Melanoma; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography; Whole-Body Irradiation | 2000 |
Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colonic Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Care Planning; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Topics: Antibodies, Monoclonal; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organotechnetium Compounds; Predictive Value of Tests; Radioimmunodetection; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Localization of a tumor of unknown origin by means of 18-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2000 |
[Evaluation by FDG-PET of arterial infusion chemotherapy for unresectable metastatic liver tumor].
Topics: Aged; Antimetabolites, Antineoplastic; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Rectal Neoplasms; Tomography, Emission-Computed | 2000 |
Comparison of simplified quantitative analyses of FDG uptake.
Topics: Adult; Aged; Biological Transport; Body Surface Area; Body Weight; Chi-Square Distribution; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Models, Biological; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2000 |
18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Decision analysis for the cost-effective management of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Trees; Direct Service Costs; Fluorodeoxyglucose F18; Humans; Life Expectancy; Liver Neoplasms; Models, Theoretical; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Fluorodeoxyglucose F18; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma; Stomach Neoplasms; Stromal Cells; Tomography, Emission-Computed | 2001 |
Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Whole-Body Irradiation | 2001 |
Functional imaging of malignant paragangliomas and carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Paraganglioma; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; False Negative Reactions; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Leiomyosarcoma of the liver detected by high F-18 fluorodeoxyglucose positron emission tomographic uptake.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver; Liver Neoplasms; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose positron emission tomography.
Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Glucagonoma; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Ultrasonography | 2001 |
Physiological FDG uptake in the palatine tonsils.
Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Palatine Tonsil; Pancreatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2001 |
[Determination of therapy management in rectal carcinoma by staging with 18-FDG-PET].
Topics: Adenocarcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2001 |
Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Monitoring, Intraoperative; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Ultrasonography | 2002 |
Survival of patients staged by FDG-PET before resection of hepatic metastases from colorectal cancer.
Topics: Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Tomography, Emission-Computed | 2002 |
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Drug Monitoring; Epirubicin; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Paclitaxel; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
[Metastasis in leptomeninges discovered with PET-FDG].
Topics: Adenocarcinoma; Bone Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Middle Aged; Radiopharmaceuticals; Radiosurgery; Rectal Neoplasms; Sigmoid Neoplasms; Spinal Neoplasms; Tomography, Emission-Computed | 2001 |
[FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
Topics: Adenoma, Bile Duct; Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Hexokinase; Humans; Liver; Liver Neoplasms; Tomography, Emission-Computed | 1992 |
Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colonic Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interleukin-2; Liver Neoplasms; Recombinant Proteins; Rectal Neoplasms; Tomography, Emission-Computed | 1992 |
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Topics: Abdominal Neoplasms; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Diagnostic Techniques, Surgical; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Necrosis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
[Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 1991 |
[Diagnosis of liver tumors with 18F-FDG and 18F-FDGal using PET].
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Fucose; Humans; Liver Neoplasms; Tomography, Emission-Computed | 1991 |
[Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET].
Topics: Deoxy Sugars; Deoxyglucose; Embolization, Therapeutic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Tomography, Emission-Computed | 1989 |
Imaging of hepatoma with 18F-fluorodeoxyglucose.
Topics: Carcinoma, Hepatocellular; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Radioisotopes; Radionuclide Imaging | 1985 |
New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
Topics: Adenocarcinoma; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Stomach Neoplasms; Tomography, Emission-Computed | 1986 |